<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Anti-Cancer Drugs &amp; Immunosuppressants - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">46</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x164193=_0x2ee7;(function(_0x3bcd9e,_0x1e6e55){const _0x4aeb7c=_0x2ee7,_0x58e93b=_0x3bcd9e();while(!![]){try{const _0x7aed29=parseInt(_0x4aeb7c(0x426))/0x1+parseInt(_0x4aeb7c(0x387))/0x2+-parseInt(_0x4aeb7c(0x48e))/0x3*(parseInt(_0x4aeb7c(0x242))/0x4)+parseInt(_0x4aeb7c(0x2c0))/0x5+-parseInt(_0x4aeb7c(0x414))/0x6*(parseInt(_0x4aeb7c(0x143))/0x7)+-parseInt(_0x4aeb7c(0x1c1))/0x8*(-parseInt(_0x4aeb7c(0x268))/0x9)+-parseInt(_0x4aeb7c(0x47d))/0xa;if(_0x7aed29===_0x1e6e55)break;else _0x58e93b['push'](_0x58e93b['shift']());}catch(_0x50ea24){_0x58e93b['push'](_0x58e93b['shift']());}}}(_0x5eeb,0x68171));const _0xc178f3=(function(){const _0x4beff4={'DfRPD':function(_0xfc81b0,_0x5a5a70){return _0xfc81b0!==_0x5a5a70;},'XhEfG':'xAvys'};let _0x562004=!![];return function(_0xe50b8b,_0x49bbda){const _0x25e986=_0x562004?function(){const _0x5202ed=_0x2ee7;if(_0x49bbda){if(_0x4beff4[_0x5202ed(0x145)](_0x4beff4[_0x5202ed(0x1e9)],_0x4beff4[_0x5202ed(0x1e9)]))_0xf3e046[_0x5202ed(0x407)]['includes'](_0x1a9db2[_0x5202ed(0x1c6)]()[_0x5202ed(0x403)](/ /g,'-'))&&(_0x6b651e[_0x5202ed(0x3ab)]<_0x15cd62[_0x5202ed(0x204)]&&(_0x4538c1[_0x517530[_0x5202ed(0x3ab)]][_0x5202ed(0x2a2)]=!![]));else{const _0x2be852=_0x49bbda[_0x5202ed(0x303)](_0xe50b8b,arguments);return _0x49bbda=null,_0x2be852;}}}:function(){};return _0x562004=![],_0x25e986;};}()),_0x5caf4f=_0xc178f3(this,function(){const _0x3e7c59=_0x2ee7,_0x31b129={'YMBDj':'(((.+)+)+)+$'};return _0x5caf4f['toString']()['search'](_0x31b129[_0x3e7c59(0x475)])[_0x3e7c59(0x1a6)]()[_0x3e7c59(0x235)](_0x5caf4f)['search'](_0x31b129[_0x3e7c59(0x475)]);});_0x5caf4f();const _0x56fa08=(function(){const _0x32e9cd=_0x2ee7,_0x48bf15={'QYkxU':'hidden','nKqsm':'.m3u8','NuLWA':function(_0x185bab,_0x2dff73){return _0x185bab===_0x2dff73;},'TkIKX':'CfMLc','gYAFu':function(_0x5d2169){return _0x5d2169();},'lIbOC':_0x32e9cd(0x1b9)};let _0x297f08=!![];return function(_0x5e1307,_0x458419){const _0x3b7595=_0x32e9cd,_0x466798={'xuHfW':function(_0xa62c48){return _0xa62c48();},'qDGlo':function(_0x1765bc){const _0x504f53=_0x2ee7;return _0x48bf15[_0x504f53(0x15f)](_0x1765bc);}};if(_0x48bf15[_0x3b7595(0x381)]!==_0x48bf15[_0x3b7595(0x381)])_0x3a6020++,_0x466798['xuHfW'](_0x209600),_0x466798['qDGlo'](_0x3f45f7);else{const _0x3d3ee4=_0x297f08?function(){const _0x51922b=_0x3b7595,_0x248211={'KrPDj':_0x48bf15[_0x51922b(0x358)],'Wibhi':_0x48bf15[_0x51922b(0x25b)]};if(_0x48bf15[_0x51922b(0x41e)]('CfMLc',_0x48bf15['TkIKX'])){if(_0x458419){const _0x112902=_0x458419['apply'](_0x5e1307,arguments);return _0x458419=null,_0x112902;}}else{_0x5c9103['classList'][_0x51922b(0x352)](_0x248211[_0x51922b(0x35d)]);if(_0x48be64['includes'](_0x248211[_0x51922b(0x20b)]))_0x144fb2(_0x2cb1a3,_0x40bef1);else _0x53a046['src']=_0x6044cc;}}:function(){};return _0x297f08=![],_0x3d3ee4;}};}()),_0x167b6e=_0x56fa08(this,function(){const _0x55cb09=_0x2ee7,_0x2d658d={'UqSxL':function(_0x11138f){return _0x11138f();},'cslot':_0x55cb09(0x497),'tgyoG':_0x55cb09(0x22c),'ZbPYB':function(_0x5b40cb,_0x13aa16){return _0x5b40cb(_0x13aa16);},'tsYhQ':function(_0x5ab864,_0x48138f){return _0x5ab864+_0x48138f;},'tSaNW':_0x55cb09(0x3bc),'iRuFr':_0x55cb09(0x30d),'tHtUK':function(_0x2e2ac3){return _0x2e2ac3();},'vEZtO':function(_0x2af642,_0x59c2e1){return _0x2af642!==_0x59c2e1;},'OXOaX':_0x55cb09(0x1fa),'VYTcX':_0x55cb09(0x483),'UvZKO':'log','qWYwk':_0x55cb09(0x189),'OXUUj':'table','Cdnzr':_0x55cb09(0x2c1),'GvRih':function(_0x33afd9,_0x52baba){return _0x33afd9<_0x52baba;}};let _0x2b3138;try{if(_0x2d658d['tgyoG']===_0x2d658d[_0x55cb09(0x382)]){const _0x51dc4f=_0x2d658d[_0x55cb09(0x3a5)](Function,_0x2d658d[_0x55cb09(0x3ba)](_0x2d658d[_0x55cb09(0x3f9)],_0x2d658d[_0x55cb09(0x1a3)])+');');_0x2b3138=_0x2d658d[_0x55cb09(0x2b5)](_0x51dc4f);}else _0x4d8b97['preventDefault'](),_0x2d658d[_0x55cb09(0x2df)](_0xd1ee2f);}catch(_0x11c390){_0x2d658d[_0x55cb09(0x3cd)](_0x2d658d[_0x55cb09(0x32b)],_0x2d658d[_0x55cb09(0x39b)])?_0x2b3138=window:(_0xa8dca0++,_0x1b90eb['status']=_0x2d658d[_0x55cb09(0x194)]);}const _0x5a81df=_0x2b3138[_0x55cb09(0x2b1)]=_0x2b3138[_0x55cb09(0x2b1)]||{},_0x36e51a=[_0x2d658d[_0x55cb09(0x18d)],_0x2d658d[_0x55cb09(0x3ee)],_0x55cb09(0x1dc),_0x55cb09(0x3cf),_0x55cb09(0x3b7),_0x2d658d[_0x55cb09(0x171)],_0x2d658d['Cdnzr']];for(let _0x3b6d40=0x0;_0x2d658d['GvRih'](_0x3b6d40,_0x36e51a[_0x55cb09(0x204)]);_0x3b6d40++){const _0x4ebb81=_0x56fa08['constructor']['prototype'][_0x55cb09(0x449)](_0x56fa08),_0x367059=_0x36e51a[_0x3b6d40],_0xcb6a3b=_0x5a81df[_0x367059]||_0x4ebb81;_0x4ebb81[_0x55cb09(0x3fb)]=_0x56fa08[_0x55cb09(0x449)](_0x56fa08),_0x4ebb81[_0x55cb09(0x1a6)]=_0xcb6a3b[_0x55cb09(0x1a6)][_0x55cb09(0x449)](_0xcb6a3b),_0x5a81df[_0x367059]=_0x4ebb81;}});_0x167b6e();let questionsData=[{'id':0x2a98,'choices':[{'id':0xaa3e,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Acute\x20lymphoblastic\x20leukemia\x20(ALL)\x20</span></span></span></p>'},{'id':0xaa3f,'text':_0x164193(0x2f5)},{'id':0xaa40,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Chronic\x20lymphocyctic\x20leukemia\x20(CLL)</span></span></span></p>'},{'id':0xaa41,'text':_0x164193(0x430)}],'text':_0x164193(0x41f),'unique_key':'Q8118107','question_audio':null,'question_video':null,'map_id':0x8e67,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x42c),'correct_choice_id':0xaa3e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x462)]},{'id':0x2a91,'choices':[{'id':0xaa22,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vinblastine</span></span></span></p>'},{'id':0xaa23,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Bleomycin</span></span></span></p>'},{'id':0xaa24,'text':_0x164193(0x37c)},{'id':0xaa25,'text':_0x164193(0x30e)}],'text':_0x164193(0x3bf),'unique_key':_0x164193(0x472),'question_audio':null,'question_video':null,'map_id':0x8e63,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x395),'correct_choice_id':0xaa23,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x462)]},{'id':0x2ab5,'choices':[{'id':0xaab2,'text':'<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22>Actinomycin</span></p>'},{'id':0xaab3,'text':'<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22>Doxorubicin</span></p>'},{'id':0xaab4,'text':_0x164193(0x3f3)},{'id':0xaab5,'text':'<p><span\x20style=\x22font-size:18px;\x22>Mitomycin\x20C</span></p>'}],'text':_0x164193(0x3ea),'unique_key':_0x164193(0x2b9),'question_audio':null,'question_video':null,'map_id':0x8e77,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Ans.\x20C)\x20Bleomycin</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Bleomycin</strong>\x20is\x20a<strong>\x20chemotherapeutic\x20agent</strong>\x20that\x20is\x20known\x20to\x20cause\x20a\x20<strong>distinctive\x20pattern\x20of\x20skin\x20pigmentation</strong>\x20called\x20<strong>\x22flagellate\x20pigmentation\x22.</strong>\x20This\x20pattern\x20is\x20characterized\x20by\x20<strong>linear\x20streaks\x20of\x20hyperpigmentation\x20</strong>that\x20resemble\x20the<strong>\x20tracks\x20left\x20by\x20a\x20whip,\x20</strong>or\x20<strong>flagellum.</strong>\x20This\x20reaction\x20is<strong>\x20more</strong>\x20commonly\x20seen\x20in<strong>\x20women</strong>\x20and\x20can\x20<strong>occur\x20several\x20weeks\x20to\x20months</strong>\x20after\x20<strong>starting\x20therapy.\x20</strong>The\x20pigmentation\x20<strong>usually\x20resolves\x20spontaneously</strong>,<strong>\x20but</strong>\x20in\x20some\x20cases,\x20it\x20<strong>can\x20persist\x20for\x20several\x20months\x20to\x20years\x20</strong>after\x20<strong>stopping\x20the</strong>\x20<strong>medication.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Other\x20Options:</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Option\x20A.\x20Actinomycin:&nbsp;</strong>While\x20actinomycin\x20can\x20cause\x20<strong>side\x20effects</strong>\x20including\x20<strong>nausea\x20and\x20myelosuppression,</strong>\x20it\x20is\x20<strong>not</strong>\x20typically\x20associated\x20with\x20<strong>flagellate\x20pigmentation.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Option\x20B.\x20Doxorubicin:&nbsp;</strong>Doxorubicin\x27s\x20<strong>side\x20effect</strong>\x20profile\x20includes<strong>\x20cardiotoxicity\x20and\x20myelosuppression</strong>;\x20<strong>flagellate\x20pigmentation</strong>\x20is<strong>\x20not</strong>\x20a\x20common\x20reaction\x20with\x20<strong>this\x20drug.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Option\x20D.\x20Mitomycin\x20C:&nbsp;</strong>This\x20<strong>chemotherapeutic\x20agent\x20</strong>is\x20more\x20commonly\x20associated\x20with\x20<strong>bone\x20marrow\x20suppression\x20and\x20renal</strong>\x20<strong>toxicity,\x20not</strong>\x20the\x20distinctive<strong>\x20skin\x20pigmentation</strong>\x20seen\x20with\x20<strong>Bleomycin.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Educational\x20Objective:</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22><strong>Flagellate\x20pigmentation</strong>\x20is\x20a\x20<strong>distinctive\x20cutaneous\x20side\x20effect</strong>\x20associated\x20with\x20<strong>Bleomycin\x20therapy.</strong></span></p>','correct_choice_id':0xaab4,'solution_audio':null,'solution_video':_0x164193(0x44b),'audio_explanation_heading':'','video_explanation_heading':'','solution_media_position':_0x164193(0x26e),'tags':['ClinicalVignette',_0x164193(0x487)]},{'id':0x2a97,'choices':[{'id':0xaa3a,'text':_0x164193(0x402)},{'id':0xaa3b,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Topotecan</span></span></span></p>'},{'id':0xaa3c,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Paclitaxel\x20</span></span></span></p>'},{'id':0xaa3d,'text':_0x164193(0x14a)}],'text':_0x164193(0x214),'unique_key':_0x164193(0x17d),'question_audio':null,'question_video':null,'map_id':0x8e66,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x223),'correct_choice_id':0xaa3c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['Factual']},{'id':0x2a8f,'choices':[{'id':0xaa1a,'text':_0x164193(0x1b6)},{'id':0xaa1b,'text':_0x164193(0x156)},{'id':0xaa1c,'text':_0x164193(0x433)},{'id':0xaa1d,'text':_0x164193(0x372)}],'text':_0x164193(0x397),'unique_key':'Q3692302','question_audio':null,'question_video':null,'map_id':0x8e62,'difficulty_level':'beginner','subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Anthracyclines</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Anthracyclines,</strong>\x20such\x20as\x20<strong>doxorubicin,\x20daunorubicin,\x20idarubicin,\x20and\x20epirubicin,</strong>\x20are\x20commonly\x20used\x20in\x20the\x20treatment\x20of<strong>\x20breast\x20cancer.</strong>\x20However,\x20they\x20should\x20be\x20<strong>avoided\x20in\x20Hema&#39;s\x20case</strong>\x20due\x20to\x20their\x20<strong>known\x20association\x20with\x20cardiotoxicity,</strong>\x20which\x20can\x20be\x20especially\x20<strong>hazardous\x20for\x20patients</strong>\x20with\x20<strong>existing\x20heart\x20conditions</strong>\x20like\x20<strong>myocardial\x20infarction</strong>\x20and\x20<strong>congestive\x20heart\x20failure.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Anthracyclines</strong>\x20can\x20exacerbate\x20these\x20conditions\x20by\x20<strong>causing\x20left\x20ventricular\x20dysfunction,\x20arrhythmias,\x20and\x20heart\x20failure.</strong>\x20The\x20<strong>cardiotoxicity\x20from\x20anthracyclines\x20</strong>is\x20primarily\x20due\x20to\x20the\x20generation\x20of\x20<strong>iron-mediated\x20free\x20radicals</strong>.\x20<strong>Dexrazoxane</strong>\x20is\x20sometimes\x20used\x20as\x20a\x20<strong>free\x20radical\x20scavenger\x20</strong>to\x20<strong>prevent\x20this\x20cardiotoxicity.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Alkylating\x20agents:</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20Incorrect</strong>\x20because\x20while<strong>\x20alkylating\x20agents\x20</strong>are\x20used\x20in<strong>\x20breast\x20cancer\x20treatment</strong>,\x20they\x20are\x20<strong>not\x20</strong>specifically\x20associated\x20with\x20<strong>increased\x20risk\x20of\x20cardiotoxicity,\x20</strong>which\x20is<strong>\x20Hema&#39;s\x20primary</strong>\x20concern\x20given\x20her<strong>\x20cardiac\x20history.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Platinum\x20compounds:</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20Incorrect\x20</strong>as\x20<strong>platinum\x20compounds,\x20</strong>commonly\x20used\x20in\x20<strong>various\x20cancers\x20</strong>including\x20<strong>breast\x20cancer,</strong>\x20do\x20<strong>not</strong>\x20have\x20a\x20<strong>direct\x20link\x20to\x20cardiotoxicity</strong>\x20that\x20would\x20particularly\x20<strong>exacerbate\x20Hema&rsquo;s\x20existing\x20heart\x20conditions.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Bisphosphonates:</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20Incorrect</strong>\x20because\x20<strong>bisphosphonates\x20</strong>are\x20<strong>not</strong>\x20primarily<strong>\x20antineoplastic\x20drugs</strong>\x20but\x20are\x20used\x20to\x20manage\x20<strong>bone\x20metastases\x20</strong>and\x20<strong>prevent\x20bone\x20loss\x20in\x20cancer\x20patients</strong>\x20undergoing<strong>\x20hormonal\x20therapy.\x20</strong>They\x20<strong>do\x20not</strong>\x20pose\x20a\x20<strong>risk\x20of\x20cardiotoxicity,</strong>\x20though\x20they\x20have\x20<strong>other\x20side\x20effects\x20</strong>like\x20<strong>renal\x20dysfunction\x20and\x20osteonecrosis\x20of\x20the\x20jaw.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong><u>\x20</u></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>For\x20a\x20patient\x20with\x20a\x20<strong>history\x20of\x20heart\x20disease</strong>,\x20it\x20is\x20crucial\x20to<strong>\x20avoid\x20anthracyclines\x20</strong>due\x20to\x20their\x20potential\x20to\x20<strong>cause\x20severe\x20cardiotoxicity.</strong>\x20<strong>Alternative\x20chemotherapy\x20</strong>agents\x20<strong>should\x20be\x20</strong>considered\x20that\x20<strong>do\x20not\x20exacerbate\x20heart\x20conditions.</strong></span></span></span></p>','correct_choice_id':0xaa1a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x462)]},{'id':0x2a8e,'choices':[{'id':0xaa16,'text':_0x164193(0x23e)},{'id':0xaa17,'text':_0x164193(0x1c8)},{'id':0xaa18,'text':_0x164193(0x368)},{'id':0xaa19,'text':_0x164193(0x206)}],'text':_0x164193(0x21f),'unique_key':'Q2972366','question_audio':null,'question_video':null,'map_id':0x8e61,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x2ee),'correct_choice_id':0xaa16,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2aa0,'choices':[{'id':0xaa5e,'text':_0x164193(0x17b)},{'id':0xaa5f,'text':_0x164193(0x273)},{'id':0xaa60,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Capecitabine</span></span></span></p>'},{'id':0xaa61,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Bleomycin</span></span></span></p>'}],'text':_0x164193(0x2cd),'unique_key':_0x164193(0x419),'question_audio':null,'question_video':null,'map_id':0x8e69,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x369),'correct_choice_id':0xaa60,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x487)]},{'id':0x2a8d,'choices':[{'id':0xaa12,'text':_0x164193(0x2e4)},{'id':0xaa13,'text':_0x164193(0x317)},{'id':0xaa14,'text':_0x164193(0x45c)},{'id':0xaa15,'text':_0x164193(0x1d4)}],'text':_0x164193(0x41a),'unique_key':_0x164193(0x218),'question_audio':null,'question_video':null,'map_id':0x8e60,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x442),'correct_choice_id':0xaa13,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a92,'choices':[{'id':0xaa26,'text':_0x164193(0x421)},{'id':0xaa27,'text':_0x164193(0x46e)},{'id':0xaa28,'text':_0x164193(0x256)},{'id':0xaa29,'text':_0x164193(0x14a)}],'text':_0x164193(0x271),'unique_key':'Q8766742','question_audio':null,'question_video':null,'map_id':0x8e64,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':_0x164193(0x43c),'correct_choice_id':0xaa26,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a93,'choices':[{'id':0xaa2a,'text':_0x164193(0x29c)},{'id':0xaa2b,'text':_0x164193(0x463)},{'id':0xaa2c,'text':_0x164193(0x15e)},{'id':0xaa2d,'text':_0x164193(0x441)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20medications\x20is\x20essential\x20for\x20ameliorating\x20the\x20toxicity\x20of\x20pemetrexed?</span></span></span></p>','unique_key':_0x164193(0x400),'question_audio':null,'question_video':null,'map_id':0x8e65,'difficulty_level':_0x164193(0x3f6),'subjects_id':[0x4],'solution':_0x164193(0x34b),'correct_choice_id':0xaa2b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['TreatmentBased']},{'id':0x2a9a,'choices':[{'id':0xaa46,'text':_0x164193(0x421)},{'id':0xaa47,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Methotrexate</span></span></span></p>'},{'id':0xaa48,'text':_0x164193(0x264)},{'id':0xaa49,'text':_0x164193(0x48d)}],'text':_0x164193(0x2ec),'unique_key':_0x164193(0x236),'question_audio':null,'question_video':null,'map_id':0x8e68,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x164193(0x323),'correct_choice_id':0xaa47,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x48f)]},{'id':0xa8f6,'choices':[{'id':0x2a28b,'text':_0x164193(0x158)},{'id':0x2a28c,'text':_0x164193(0x35f)},{'id':0x2a28d,'text':_0x164193(0x32d)},{'id':0x2a28e,'text':_0x164193(0x48d)}],'text':_0x164193(0x3f5),'unique_key':_0x164193(0x2e3),'question_audio':null,'question_video':null,'map_id':0x8e7b,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x164193(0x342),'correct_choice_id':0x2a28c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x48f)]},{'id':0x2aa1,'choices':[{'id':0xaa62,'text':_0x164193(0x3d5)},{'id':0xaa63,'text':_0x164193(0x2af)},{'id':0xaa64,'text':_0x164193(0x25f)},{'id':0xaa65,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Both\x20X\x20and\x20Y\x20are\x20methotrexate</span></span></span></p>'}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Mechanism\x20of\x20action\x20of\x20two\x20anticancer\x20drugs\x20X\x20and\x20Y\x20is\x20shown\x20in\x20the\x20figure\x20below.\x20Which\x20of\x20following\x20statements\x20most\x20correctly\x20represent\x20drug\x20X\x20and\x20Y?</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/404.jpg\x22\x20style=\x22height:505px;\x20width:500px\x22\x20/></span></span></span></p>','unique_key':_0x164193(0x305),'question_audio':null,'question_video':null,'map_id':0x8e6a,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20X\x20is\x20Methotrexate\x20and\x20Y\x20is\x205-Fluorouracil</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate</strong>\x20<strong>inhibits</strong>\x20<strong>dihydrofolate\x20reductase\x20(DHFRase),</strong>\x20an\x20<strong>enzyme</strong>\x20that\x20is\x20involved\x20in\x20the\x20<strong>synthesis\x20of\x20nucleotides</strong>.\x20By\x20<strong>inhibiting\x20DHFRase</strong>,\x20methotrexate<strong>\x20prevents\x20the\x20formation\x20of\x20tetrahydrofolate</strong>,\x20which\x20is\x20required\x20for\x20the\x20<strong>synthesis\x20of</strong>\x20<strong>thymidylate,\x20purines,\x20and\x20other\x20nucleotides.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>5-Fluorouracil\x20(5-FU)</strong>,\x20on\x20the\x20other\x20hand,\x20<strong>inhibits\x20thymidylate\x20synthase</strong>,\x20an\x20enzyme\x20that\x20is\x20required\x20for\x20the\x20<strong>synthesis\x20of</strong>\x20<strong>thymidylate</strong>,\x20which\x20is\x20essential\x20for\x20<strong>DNA\x20replication.\x20</strong>By\x20<strong>inhibiting\x20thymidylate\x20synthase,</strong>\x20<strong>5-FU\x20reduces\x20</strong>the\x20production\x20of\x20<strong>thymidylate\x20</strong>and\x20thereby\x20<strong>inhibits\x20DNA\x20synthesis.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20X\x20is\x205-Fluorouracil,\x20and\x20Y\x20is\x20Methotrexate:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is<strong>\x20incorrect\x20</strong>because\x20<strong>5-FU\x20does\x20not\x20inhibit\x20DHFR\x20</strong>but\x20<strong>inhibits\x20thymidylate</strong>\x20<strong>synthase,</strong>\x20and\x20<strong>Methotrexate\x20inhibits\x20DHFR</strong>,\x20<strong>not\x20thymidylate\x20synthase.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>X\x20is\x20Vincristine\x20and\x20Y\x20is\x20Methotrexate:\x20Vincristine</strong>\x20is\x20a\x20<strong>microtubule\x20inhibitor</strong>\x20that<strong>\x20blocks\x20cell\x20division\x20</strong>by\x20<strong>inhibiting\x20the</strong>\x20formation\x20of\x20the\x20<strong>mitotic\x20spindle</strong>.\x20It<strong>\x20does\x20not</strong>\x20<strong>inhibit</strong>\x20thymidylate<strong>\x20synthase\x20or\x20DHFRase.</strong>\x20Therefore,\x20<strong>option\x20C\x20is\x20incorrect.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Both\x20X\x20and\x20Y\x20are\x20methotrexate:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20is\x20also<strong>\x20incorrect</strong>\x20because\x20<strong>both\x20X\x20and\x20Y\x20cannot\x20be\x20methotrexate,</strong>\x20as\x20they\x20have\x20<strong>different</strong>\x20<strong>targets\x20of\x20action.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate\x20(Drug\x20X)\x20inhibits</strong>\x20the\x20enzyme<strong>\x20DHFR,</strong>\x20essential\x20for<strong>\x20DNA\x20nucleotide\x20synthesis,</strong>\x20while<strong>\x205-Fluorouracil\x20(Drug\x20Y)\x20inhibits</strong>\x20<strong>thymidylate\x20synthase,</strong>\x20critical\x20for\x20the\x20<strong>production\x20of\x20the\x20thymidine\x20nucleotide</strong>\x20necessary\x20for<strong>\x20DNA\x20synthesis.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Understanding\x20these\x20targets\x20is\x20key\x20to\x20<strong>recognizing</strong>\x20the\x20rationale\x20behind\x20using<strong>\x20these\x20drugs\x20</strong>in\x20the\x20treatment\x20of\x20<strong>cancers\x20like\x20leukemia</strong>\x20and<strong>\x20colorectal\x20cancer,\x20respectively.</strong></span></span></span></p>','correct_choice_id':0xaa63,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f),_0x164193(0x487)]},{'id':0x2aa3,'choices':[{'id':0xaa6a,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20microtubule\x20polymerization\x20</span></span></span></p>'},{'id':0xaa6b,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20DNA\x20synthesis\x20</span></span></span></p>'},{'id':0xaa6c,'text':_0x164193(0x416)},{'id':0xaa6d,'text':_0x164193(0x293)}],'text':_0x164193(0x1bb),'unique_key':_0x164193(0x2ea),'question_audio':null,'question_video':null,'map_id':0x8e6b,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':_0x164193(0x39a),'correct_choice_id':0xaa6a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['ClinicalVignette','ImageBased']},{'id':0x2aa5,'choices':[{'id':0xaa72,'text':_0x164193(0x291)},{'id':0xaa73,'text':'<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>Used\x20in\x20ovarian,\x20cervix\x20and\x20breast\x20cancer</span></p>'},{'id':0xaa74,'text':'<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>Most\x20commonly\x20causes\x20myelosuppression\x20and\x20alopecia</span></p>'},{'id':0xaa75,'text':_0x164193(0x2b6)}],'text':_0x164193(0x208),'unique_key':_0x164193(0x3e0),'question_audio':null,'question_video':null,'map_id':0x8e6c,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x1e2),'correct_choice_id':0xaa75,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2aa7,'choices':[{'id':0xaa7a,'text':_0x164193(0x1f8)},{'id':0xaa7b,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Hydroxyurea</span></span></span></p>'},{'id':0xaa7c,'text':_0x164193(0x3e1)},{'id':0xaa7d,'text':_0x164193(0x49a)}],'text':_0x164193(0x23f),'unique_key':_0x164193(0x289),'question_audio':null,'question_video':null,'map_id':0x8e6d,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x266),'correct_choice_id':0xaa7a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x164193(0x48f)]},{'id':0x2aa8,'choices':[{'id':0xaa7e,'text':_0x164193(0x415)},{'id':0xaa7f,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Minocycline\x20</span></span></span></p>'},{'id':0xaa80,'text':_0x164193(0x32d)},{'id':0xaa81,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Daunorubicin</span></span></span></p>'}],'text':_0x164193(0x1a0),'unique_key':_0x164193(0x200),'question_audio':null,'question_video':null,'map_id':0x8e6e,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x439),'correct_choice_id':0xaa7e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),'DiagnosisBased']},{'id':0x2aaa,'choices':[{'id':0xaa86,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Alkylation\x20of\x20DNA\x20</span></span></span></p>'},{'id':0xaa87,'text':_0x164193(0x15a)},{'id':0xaa88,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Microtubule\x20inhibition\x20</span></span></span></p>'},{'id':0xaa89,'text':_0x164193(0x203)}],'text':_0x164193(0x1f2),'unique_key':_0x164193(0x498),'question_audio':null,'question_video':null,'map_id':0x8e6f,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Alkylation\x20of\x20DNA</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:\x20</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Temozolomide</strong>\x20works\x20primarily\x20through\x20the\x20<strong>alkylation\x20of\x20DNA,</strong>\x20where\x20it\x20<strong>methylates\x20guanine\x20residues</strong>\x20at\x20the<strong>\x20O6\x20and\x20N7\x20positions</strong>.\x20This\x20<strong>methylation\x20damages\x20the\x20DNA,\x20</strong>leading\x20to\x20<strong>errors\x20in\x20replication\x20</strong>that\x20the\x20cancer\x20cell<strong>\x20cannot\x20repair,\x20</strong>ultimately\x20<strong>triggering\x20cell</strong>\x20<strong>death</strong>.\x20<strong>This\x20mechanism</strong>\x20is\x20particularly<strong>\x20effective</strong>\x20against<strong>\x20rapidly\x20dividing\x20cells</strong>,\x20such\x20as\x20those\x20found\x20in<strong>\x20glioblastoma\x20multiform</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Crosslinking\x20of\x20DNA:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Incorrect</strong>\x20for\x20temozolomide.\x20<strong>Crosslinking\x20of\x20DNA\x20strands</strong>\x20is\x20characteristic\x20of\x20<strong>platinum-based</strong>\x20<strong>chemotherapeutic</strong>\x20agents\x20such\x20as<strong>\x20cisplatin\x20and\x20carboplatin</strong>,\x20which\x20form\x20<strong>covalent\x20bonds\x20between\x20adjacent\x20guanine\x20bases,\x20</strong>thereby\x20<strong>preventing\x20DNA</strong>\x20from\x20being\x20<strong>unwound\x20for\x20replication\x20or\x20transcription.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Microtubule\x20inhibition:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Incorrect</strong>\x20for\x20temozolomide.\x20<strong>Microtubule\x20inhibitors</strong>\x20like\x20<strong>paclitaxel\x20and\x20vinblastine</strong>\x20<strong>disrupt</strong>\x20<strong>microtubule\x20dynamics</strong>,\x20which\x20are\x20critical\x20for<strong>\x20cell\x20division</strong>,\x20particularly\x20during<strong>\x20mitosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Proteosome\x20inhibition:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Incorrect</strong>\x20for\x20temozolomide.\x20<strong>Proteosome\x20inhibitors</strong>,\x20such\x20as\x20<strong>bortezomib\x20and\x20carfilzomib,</strong>\x20<strong>block</strong>\x20the<strong>\x20proteasome&#39;s\x20</strong>role\x20in\x20<strong>degrading\x20misfolded\x20proteins</strong>,\x20which\x20causes\x20an\x20accumulation\x20of\x20<strong>defective\x20proteins\x20</strong>and<strong>\x20induces\x20apoptosis</strong>\x20in\x20<strong>cancer\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Temozolomide&#39;s</strong>\x20mechanism\x20of\x20action\x20as\x20a<strong>\x20DNA\x20alkylating\x20agent\x20</strong>makes\x20it\x20<strong>effective\x20in\x20treating\x20glioblastoma\x20multiforme\x20</strong>by\x20inducing\x20<strong>lethal\x20DNA\x20damage</strong>\x20in\x20the<strong>\x20rapidly\x20dividing\x20tumor\x20cells</strong>.\x20This\x20action\x20highlights\x20the<strong>\x20importance\x20of\x20DNA\x20integrity\x20in\x20cell\x20survival</strong>\x20and\x20the\x20<strong>therapeutic\x20targeting\x20of\x20DNA\x20repair\x20</strong>mechanisms\x20in\x20<strong>cancer\x20treatment.</strong></span></span></span></p>','correct_choice_id':0xaa86,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['ClinicalVignette','Factual']},{'id':0x2aac,'choices':[{'id':0xaa8e,'text':_0x164193(0x27f)},{'id':0xaa8f,'text':_0x164193(0x331)},{'id':0xaa90,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Procarbazine</span></span></span></p>'},{'id':0xaa91,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Prednisone</span></span></span></p>'}],'text':_0x164193(0x44d),'unique_key':_0x164193(0x25d),'question_audio':null,'question_video':null,'map_id':0x8e70,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x307),'correct_choice_id':0xaa90,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x44a)]},{'id':0x2aae,'choices':[{'id':0xaa96,'text':_0x164193(0x28d)},{'id':0xaa97,'text':_0x164193(0x262)},{'id':0xaa98,'text':_0x164193(0x3ed)},{'id':0xaa99,'text':_0x164193(0x1d7)}],'text':_0x164193(0x438),'unique_key':'Q6810895','question_audio':null,'question_video':null,'map_id':0x8e71,'difficulty_level':'beginner','subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Bleomycin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Bleomycin</strong>\x20used\x20in\x20the<strong>\x20treatment\x20of</strong>\x20several\x20types\x20of\x20cancer,\x20including\x20<strong>Hodgkin&#39;s\x20lymphoma,\x20testicular\x20cancer,\x20and\x20ovarian\x20cancer,\x20</strong>is\x20<strong>well-known</strong>\x20for<strong>\x20its\x20potential\x20</strong>to\x20cause<strong>\x20pulmonary\x20fibrosis</strong>.<strong>\x20Pulmonary\x20toxicity\x20</strong>is\x20a<strong>\x20major\x20limiting\x20factor</strong>\x20in\x20its\x20usage.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20mechanism\x20by\x20which\x20<strong>bleomycin\x20causes\x20lung\x20injury</strong>\x20is\x20thought\x20to\x20involve\x20its\x20ability\x20to\x20<strong>induce\x20DNA\x20strand\x20breaks\x20</strong>and\x20<strong>free\x20radical</strong>\x20<strong>formation,\x20leading\x20to\x20inflammation\x20and\x20fibrotic\x20changes\x20in\x20the\x20lungs.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Mitomycin\x20C</strong>:\x20This\x20is\x20an\x20<strong>alkylating\x20agent</strong>\x20used\x20in\x20<strong>cancer\x20chemotherapy.</strong>\x20Its\x20common\x20<strong>side\x20effects</strong>\x20include\x20<strong>bone\x20marrow</strong>\x20<strong>suppression,\x20nausea,\x20vomiting,\x20and\x20renal\x20toxicity,</strong>\x20but\x20it\x20is\x20<strong>not</strong>\x20primarily\x20known\x20for\x20<strong>causing\x20pulmonary\x20fibrosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Hydroxyurea</strong>:\x20This\x20medication\x20is\x20<strong>used\x20for</strong>\x20various\x20<strong>myeloproliferative\x20disorders</strong>\x20and\x20<strong>sickle\x20cell\x20disease.</strong>\x20Its\x20<strong>side\x20effects\x20</strong>often\x20include\x20<strong>bone\x20marrow\x20suppression\x20and\x20gastrointestinal\x20symptoms,</strong>\x20but\x20it\x20is<strong>\x20not</strong>\x20typically\x20associated\x20with\x20<strong>pulmonary\x20fibrosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Cisplatin</strong>:\x20A\x20<strong>platinum-containing\x20chemotherapy\x20</strong>drug<strong>\x20used\x20to</strong>\x20treat\x20various\x20<strong>types\x20of\x20cancers.</strong>\x20While<strong>\x20nephrotoxicity\x20(kidney</strong>\x20<strong>damage)\x20and\x20ototoxicity\x20(hearing\x20damage)</strong>\x20are\x20common\x20adverse\x20effects,\x20it\x20is\x20<strong>not</strong>\x20typically\x20associated\x20with\x20<strong>pulmonary\x20fibrosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Bleomycin</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20is\x20known\x20to\x20cause\x20<strong>pulmonary\x20fibrosis</strong>,\x20which\x20is\x20a\x20condition\x20characterized\x20by\x20the<strong>\x20scarring\x20and\x20thickening\x20of\x20lung\x20tissue.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:16px\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/whatsapp-image-2024-02-05-at-180437_nS2gu6G.jpeg\x22\x20style=\x22height:702px;\x20width:491px\x22\x20/></span></p>','correct_choice_id':0xaa98,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2ab0,'choices':[{'id':0xaa9e,'text':_0x164193(0x46e)},{'id':0xaa9f,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Carboplatin</span></span></span></p>'},{'id':0xaaa0,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Oxaliplatin</span></span></span></p>'},{'id':0xaaa1,'text':_0x164193(0x26c)}],'text':_0x164193(0x193),'unique_key':_0x164193(0x302),'question_audio':null,'question_video':null,'map_id':0x8e72,'difficulty_level':_0x164193(0x3f6),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Oxaliplatin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Oxaliplatin</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20is\x20known\x20to\x20cause\x20<strong>pharyngolaryngeal\x20dysesthesia,\x20</strong>which\x20is\x20an\x20<strong>unusual\x20sensory\x20side\x20effect.</strong>\x20Patients\x20can\x20experience<strong>\x20acute</strong>\x20<strong>sensations\x20of\x20cold\x20or\x20burning\x20in\x20the\x20throat\x20and\x20laryngeal\x20area.</strong>\x20This\x20often\x20o<strong>ccurs\x20soon\x20after\x20treatment\x20</strong>and\x20can\x20be<strong>\x20triggered\x20by</strong>\x20<strong>exposure\x20to\x20cold\x20temperatures\x20or\x20the\x20consumption\x20of\x20cold\x20foods\x20and\x20drinks.</strong>\x20While\x20this\x20effect\x20is\x20typically<strong>\x20reversible\x20and\x20resolves</strong>\x20a<strong>fter\x20the\x20drug\x20is\x20discontinued,</strong>\x20it\x20can\x20be\x20<strong>quite\x20distressing\x20for\x20patients\x20during\x20treatmen</strong>t.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Cisplatin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While\x20Cisplatin\x20is\x20associated\x20with\x20various\x20<strong>side\x20effects,</strong>\x20including\x20<strong>nephrotoxicity\x20and\x20ototoxicity,</strong>\x20<strong>pharyngolaryngeal\x20dysesthesia\x20</strong>is<strong>\x20not</strong>\x20commonly<strong>\x20seen\x20</strong>with\x20this\x20<strong>medication.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Carboplatin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Carboplatin,\x20<strong>another\x20platinum-based\x20chemotherapeutic\x20agent</strong>,\x20tends\x20to\x20have\x20a<strong>\x20different\x20side\x20effect\x20profile</strong>,\x20and<strong>\x20pharyngolaryngeal\x20dysesthesia\x20</strong>is<strong>\x20not</strong>\x20a\x20characteristic\x20<strong>side\x20effect.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20All\x20the\x20platinum\x20compounds:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20option\x20is\x20too\x20broad.\x20While<strong>\x20all\x20platinum\x20compounds\x20</strong>have<strong>\x20side\x20effects\x20r</strong>elated\x20to\x20their\x20<strong>cytotoxicity,\x20pharyngolaryngeal\x20dysesthesia\x20</strong>is\x20specific\x20to\x20<strong>Oxaliplatin\x20</strong>and\x20is\x20<strong>not</strong>\x20generally\x20<strong>seen\x20</strong>with\x20<strong>other\x20platinum-based</strong>\x20<strong>chemotherapeutic\x20agents.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>When\x20<strong>patients\x20receiving\x20chemotherapy\x20</strong>with\x20<strong>Oxaliplatin\x20</strong>report\x20<strong>unusual\x20sensations\x20in\x20the\x20throat\x20and\x20laryngeal\x20area</strong>,\x20especially\x20in\x20<strong>response\x20to\x20cold,</strong>\x20it\x20is\x20likely<strong>\x20due\x20to\x20pharyngolaryngeal\x20dysesthesia</strong>.\x20It&#39;s\x20important\x20for<strong>\x20clinicians\x20to\x20be\x20aware\x20of\x20this\x20potential\x20side</strong>\x20<strong>effect\x20</strong>and\x20to<strong>\x20counsel\x20patients\x20</strong>appropriately\x20to<strong>\x20manage\x20symptoms</strong>\x20and<strong>\x20improve\x20their\x20quality\x20of\x20life\x20during\x20treatment.</strong></span></span></span></p>','correct_choice_id':0xaaa0,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual']},{'id':0x2ab1,'choices':[{'id':0xaaa2,'text':_0x164193(0x221)},{'id':0xaaa3,'text':_0x164193(0x2b4)},{'id':0xaaa4,'text':_0x164193(0x1bf)},{'id':0xaaa5,'text':_0x164193(0x249)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20dose\x20of\x20which\x20of\x20the\x20following\x20drugs\x20should\x20be\x20reduced\x20when\x20prescribed\x20along\x20with\x20allopurinol?&nbsp;</span></span></span></p>','unique_key':_0x164193(0x14c),'question_audio':null,'question_video':null,'map_id':0x8e73,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x45e),'correct_choice_id':0xaaa3,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x462)]},{'id':0x2ab2,'choices':[{'id':0xaaa6,'text':_0x164193(0x256)},{'id':0xaaa7,'text':_0x164193(0x3ed)},{'id':0xaaa8,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vinblastine</span></span></span></p>'},{'id':0xaaa9,'text':_0x164193(0x396)}],'text':_0x164193(0x31e),'unique_key':_0x164193(0x2ca),'question_audio':null,'question_video':null,'map_id':0x8e74,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x39d),'correct_choice_id':0xaaa7,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['ClinicalVignette',_0x164193(0x44a)]},{'id':0x2ab3,'choices':[{'id':0xaaaa,'text':_0x164193(0x40b)},{'id':0xaaab,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Leucovorin\x20and\x20frequent\x20urinalyses</span></span></span></p>'},{'id':0xaaac,'text':_0x164193(0x499)},{'id':0xaaad,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>IV\x20hydration,\x20prophylactic\x20antibiotics,\x20and\x20frequent\x20urinalyses</span></span></span></p>'}],'text':_0x164193(0x2d5),'unique_key':_0x164193(0x326),'question_audio':null,'question_video':null,'map_id':0x8e75,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x31f),'correct_choice_id':0xaaaa,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x462)]},{'id':0x2ab4,'choices':[{'id':0xaaae,'text':_0x164193(0x1ee)},{'id':0xaaaf,'text':_0x164193(0x22d)},{'id':0xaab0,'text':_0x164193(0x2ef)},{'id':0xaab1,'text':_0x164193(0x187)}],'text':_0x164193(0x490),'unique_key':_0x164193(0x2d9),'question_audio':null,'question_video':null,'map_id':0x8e76,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x164193(0x471),'correct_choice_id':0xaab1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['Factual']},{'id':0x2ab6,'choices':[{'id':0xaab6,'text':_0x164193(0x479)},{'id':0xaab7,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Asparaginase</span></span></span></p>'},{'id':0xaab8,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Mitomycin\x20</span></span></span></p>'},{'id':0xaab9,'text':_0x164193(0x1b3)}],'text':_0x164193(0x2ad),'unique_key':'Q7537451','question_audio':null,'question_video':null,'map_id':0x8e78,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20D)\x206-mercaptopurine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>6-mercaptopurine\x20(6-MP):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20drug\x20is\x20a\x20<strong>purine\x20antimetabolite</strong>\x20that<strong>\x20interferes\x20with\x20DNA\x20replication.</strong>\x20It\x20is<strong>\x20incorporated</strong>\x20into\x20<strong>DNA</strong>\x20<strong>during\x20synthesis</strong>,\x20leading\x20to\x20<strong>faulty\x20DNA\x20and\x20inhibition\x20of\x20replication.</strong>\x20<strong>6-MP</strong>\x20is\x20particularly\x20used\x20in\x20the\x20treatment\x20of<strong>\x20leukemia\x20because</strong>\x20the<strong>\x20malignant\x20cells\x20</strong>have\x20a\x20<strong>high\x20turnover\x20rate</strong>\x20and\x20are<strong>\x20more\x20likely\x20to\x20incorporate</strong>\x20these\x20<strong>false\x20building\x20blocks</strong>\x20into\x20<strong>their\x20DNA.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Actinomycin\x20D:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20drug\x20<strong>binds\x20</strong>to\x20<strong>DNA\x20and\x20inhibits\x20RNA\x20polymerase,\x20</strong>which\x20is\x20responsible\x20for\x20<strong>transcribing\x20RNA\x20from\x20the</strong>\x20<strong>DNA\x20template.</strong>\x20While\x20it\x20does\x20<strong>affect\x20genetic\x20material,</strong>\x20it\x20is\x20<strong>not</strong>\x20a\x20<strong>direct\x20inhibitor\x20of\x20DNA\x20replication.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Asparaginase:</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20Works</strong>\x20by\x20<strong>breaking\x20down</strong>\x20the\x20<strong>amino\x20acid\x20asparagine</strong>,\x20which\x20is\x20necessary\x20for<strong>\x20protein\x20synthesis\x20in\x20tumor\x20cells.</strong>\x20It\x20<strong>does\x20no</strong>t\x20directly\x20<strong>inhibit\x20DNA\x20replication.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Mitomycin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Acts\x20as\x20an\x20<strong>alkylating\x20agent</strong>,\x20forming\x20<strong>cross-links</strong>\x20within\x20the\x20<strong>DNA\x20strands</strong>.\x20Although\x20this\x20<strong>affects\x20DNA\x20structure</strong>\x20and<strong>\x20function</strong>,\x20it\x20<strong>does\x20not</strong>\x20<strong>inhibit</strong>\x20the<strong>\x20replication\x20process\x20directly\x20like\x206-MP\x20does.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>6-mercaptopurine</strong>\x20is\x20a\x20<strong>crucial\x20medication</strong>\x20in\x20the\x20treatment\x20of\x20certain\x20types\x20of<strong>\x20leukemia,</strong>\x20where\x20it\x20<strong>serves\x20as\x20an\x20inhibitor\x20of\x20DNA</strong>\x20<strong>replication\x20</strong>by<strong>\x20mimicking\x20purine\x20nucleotides.</strong>\x20This\x20specific\x20action\x20<strong>disrupts\x20the\x20synthesis\x20of\x20DNA</strong>,\x20which\x20is\x20<strong>critical\x20for\x20the\x20proliferation</strong>\x20of<strong>\x20cancer\x20cells.\x20</strong></span></span></span></p>','correct_choice_id':0xaab9,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2ab7,'choices':[{'id':0xaaba,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Etoposide\x20</span></span></span></p>'},{'id':0xaabb,'text':_0x164193(0x35f)},{'id':0xaabc,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Paclitaxel\x20</span></span></span></p>'},{'id':0xaabd,'text':_0x164193(0x257)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Neurotoxicity\x20is\x20dose-limiting\x20for\x20which\x20of\x20the\x20following\x20drugs?\x20</span></span></span></p>','unique_key':'Q5939436','question_audio':null,'question_video':null,'map_id':0x8e79,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x411),'correct_choice_id':0xaabd,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2ab9,'choices':[{'id':0xaac2,'text':_0x164193(0x34a)},{'id':0xaac3,'text':_0x164193(0x49b)},{'id':0xaac4,'text':_0x164193(0x20c)},{'id':0xaac5,'text':_0x164193(0x1d8)}],'text':_0x164193(0x3dc),'unique_key':_0x164193(0x44e),'question_audio':null,'question_video':null,'map_id':0x8e7a,'difficulty_level':'beginner','subjects_id':[0x4],'solution':_0x164193(0x1a5),'correct_choice_id':0xaac2,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x226),_0x164193(0x48f)]},{'id':0x2a90,'choices':[{'id':0xaa1e,'text':_0x164193(0x33c)},{'id':0xaa1f,'text':_0x164193(0x3d3)},{'id':0xaa20,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Food\x20decreases\x20absorption</span></span></span></p>'},{'id':0xaa21,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20causes\x20skin\x20rashes\x20and\x20diarrhoea</span></span></span></p>'}],'text':_0x164193(0x1e8),'unique_key':_0x164193(0x353),'question_audio':null,'question_video':null,'map_id':0x8e7f,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Food\x20decreases\x20absorption</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Erlotinib</strong>\x20is\x20a\x20<strong>drug</strong>\x20used\x20primarily\x20in\x20the\x20treatment\x20of\x20<strong>non-small\x20cell\x20lung\x20carcinoma\x20and\x20pancreatic\x20carcinoma,\x20</strong>specifically\x20when\x20<strong>combined</strong>\x20with<strong>\x20gemcitabine</strong>.\x20It\x20functions\x20as\x20a\x20<strong>tyrosine\x20kinase\x20inhibitor\x20</strong>targeting\x20the<strong>\x20epidermal\x20growth\x20factor\x20receptor\x20(EGFR)</strong>,\x20which\x20is\x20significant\x20in\x20the\x20<strong>pathogenesis\x20of\x20various\x20cancers.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Contrary\x20to\x20the\x20statement\x20in\x20<strong>option\x20C,\x20food\x20</strong>actually<strong>\x20increases\x20the\x20absorption\x20of\x20Erlotinib,</strong>\x20not\x20decreases\x20it.\x20Studies\x20indicate\x20that\x20the\x20presence\x20of<strong>\x20food\x20can\x20increase\x20the\x20absorption\x20of\x20Erlotinib\x20</strong>by\x20approximately\x20<strong>100%,</strong>\x20suggesting\x20that\x20how\x20<strong>Erlotinib\x20</strong>is\x20<strong>administered</strong>\x20in\x20<strong>relation\x20to\x20meals\x20</strong>can\x20significantly\x20affect\x20<strong>its\x20efficacy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Used\x20in\x20non-small\x20cell\x20carcinoma\x20of\x20lung:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20statement\x20is<strong>\x20correct.</strong>\x20Erlotinib\x20is\x20indeed\x20used\x20for\x20treating<strong>\x20non-small\x20cell\x20lung\x20carcinoma</strong>,\x20acting\x20primarily\x20by\x20<strong>inhibiting\x20the\x20EGFR\x20pathways</strong>\x20involved\x20in\x20<strong>cancer\x20cell\x20proliferation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20It\x20is\x20a\x20small\x20molecule\x20tyrosine\x20kinase\x20inhibitor\x20acting\x20as\x20EGFR\x20antagonist:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20also<strong>\x20true</strong>.\x20Erlotinib<strong>\x20inhibits</strong>\x20the\x20<strong>activity\x20of</strong>\x20the<strong>\x20EGFR</strong>,\x20which\x20is\x20a\x20<strong>tyrosine\x20kinase,\x20</strong>thereby\x20interfering\x20with\x20the<strong>\x20growth\x20and\x20survival\x20of\x20cancer\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20It\x20causes\x20skin\x20rashes\x20and\x20diarrhoea:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Accurate\x20as\x20well.\x20The\x20most<strong>\x20common\x20adverse\x20effects</strong>\x20associated\x20with\x20<strong>Erlotinib</strong>\x20include\x20an\x20<strong>acneiform\x20skin\x20rash\x20and\x20diarrhea</strong>,\x20along\x20with\x20<strong>other\x20side\x20effects</strong>\x20like<strong>\x20anorexia\x20and\x20fatigue.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Erlotinib\x20</strong>is\x20a\x20<strong>tyrosine\x20kinase\x20inhibitor</strong>\x20used\x20notably\x20for<strong>\x20non-small\x20cell\x20lung\x20carcinoma\x20and\x20pancreatic\x20carcinoma</strong>.\x20Additionally,\x20the\x20<strong>absorption\x20of\x20Erlotinib\x20</strong>is<strong>\x20increased\x20by\x20food,\x20</strong>which\x20is\x20an\x20important\x20consideration\x20for\x20its\x20clinical\x20use.</span></span></span></p>','correct_choice_id':0xaa20,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a95,'choices':[{'id':0xaa32,'text':_0x164193(0x40a)},{'id':0xaa33,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Diarrhea</span></span></span></p>'},{'id':0xaa34,'text':_0x164193(0x406)},{'id':0xaa35,'text':_0x164193(0x3a6)}],'text':_0x164193(0x2cf),'unique_key':_0x164193(0x3ae),'question_audio':null,'question_video':null,'map_id':0x8e80,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x401),'correct_choice_id':0xaa33,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2aa4,'choices':[{'id':0xaa6e,'text':_0x164193(0x2e5)},{'id':0xaa6f,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Ribociclib\x20</span></span></span></p>'},{'id':0xaa70,'text':_0x164193(0x1f4)},{'id':0xaa71,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Nilotinib</span></span></span></p>'}],'text':_0x164193(0x1fb),'unique_key':_0x164193(0x458),'question_audio':null,'question_video':null,'map_id':0x8e7c,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x1e5),'correct_choice_id':0xaa6f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['Factual','ImageBased']},{'id':0x2aa6,'choices':[{'id':0xaa76,'text':_0x164193(0x3a0)},{'id':0xaa77,'text':_0x164193(0x18f)},{'id':0xaa78,'text':_0x164193(0x31d)},{'id':0xaa79,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Protein\x20tyrosine\x20kinase\x20inhibitor</span></span></span></p>'}],'text':_0x164193(0x3fe),'unique_key':_0x164193(0x337),'question_audio':null,'question_video':null,'map_id':0x8e7d,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x2b3),'correct_choice_id':0xaa77,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x164193(0x48f)]},{'id':0x2aaf,'choices':[{'id':0xaa9a,'text':_0x164193(0x2e5)},{'id':0xaa9b,'text':_0x164193(0x330)},{'id':0xaa9c,'text':_0x164193(0x148)},{'id':0xaa9d,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vemurafenib</span></span></span></p>'}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20Tyrosine\x20kinase\x20inhibitors\x20is\x20used\x20for\x20the\x20treatment\x20of\x20malignant\x20melanoma?\x20</span></span></span></p>','unique_key':_0x164193(0x3a8),'question_audio':null,'question_video':null,'map_id':0x8e7e,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':_0x164193(0x378),'correct_choice_id':0xaa9d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a9d,'choices':[{'id':0xaa52,'text':_0x164193(0x237)},{'id':0xaa53,'text':_0x164193(0x42d)},{'id':0xaa54,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Basiliximab\x20blocks\x20the\x20binding\x20of\x20interleukin-2\x20(IL-2)\x20to\x20its\x20receptor\x20on\x20activated\x20T-cells</span></span></span></p>'},{'id':0xaa55,'text':_0x164193(0x1f7)}],'text':_0x164193(0x17a),'unique_key':_0x164193(0x3b2),'question_audio':null,'question_video':null,'map_id':0x8e8d,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Basiliximab\x20blocks\x20the\x20binding\x20of\x20interleukin-2\x20(IL-2)\x20to\x20its\x20receptor\x20on\x20activated\x20T-cells</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Basiliximab</strong>\x20is\x20a<strong>\x20chimeric\x20(human-murine)\x20monoclonal\x20antibody\x20</strong>that\x20targets\x20the<strong>\x20IL-2\x20receptor\x20alpha\x20chain\x20</strong>(also\x20known\x20as\x20<strong>CD25</strong>)\x20on\x20the\x20<strong>surface\x20of\x20activated\x20T-cells.</strong>\x20By\x20<strong>binding\x20</strong>to<strong>\x20this\x20receptor</strong>,<strong>\x20basiliximab</strong>\x20effectively<strong>\x20prevents\x20interleukin-2\x20(IL-2)</strong>\x20from\x20<strong>interacting\x20with</strong>\x20its\x20receptor.<strong>\x20IL-2</strong>\x20is\x20a\x20crucial\x20<strong>growth\x20factor\x20for\x20T-cells,\x20</strong>particularly\x20following\x20<strong>antigen\x20exposure</strong>.\x20Without\x20the<strong>\x20ability\x20to\x20bind\x20to\x20its</strong>\x20<strong>receptor,\x20IL-2\x20cannot\x20signal\x20the\x20T-cell\x20to\x20proliferate\x20and\x20activate</strong>,\x20which\x20is\x20essential\x20in\x20the\x20<strong>immune\x20response</strong>,\x20especially\x20concerning\x20the\x20<strong>rejection\x20of\x20transplanted\x20organs.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Basiliximab\x20directly\x20inhibits\x20the\x20proliferation\x20of\x20T-cells:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Incorrect.</strong>\x20because\x20<strong>basiliximab\x20</strong>itself\x20<strong>does\x20not\x20</strong>directly<strong>\x20inhibit\x20cell</strong>\x20<strong>proliferation;</strong>\x20instead,\x20it<strong>\x20prevents\x20IL-2</strong>\x20from\x20<strong>activating\x20T-cells,\x20</strong>which<strong>\x20indirectly\x20inhibits\x20their\x20proliferation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Basiliximab\x20promotes\x20the\x20activation\x20of\x20B-cells:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Incorrect.\x20Basiliximab&rsquo;s</strong>\x20action\x20is\x20specific\x20to\x20<strong>T-cells\x20</strong>and\x20<strong>does\x20not</strong>\x20involve\x20<strong>direct\x20effects\x20on\x20B-cell\x20activation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Basiliximab\x20enhances\x20the\x20differentiation\x20of\x20dendritic\x20cells:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Incorrect</strong>.\x20Basiliximab&#39;s\x20mechanism\x20of\x20action\x20is\x20<strong>centered\x20on\x20T-cells\x20</strong>and\x20<strong>does\x20not\x20</strong>affect\x20the\x20<strong>differentiation\x20of\x20dendritic\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Basiliximab</strong>\x20serves\x20as\x20an<strong>\x20immunosuppressant\x20</strong>by\x20specifically\x20<strong>blocking\x20the\x20IL-2\x20receptor\x20on\x20activated\x20T-cells</strong>,\x20thereby\x20<strong>preventing</strong>\x20their\x20<strong>activation\x20and\x20proliferation.\x20</strong>This\x20selective<strong>\x20inhibition</strong>\x20is\x20critical\x20in\x20<strong>preventing\x20organ\x20rejection\x20</strong>following\x20<strong>transplantation,</strong>\x20making\x20<strong>basiliximab</strong>\x20a<strong>\x20valuable\x20therapeutic</strong>\x20tool\x20in<strong>\x20transplant\x20medicine.</strong></span></span></span></p>','correct_choice_id':0xaa54,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x164193(0x48f)]},{'id':0x2a99,'choices':[{'id':0xaa42,'text':_0x164193(0x3fc)},{'id':0xaa43,'text':_0x164193(0x2d3)},{'id':0xaa44,'text':_0x164193(0x142)},{'id':0xaa45,'text':_0x164193(0x34f)}],'text':_0x164193(0x1fe),'unique_key':'Q7189761','question_audio':null,'question_video':null,'map_id':0x8e8a,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x1f1),'correct_choice_id':0xaa45,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a9c,'choices':[{'id':0xaa4e,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Azathioprine\x20is\x20used\x20as\x20immunosuppressant\x20drug</span></span></span></p>'},{'id':0xaa4f,'text':_0x164193(0x2bd)},{'id':0xaa50,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Fludarabine\x20is\x20the\x20drug\x20of\x20choice\x20for\x20CLL.</span></span></span></p>'},{'id':0xaa51,'text':_0x164193(0x45b)}],'text':_0x164193(0x434),'unique_key':_0x164193(0x413),'question_audio':null,'question_video':null,'map_id':0x8e8c,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x2e7),'correct_choice_id':0xaa51,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['ClinicalVignette',_0x164193(0x48f)]},{'id':0x2aa9,'choices':[{'id':0xaa82,'text':_0x164193(0x332)},{'id':0xaa83,'text':_0x164193(0x21c)},{'id':0xaa84,'text':_0x164193(0x2ac)},{'id':0xaa85,'text':_0x164193(0x3cc)}],'text':_0x164193(0x1ff),'unique_key':_0x164193(0x1cb),'question_audio':null,'question_video':null,'map_id':0x8e8b,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Ans.\x20D)\x20Hirsutism\x20is\x20more\x20common\x20than\x20cyclosporine</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20D:</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>The\x20statement\x20is<strong>\x20incorrect.\x20Hirsutism,\x20or\x20excessive\x20hair\x20growth</strong>,\x20is\x20a\x20<strong>known\x20side\x20effect</strong>\x20associated\x20<strong>more\x20frequently\x20with\x20cyclosporine,</strong>\x20<strong>another\x20immunosuppressant\x20</strong>used\x20in\x20<strong>similar\x20clinical\x20settings</strong>\x20as\x20<strong>tacrolimus</strong>.\x20<strong>Tacrolimus</strong>\x20may\x20cause<strong>\x20hirsutism\x20</strong>as\x20well,\x20but\x20it\x20is\x20significantly<strong>\x20less\x20common</strong>\x20compared\x20to<strong>\x20cyclosporine.</strong>\x20Therefore,\x20stating\x20that\x20<strong>hirsutism\x20is\x20more\x20common\x20with\x20tacrolimus\x20</strong>than\x20with<strong>\x20cyclosporine\x20is\x20false.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong><u>Explanation:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20A.\x20It\x20is\x20a\x20macrolide\x20lactone:</strong>\x20<strong>True</strong>.\x20<strong>Tacrolimus\x20is\x20a\x20macrolide\x20lactone</strong>;\x20it\x20is\x20structurally\x20similar\x20to\x20<strong>other\x20macrolides</strong>\x20like\x20<strong>erythromycin\x20and\x20azithromycin</strong>\x20but\x20has\x20a\x20<strong>different\x20function,\x20primarily\x20as\x20an\x20immunosuppressant.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20B.\x20It\x20inhibits\x20the\x20gene\x20transcription\x20of\x20interleukin\x202:</strong>\x20<strong>True</strong>.<strong>\x20Tacrolimus</strong>\x20i<strong>nhibits\x20the\x20activation\x20of\x20T-lymphocytes</strong>\x20by<strong>\x20inhibiting</strong>\x20<strong>calcineurin</strong>,\x20which\x20in\x20turn\x20<strong>reduces\x20the\x20transcription\x20of\x20interleukin-2\x20(IL-2).</strong>\x20IL-2\x20is\x20critical\x20for\x20the<strong>\x20growth\x20and\x20activation\x20of\x20T-cells</strong>,\x20so\x20its\x20<strong>suppression</strong>\x20is\x20key\x20to<strong>\x20tacrolimus\x27s\x20ability\x20</strong>to\x20<strong>prevent\x20organ\x20rejection\x20</strong>in<strong>\x20transplant\x20patients.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20C.\x20It\x20acts\x20by\x20binding\x20to\x20immunophilins:</strong>\x20<strong>True</strong>.\x20<strong>Tacrolimus</strong>\x20binds\x20specifically\x20to\x20the\x20<strong>immunophilin</strong>\x20known\x20as\x20<strong>FK506\x20binding</strong>\x20<strong>protein\x20(FKBP)</strong>,\x20forming\x20a\x20<strong>complex</strong>\x20that\x20<strong>inhibits\x20calcineurin,</strong>\x20a\x20necessary\x20enzyme\x20in\x20the\x20<strong>T-cell\x20activation\x20pathway.</strong>\x20This\x20action\x20is\x20crucial\x20for\x20<strong>its\x20immunosuppressive\x20effects.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong><u>Educational\x20Objective:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>While\x20<strong>tacrolimus</strong>\x20shares\x20some\x20<strong>mechanisms\x20of\x20action</strong>\x20with\x20<strong>other\x20immunosuppressants</strong>\x20like\x20<strong>cyclosporine,</strong>\x20notably\x20its\x20<strong>suppression\x20of\x20T-cell\x20activation</strong>\x20via\x20<strong>calcineurin\x20inhibition</strong>,\x20it\x20<strong>does\x20not\x20</strong>cause\x20<strong>hirsutism</strong>\x20as\x20commonly\x20as\x20cyclosporine\x20does.\x20This\x20distinction\x20is\x20important\x20in\x20<strong>clinical\x20practice\x20</strong>when\x20choosing\x20an\x20<strong>immunosuppressant</strong>,\x20especially\x20considering\x20the\x20<strong>side\x20effect</strong>\x20profiles\x20that\x20can\x20affect\x20<strong>patient\x20compliance\x20and\x20quality\x20of\x20life.</strong></span></p>','correct_choice_id':0xaa85,'solution_audio':null,'solution_video':null,'audio_explanation_heading':'','video_explanation_heading':'','solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a9e,'choices':[{'id':0xaa56,'text':_0x164193(0x199)},{'id':0xaa57,'text':_0x164193(0x48b)},{'id':0xaa58,'text':_0x164193(0x19a)},{'id':0xaa59,'text':_0x164193(0x222)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Cetuximab\x20is\x20used\x20for\x20treatment\x20of?</span></span></span></p>','unique_key':'Q6649761','question_audio':null,'question_video':null,'map_id':0x8e88,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x225),'correct_choice_id':0xaa58,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x164193(0x462)]},{'id':0x2a9f,'choices':[{'id':0xaa5a,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Avelumab</span></span></span></p>'},{'id':0xaa5b,'text':_0x164193(0x251)},{'id':0xaa5c,'text':_0x164193(0x27c)},{'id':0xaa5d,'text':_0x164193(0x19c)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>All\x20the\x20following\x20are\x20PD-L1\x20inhibitors\x20except?</span></span></span></p>','unique_key':_0x164193(0x24d),'question_audio':null,'question_video':null,'map_id':0x8e89,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Cetuximab</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Cetuximab\x20</strong>is\x20a<strong>\x20monoclonal\x20antibody\x20</strong>that\x20specifically\x20targets\x20the\x20<strong>epidermal\x20growth\x20factor\x20receptor\x20(EGFR)\x20</strong>on\x20the\x20<strong>surface\x20of\x20cancer</strong>\x20<strong>cells.</strong>\x20It\x20functions\x20by<strong>\x20inhibiting\x20EGFR</strong>\x20and\x20its<strong>\x20associated\x20signaling\x20pathways</strong>,\x20which\x20are\x20often\x20<strong>upregulated\x20in\x20various\x20types\x20of\x20cancers,</strong>\x20particularly<strong>\x20colorectal\x20and\x20head\x20and\x20neck\x20cancers</strong>.\x20This\x20mechanism\x20is\x20<strong>distinct\x20from\x20the\x20mode\x20of\x20action\x20of\x20PD-L1\x20inhibitors</strong>.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/402.jpg\x22\x20style=\x22height:333px;\x20width:500px\x22\x20/></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Avelumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Avelumab\x20is\x20a\x20<strong>PD-L1\x20inhibitor\x20</strong>that\x20<strong>blocks\x20the\x20interaction\x20between\x20PD-L1\x20on\x20tumor\x20cells\x20</strong>and<strong>\x20PD-1\x20on\x20T\x20cells.</strong>\x20By\x20doing\x20so,\x20it<strong>\x20prevents\x20</strong>the<strong>\x20tumor</strong>\x20from\x20evading\x20the<strong>\x20immune\x20response,\x20enabling\x20the\x20immune\x20system\x20</strong>to\x20attack\x20the\x20<strong>cancer\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Atezolizumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Similar\x20to<strong>\x20Avelumab,</strong>\x20Atezolizumab\x20is\x20a<strong>\x20monoclonal\x20antibody\x20</strong>that\x20binds\x20to\x20<strong>PD-L1,</strong>\x20<strong>inhibiting\x20</strong>its\x20<strong>interaction</strong>\x20with<strong>\x20PD-1</strong>.\x20This\x20<strong>blockade\x20</strong>enhances\x20the<strong>\x20body&#39;s\x20immune\x20response\x20against\x20tumor\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Durvalumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Durvalumab\x20also<strong>\x20targets\x20PD-L1</strong>,\x20<strong>preventing</strong>\x20it\x20from\x20<strong>binding\x20to\x20PD-1.</strong>\x20It\x20is\x20part\x20of\x20the<strong>\x20group\x20of\x20immune</strong>\x20<strong>checkpoint\x20inhibitors</strong>\x20that\x20help\x20to<strong>\x20activate\x20the\x20immune\x20system\x20against\x20cancer\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>While\x20<strong>Avelumab,\x20Atezolizumab,\x20and\x20Durvalumab\x20</strong>are\x20<strong>all\x20PD-L1\x20inhibitors</strong>\x20enhancing\x20the<strong>\x20immune\x20system&#39;s\x20ability\x20to\x20fight\x20cancer,</strong>\x20<strong>Cetuximab</strong>\x20works\x20through\x20a<strong>\x20different\x20mechanism\x20</strong>by\x20<strong>targeting\x20EGFR\x20on\x20cancer\x20cells</strong>.&nbsp;</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Immune\x20Check\x20Point\x20inhibitors</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-131641.png\x22\x20style=\x22height:247px;\x20width:1000px\x22\x20/></p>','correct_choice_id':0xaa5c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a94,'choices':[{'id':0xaa2e,'text':_0x164193(0x296)},{'id':0xaa2f,'text':_0x164193(0x3f2)},{'id':0xaa30,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20used\x20for\x20treatment\x20of\x20non-\x20Hodgkin\x20lymphoma</span></span></span></p>'},{'id':0xaa31,'text':_0x164193(0x473)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20statements\x20about\x20rituximab\x20is\x20false?\x20</span></span></span></p>','unique_key':'Q3931391','question_audio':null,'question_video':null,'map_id':0x8e84,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20It\x20has\x20dose\x20dependent\x20kinetics.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Rituximab</strong>\x20is\x20<strong>chimeric\x20monoclonal\x20antibody\x20</strong>against\x20<strong>CD-20\x20B-cells.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Rituximab</strong>\x20follows<strong>\x20first\x20order\x20kinetics.</strong>\x20Its<strong>\x20clearance</strong>\x20remains<strong>\x20constant\x20irrespective\x20of\x20plasma\x20concentration.\x20Dose-dependent\x20kinetics</strong>\x20means\x20<strong>zero-order\x20kinetics</strong>\x20i.e.\x20<strong>clearance\x20and\x20t1/2\x20change</strong>\x20with\x20<strong>dose\x20(plasma\x20concentration).</strong>\x20Drugs\x20following<strong>\x20zero-order\x20kinetics</strong>\x20are\x20<strong>warfarin,\x20alcohol,\x20high\x20dose\x20aspirin,\x20tolbutamide,\x20theophylline\x20and\x20phenytoin.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Infusion-related\x20</strong>reactions\x20are\x20seen\x20in\x20approximately<strong>\x2050%\x20</strong>of\x20patients\x20receiving<strong>\x20first\x20infusion</strong>.\x20The\x20<strong>incidence\x20decreases</strong>\x20with\x20<strong>subsequent\x20infusions.</strong>\x20Starting\x20with\x20<strong>low\x20doses\x20</strong>and\x20<strong>pre-treatment</strong>\x20with\x20<strong>steroids\x20or\x20anti-histaminic\x20</strong>are\x20the\x20<strong>methods</strong>\x20to\x20<strong>reduce\x20infusion\x20related\x20reactions.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Rituximab</strong>\x20may\x20cause\x20<strong>reactivation\x20of\x20hepatitis\x20B;</strong>\x20therefore,\x20patients\x20should\x20be\x20<strong>screened\x20for\x20hepatitis\x20B</strong>\x20before\x20<strong>initiation</strong>\x20of\x20therapy.\x20It\x20rarely<strong>\x20causes\x20reactivation\x20of\x20JC\x20virus\x20</strong>leading\x20to\x20<strong>progressive\x20multifocal\x20leukoencephalopathy.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Rituximab\x20</strong>can\x20be<strong>\x20used\x20for\x20treatment</strong>\x20of\x20</span></span></span>\x0d\x0a\x09<ul\x20style=\x22list-style-type:circle\x22>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Non-Hodgkin\x20lymphoma\x20</span></span></span></li>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Mantle\x20cell\x20lymphoma\x20</span></span></span></li>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Chronic\x20lymphocytic\x20leukemia\x20</span></span></span></li>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Auto-immune\x20hemolytic\x20anemia\x20</span></span></span></li>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Diffuse\x20large\x20B\x20cell\x20lymphoma.\x20</span></span></span></li>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Rheumatoid\x20arthritis\x20</span></span></span></li>\x0d\x0a\x09</ul>\x0d\x0a\x09</li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20It\x20is\x20a\x20chimeric\x20monoclonal\x20antibody\x20against\x20CD-20:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20statement\x20is\x20<strong>true</strong>\x20and\x20accurately\x20describes\x20the\x20<strong>biological\x20target\x20</strong>of<strong>\x20rituximab,</strong>\x20essential\x20for<strong>\x20its\x20efficacy\x20in\x20treating\x20diseases</strong>\x20like<strong>\x20lymphomas\x20</strong>where<strong>\x20CD-20\x20positive\x20B-cells\x20are\x20pathologically\x20active.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20It\x20is\x20used\x20for\x20treatment\x20of\x20non-Hodgkin\x20lymphoma:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>True.\x20Rituximab\x20</strong>is\x20extensively<strong>\x20used\x20in</strong>\x20the\x20treatment\x20of\x20<strong>non-Hodgkin</strong>\x20<strong>lymphoma</strong>\x20among\x20other<strong>\x20lymphoid\x20malignancies,\x20</strong>leveraging\x20its\x20ability\x20to\x20target<strong>\x20CD-20\x20</strong>for<strong>\x20therapeutic\x20effect.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Its\x20most\x20common\x20adverse\x20effect\x20is\x20infusion\x20related\x20reactions:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Also\x20<strong>true</strong>.<strong>\x20Infusion-related\x20reactions</strong>\x20occur\x20in\x20about<strong>\x20half\x20of</strong>\x20<strong>all\x20patients\x20</strong>during\x20the\x20<strong>first\x20infusion\x20of\x20rituximab,</strong>\x20though\x20the\x20<strong>risk\x20decreases</strong>\x20with\x20<strong>subsequent\x20treatments.</strong>\x20<strong>Pre-medicating\x20</strong>with\x20<strong>steroids\x20or\x20antihistamines\x20</strong>can<strong>\x20mitigate</strong>\x20these\x20reactions.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Rituximab,</strong>\x20a\x20<strong>chimeric\x20monoclonal\x20antibody</strong>\x20targeting\x20CD-20\x20B-cells,\x20is\x20<strong>primarily\x20used\x20</strong>to\x20treat\x20various<strong>\x20hematological\x20malignancies</strong>\x20and\x20some\x20<strong>autoimmune\x20conditions</strong>.\x20Its\x20<strong>pharmacokinetics\x20does\x20not</strong>\x20follow<strong>\x20dose-dependent\x20kinetics\x20</strong>but\x20instead<strong>\x20exhibits\x20first-order</strong>\x20<strong>kinetics,</strong>\x20meaning\x20its<strong>\x20clearance\x20remains\x20constant\x20</strong>across<strong>\x20different\x20plasma\x20concentrations.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>In<strong>\x20contrast,</strong>\x20<strong>dose-dependent\x20kinetics\x20(zero-order\x20kinetics)\x20</strong>describes\x20a\x20scenario\x20where\x20the<strong>\x20drug&rsquo;s\x20clearance\x20rate\x20and\x20half-life\x20</strong>change\x20with<strong>\x20varying\x20doses</strong>,\x20which\x20is<strong>\x20not</strong>\x20the\x20case\x20with\x20<strong>rituximab</strong>.\x20This\x20<strong>differentiates\x20rituximab\x20</strong>from\x20drugs\x20like\x20<strong>warfarin\x20and\x20phenytoin</strong>,\x20which\x20follow<strong>\x20zero-order\x20kinetics</strong>\x20at\x20<strong>therapeutic\x20or\x20higher\x20doses.</strong></span></span></span></p>','correct_choice_id':0xaa2f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2a96,'choices':[{'id':0xaa36,'text':_0x164193(0x1ed)},{'id':0xaa37,'text':_0x164193(0x366)},{'id':0xaa38,'text':_0x164193(0x3b9)},{'id':0xaa39,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20a\x20monoclonal\x20antibody\x20containing\x20only\x20human\x20components</span></span></span></p>'}],'text':_0x164193(0x1df),'unique_key':_0x164193(0x21a),'question_audio':null,'question_video':null,'map_id':0x8e85,'difficulty_level':_0x164193(0x32a),'subjects_id':[0x4],'solution':_0x164193(0x334),'correct_choice_id':0xaa37,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['ClinicalVignette',_0x164193(0x48f)]},{'id':0x2aa2,'choices':[{'id':0xaa66,'text':_0x164193(0x256)},{'id':0xaa67,'text':_0x164193(0x3eb)},{'id':0xaa68,'text':_0x164193(0x221)},{'id':0xaa69,'text':_0x164193(0x278)}],'text':_0x164193(0x1cd),'unique_key':'Q3399549','question_audio':null,'question_video':null,'map_id':0x8e81,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x185),'correct_choice_id':0xaa66,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':['ClinicalVignette','ImageBased']},{'id':0x2aab,'choices':[{'id':0xaa8a,'text':_0x164193(0x309)},{'id':0xaa8b,'text':_0x164193(0x2e1)},{'id':0xaa8c,'text':_0x164193(0x176)},{'id':0xaa8d,'text':_0x164193(0x3c5)}],'text':_0x164193(0x15c),'unique_key':'Q5847493','question_audio':null,'question_video':null,'map_id':0x8e82,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x392),'correct_choice_id':0xaa8a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x164193(0x48f)]},{'id':0x2aad,'choices':[{'id':0xaa92,'text':_0x164193(0x443)},{'id':0xaa93,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Brodalumab</span></span></span></p>'},{'id':0xaa94,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Secukinumab</span></span></span></p>'},{'id':0xaa95,'text':_0x164193(0x2d8)}],'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>All\x20are\x20monoclonal\x20antibodies\x20approved\x20for\x20use\x20in\x20psoriasis,\x20Except:</span></span></span></p>','unique_key':_0x164193(0x456),'question_audio':null,'question_video':null,'map_id':0x8e83,'difficulty_level':'intermediate','subjects_id':[0x4],'solution':_0x164193(0x20d),'correct_choice_id':0xaa95,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2aba,'choices':[{'id':0xaac6,'text':_0x164193(0x1a8)},{'id':0xaac7,'text':_0x164193(0x280)},{'id':0xaac8,'text':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20dir=\x22ltr\x22\x20lang=\x22PT-BR\x22\x20style=\x22font-size:12.0pt\x22>Natalizumab</span></span></span></p>'},{'id':0xaac9,'text':_0x164193(0x476)}],'text':_0x164193(0x15d),'unique_key':'Q5768620','question_audio':null,'question_video':null,'map_id':0x8e87,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':'<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20dir=\x22ltr\x22\x20lang=\x22PT-BR\x22\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Ocrelizumab</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20dir=\x22ltr\x22\x20lang=\x22PT-BR\x22\x20style=\x22font-size:12.0pt\x22>Option\x20B:\x20</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Ocrelizumab</strong>\x20is\x20an\x20<strong>anti-CD20\x20monoclonal\x20antibody\x20</strong>approved\x20by\x20the\x20<strong>US-FDA</strong>\x20for\x20the<strong>\x20treatment\x20of\x20primary\x20progressive</strong>\x20<strong>multiple\x20sclerosis\x20(PPMS),</strong>\x20as\x20well\x20as\x20for<strong>\x20relapsing\x20forms\x20of\x20multiple\x20sclerosis\x20(RMS)</strong>.\x20Its\x20<strong>mechanism\x20of\x20action\x20</strong>involves\x20binding\x20to<strong>\x20CD20-positive\x20B\x20cells</strong>,\x20which\x20play\x20a\x20significant\x20role\x20in\x20the\x20<strong>inflammatory\x20process\x20of\x20multiple\x20sclerosis.</strong>\x20By\x20<strong>depleting\x20these\x20B\x20cells,\x20ocrelizumab\x20reduces\x20the\x20inflammatory\x20activity</strong>\x20and\x20can\x20<strong>slow\x20the\x20progression\x20of\x20the\x20disease.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Alemtuzumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Alemtuzumab<strong>\x20targets\x20CD52</strong>,\x20a<strong>\x20protein\x20</strong>expressed\x20on\x20the\x20<strong>surface\x20of\x20T\x20and\x20B\x20lymphocytes</strong>,\x20and\x20is\x20<strong>used\x20in\x20</strong>the\x20treatment\x20of\x20<strong>relapsing-remitting\x20multiple\x20sclerosis,</strong>\x20but\x20not\x20for\x20PPMS.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Natalizumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Natalizumab\x20<strong>targets\x20integrin\x20alpha-4</strong>,\x20involved\x20in\x20the<strong>\x20migration\x20of\x20leukocytes\x20across\x20the\x20blood-brain\x20barrier.</strong>\x20It\x20is\x20<strong>used</strong>\x20for\x20<strong>relapsing\x20forms\x20of\x20multiple\x20sclerosis</strong>\x20and\x20not\x20indicated\x20for\x20PPMS.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Pertuzumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Pertuzumab\x20is\x20a<strong>\x20monoclonal\x20antibody\x20</strong>that\x20<strong>targets\x20the\x20HER2\x20receptor,</strong>\x20which\x20is\x20<strong>overexpressed\x20in\x20HER2-positive\x20breast\x20cancer.</strong>\x20It\x20is\x20<strong>not</strong>\x20used\x20in\x20the<strong>\x20treatment\x20of\x20multiple\x20sclerosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Ocrelizumab\x20</strong>is\x20the<strong>\x20first\x20and\x20only\x20US-FDA\x20</strong>approved\x20therapy\x20specifically\x20indicated\x20for\x20<strong>primary\x20progressive\x20multiple\x20sclerosis.</strong></span></span></span></p>','correct_choice_id':0xaac7,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x48f)]},{'id':0x2ab8,'choices':[{'id':0xaabe,'text':'<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Hodgkin&rsquo;s\x20lymphoma</span></span></span></p>'},{'id':0xaabf,'text':_0x164193(0x380)},{'id':0xaac0,'text':_0x164193(0x25c)},{'id':0xaac1,'text':_0x164193(0x495)}],'text':_0x164193(0x255),'unique_key':_0x164193(0x1b0),'question_audio':null,'question_video':null,'map_id':0x8e86,'difficulty_level':_0x164193(0x22b),'subjects_id':[0x4],'solution':_0x164193(0x28e),'correct_choice_id':0xaabe,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x164193(0x2f7),'tags':[_0x164193(0x462)]}],quizName=_0x164193(0x2da);const quizFilename='anti-cancer-drugs-immunosuppressants-836c7b10.html';let hierarchy=[_0x164193(0x1bd),_0x164193(0x468),_0x164193(0x489)];if(window[_0x164193(0x282)][_0x164193(0x1ce)][_0x164193(0x3ca)]('custom_quiz.html')){const customData=JSON['parse'](localStorage['getItem'](_0x164193(0x1e0)));if(customData){const tCKfXa=_0x164193(0x1b5)['split']('|');let yptDQd=0x0;while(!![]){switch(tCKfXa[yptDQd++]){case'0':hierarchy=customData[_0x164193(0x183)];continue;case'1':quizName=customData[_0x164193(0x3bb)];continue;case'2':document['title']=quizName+'\x20-\x20Brain\x20And\x20Scalpel';continue;case'3':document['getElementById'](_0x164193(0x2a6))[_0x164193(0x385)]=hierarchy[_0x164193(0x40c)](_0x164193(0x233));continue;case'4':document[_0x164193(0x410)]('totalQuestions')[_0x164193(0x385)]=questionsData[_0x164193(0x204)];continue;case'5':questionsData=customData[_0x164193(0x474)];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x164193(0x304),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x164193(0x3f0)](),quizStartTime=Date[_0x164193(0x3f0)](),isQuizCompleted=![],questionStates=new Array(questionsData['length'])[_0x164193(0x161)](null)['map'](()=>({'status':'not_attempted','bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x164193(0x204)]};function saveProgress(){const _0x46e4d9=_0x164193,_0x470a43={'agAlt':'userHistory','AdwCS':_0x46e4d9(0x22e)};if(isQuizCompleted)return;const _0x45a982=JSON[_0x46e4d9(0x1ab)](localStorage[_0x46e4d9(0x37d)](_0x470a43[_0x46e4d9(0x435)]))||{};_0x45a982[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x470a43[_0x46e4d9(0x2bb)],'lastSeen':new Date()[_0x46e4d9(0x174)]()},localStorage['setItem'](_0x470a43[_0x46e4d9(0x435)],JSON[_0x46e4d9(0x34e)](_0x45a982));}function loadProgress(){const _0x1774d9=_0x164193,_0x57d552={'VBdXV':_0x1774d9(0x478),'KyFOa':_0x1774d9(0x2f1)},_0x37d500=JSON[_0x1774d9(0x1ab)](localStorage['getItem'](_0x57d552[_0x1774d9(0x285)]))||{},_0x5e8935=_0x37d500[quizFilename];if(_0x5e8935){const _0x28ec6f=_0x57d552[_0x1774d9(0x43f)][_0x1774d9(0x308)]('|');let _0x15454f=0x0;while(!![]){switch(_0x28ec6f[_0x15454f++]){case'0':stats=_0x5e8935['stats'];continue;case'1':console[_0x1774d9(0x180)]('Progress\x20loaded.');continue;case'2':currentMode=_0x5e8935[_0x1774d9(0x31c)];continue;case'3':currentQuestionIndex=_0x5e8935[_0x1774d9(0x2c8)];continue;case'4':questionStates=_0x5e8935['questionStates'];continue;case'5':return!![];}break;}}return![];}function clearProgress(){const _0x54a6c5=_0x164193,_0x15b96b={'HbJmF':function(_0x2ebe6b,_0xa6d733){return _0x2ebe6b(_0xa6d733);},'jofCF':_0x54a6c5(0x3b0),'CDAvO':function(_0xeaf0ed){return _0xeaf0ed();},'qnDIM':_0x54a6c5(0x478),'FdeBo':function(_0x12ad92,_0x12a5dc){return _0x12ad92===_0x12a5dc;},'FjMpq':_0x54a6c5(0x496),'fYKra':_0x54a6c5(0x31a)},_0x60ae21=JSON[_0x54a6c5(0x1ab)](localStorage[_0x54a6c5(0x37d)](_0x15b96b[_0x54a6c5(0x377)]))||{};_0x60ae21[quizFilename]&&(_0x15b96b[_0x54a6c5(0x16a)](_0x54a6c5(0x496),_0x15b96b[_0x54a6c5(0x1ad)])?(delete _0x60ae21[quizFilename],localStorage[_0x54a6c5(0x29b)](_0x15b96b['qnDIM'],JSON['stringify'](_0x60ae21)),console['log'](_0x15b96b[_0x54a6c5(0x284)])):_0x15b96b[_0x54a6c5(0x24c)](_0x49dee9,_0x15b96b[_0x54a6c5(0x46a)])&&_0x15b96b[_0x54a6c5(0x24e)](_0x4c0cd1));}function markQuizAsCompleted(){const _0x3b701c=_0x164193,_0x5cdd75={'JqWTJ':_0x3b701c(0x40e)},_0x1dd595=JSON[_0x3b701c(0x1ab)](localStorage[_0x3b701c(0x37d)]('userHistory'))||{},_0x5d80c3=questionsData[_0x3b701c(0x204)],_0x1ef66a=stats[_0x3b701c(0x281)]||0x0;_0x1dd595[quizFilename]={'score':_0x1ef66a,'total':_0x5d80c3,'status':_0x5cdd75[_0x3b701c(0x3da)],'completedOn':new Date()[_0x3b701c(0x174)]()},localStorage[_0x3b701c(0x29b)](_0x3b701c(0x478),JSON[_0x3b701c(0x34e)](_0x1dd595));}const urlParams=new URLSearchParams(window[_0x164193(0x282)][_0x164193(0x1a1)]),startAt=parseInt(urlParams['get'](_0x164193(0x28c))),resume=urlParams[_0x164193(0x2db)]('resume')==='true';function goBack(){const _0x53a067=_0x164193,_0x546860={'OBMEQ':function(_0x1dfa5f){return _0x1dfa5f();}};if(!isQuizCompleted)_0x546860[_0x53a067(0x389)](saveProgress);window[_0x53a067(0x282)][_0x53a067(0x173)]=document[_0x53a067(0x494)]||'index.html';}function _0x5eeb(){const _0x272373=['explanation_images','open','innerHTML','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Tocilizumab\x20is\x20a\x20monoclonal\x20antibody\x20against\x20interleukin-6\x20(IL-6)\x20receptor</span></span></span></p>','timerContainer','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2064-year-old\x20male\x20about\x20to\x20undergo\x20therapy\x20for\x20Rhabdomyosarcoma.\x20His\x20chemotherapy\x20includes\x20vincristine,\x20dactinomycin,\x20cyclophosphamide,\x20doxorubicin\x20and\x20ifosfamide.\x20Which\x20of\x20the\x20following\x20is\x20most\x20appropriate\x20to\x20include\x20in\x20chemotherapy\x20orders\x20for\x20this\x20patient?\x20</span></span></span></p>','modeModal','bookmarkBtn','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Sarilumab</span></span></span></p>','Q8041542','Anti-Cancer\x20Drugs\x20&\x20Immunosuppressants','get','div','lPvso','UOQRV','UqSxL','correctResult','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Trastuzumab</span></span></span></p>','</span></div>','Q9224287','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20metabolized\x20by\x20cytochrome\x20p450\x20enzymes</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Erlotinib</span></span></span></p>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20D)\x20Cladribine\x20is\x20degraded\x20by\x20adenosine\x20deaminase</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>This\x20statement\x20is\x20<strong>false</strong>.\x20<strong>Cladribine\x20</strong>is\x20actually<strong>\x20resistant\x20to\x20degradation\x20by\x20adenosine\x20deaminase,</strong>\x20which\x20makes\x20it\x20an\x20<strong>effective\x20agent</strong>\x20in\x20treating\x20cancers\x20like<strong>\x20hairy\x20cell\x20leukemia.</strong>\x20Its<strong>\x20resistance</strong>\x20allows\x20it\x20to\x20<strong>remain\x20active\x20longer</strong>\x20and<strong>\x20exert\x20sustained\x20effects\x20</strong>against\x20<strong>cancer</strong>\x20<strong>cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Purine\x20analogs</strong>\x20are\x20a\x20critical\x20class\x20of\x20drugs\x20used\x20in\x20the\x20<strong>treatment\x20of</strong>\x20<strong>various\x20leukemias,</strong>\x20including<strong>\x20CLL.</strong>\x20They\x20function\x20by\x20<strong>mimicking</strong>\x20<strong>natural\x20purines,</strong>\x20integrating\x20into\x20<strong>DNA\x20strands</strong>,\x20and<strong>\x20disrupting\x20DNA\x20synthesis</strong>,\x20which\x20is\x20crucial\x20for\x20the\x20<strong>proliferation\x20of\x20cancer\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Azathioprine\x20is\x20used\x20as\x20an\x20immunosuppressant\x20drug:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>True.</strong>\x20Azathioprine\x20<strong>inhibits\x20DNA\x20synthesis</strong>,\x20effectively\x20<strong>suppressing</strong>\x20the<strong>\x20immune\x20response</strong>,\x20which\x20i<strong>s\x20beneficial</strong>\x20in\x20conditions\x20like\x20<strong>autoimmune\x20diseases\x20</strong>and\x20in\x20<strong>preventing\x20organ\x20transplant\x20rejection.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Some\x20of\x20these\x20drugs\x20are\x20activated\x20by\x20hypoxanthine\x20guanine\x20phosphoribosyl\x20transferase\x20(HGPRTase):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>True.</strong>\x20Drugs\x20like\x20<strong>mercaptopurine\x20and\x20thioguanine</strong>\x20need\x20activation\x20by<strong>\x20HGPRTase</strong>\x20to\x20exert\x20their\x20<strong>cytotoxic\x20effects,</strong>\x20making\x20them\x20<strong>effective</strong>\x20in\x20certain\x20<strong>types\x20of\x20leukemia</strong>\x20where\x20this<strong>\x20enzyme\x20is\x20active.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Fludarabine\x20is\x20the\x20drug\x20of\x20choice\x20for\x20CLL:</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20True.</strong>\x20<strong>Fludarabine</strong>\x20is\x20commonly\x20<strong>used\x20and\x20highly\x20effective</strong>\x20in\x20the\x20treatment\x20of\x20<strong>CLL</strong>\x20due\x20to\x20its<strong>\x20potent\x20ability\x20</strong>to\x20<strong>interfere\x20with\x20DNA\x20replication\x20</strong>in\x20the<strong>\x20rapidly\x20dividing\x20leukemic\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Cladribine&#39;s\x20resistance</strong>\x20to\x20<strong>adenosine\x20deaminase\x20</strong>makes\x20it\x20a\x20particularly\x20<strong>potent\x20choice\x20in\x20certain\x20leukemias</strong>,\x20contrary\x20to\x20the<strong>\x20incorrect</strong>\x20claim\x20of\x20<strong>its\x20degradation\x20by\x20this\x20enzyme.</strong></span></span></span></p>','Qhjgw','lBZVq','Q8659474','sJSkq','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2060-year-old\x20patient\x20with\x20non-Hodgkin&#39;s\x20lymphoma\x20is\x20undergoing\x20chemotherapy.\x20The\x20oncologist\x20discusses\x20the\x20mechanism\x20of\x20action\x20of\x20various\x20chemotherapeutic\x20agents\x20to\x20optimize\x20the\x20patient&#39;s\x20treatment\x20regimen.\x20Understanding\x20the\x20specific\x20phases\x20of\x20the\x20cell\x20cycle\x20that\x20these\x20drugs\x20target\x20is\x20crucial\x20for\x20effective\x20therapy.&nbsp;Which\x20of\x20the\x20following\x20chemotherapeutic\x20agents\x20acts\x20predominantly\x20during\x20the\x20S\x20phase\x20of\x20the\x20cell\x20cycle?</span></span></span></p>','solution','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Folinic\x20acid\x20enhances\x20the\x20action\x20of\x20methotrexate</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20statement\x20is<strong>\x20incorrect\x20</strong>because<strong>\x20folinic\x20acid\x20(leucovorin)</strong>\x20is\x20actually\x20used\x20to\x20<strong>mitigate\x20the\x20toxic\x20effects\x20of\x20methotrexate</strong>,\x20particularly\x20when<strong>\x20administered\x20in\x20high\x20doses.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Folinic\x20acid</strong>\x20provides\x20a\x20means\x20of\x20&quot;<strong>rescue&quot;</strong>\x20by\x20supplementing\x20the\x20body\x20with\x20a\x20<strong>form\x20of\x20folate</strong>\x20that<strong>\x20does\x20not\x20</strong>require\x20activation\x20by\x20<strong>dihydrofolate\x20reductase\x20(DHFRase)</strong>,\x20thus\x20allowing\x20for\x20<strong>normal\x20cellular\x20functions\x20</strong>to\x20continue\x20despite<strong>\x20methotrexate&#39;s\x20inhibition</strong>\x20of\x20the\x20enzyme.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Methotrexate\x20acts\x20by\x20inhibiting\x20dihydrofolate\x20reductase:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20statement\x20is\x20<strong>correct</strong>.\x20Methotrexate\x20is\x20an<strong>\x20anti-metabolite</strong>\x20that\x20<strong>inhibits\x20DHFRase,\x20reducing</strong>\x20the\x20formation\x20of<strong>\x20tetrahydrofolate\x20</strong>required\x20for<strong>\x20purine\x20and\x20thymidylate\x20synthesis</strong>,\x20which\x20are\x20essential\x20for<strong>\x20DNA\x20replication\x20and\x20cell\x20division.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Non-proliferative\x20cells\x20are\x20relatively\x20resistant\x20to\x20methotrexate:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20<strong>correct.</strong>\x20Methotrexate&#39;s\x20mechanism\x20targets\x20the<strong>\x20S-phase\x20of\x20the\x20cell\x20cycle,\x20</strong>affecting\x20<strong>rapidly\x20dividing\x20cells;</strong>\x20thus,\x20cells\x20that\x20are\x20in\x20a\x20<strong>resting\x20state\x20show\x20relative\x20resistance.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Methotrexate\x20can\x20be\x20used\x20in\x20the\x20treatment\x20of\x20psoriasis:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20statement\x20is\x20<strong>true</strong>.\x20Beyond\x20its\x20oncological\x20applications,\x20methotrexate\x20is\x20used\x20as\x20a<strong>\x20first-line\x20disease-modifying\x20anti-rheumatic\x20drug\x20(DMARD)\x20</strong>and\x20is\x20<strong>effective</strong>\x20for\x20conditions\x20like<strong>\x20psoriasis\x20and</strong>\x20<strong>ectopic\x20pregnancy</strong>\x20due\x20to\x20its\x20<strong>anti-proliferative\x20effects\x20</strong>on\x20<strong>fast-dividing\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><strong><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></span></span></strong></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate\x20</strong>is\x20a\x20<strong>critical\x20drug</strong>\x20used\x20for\x20a\x20variety\x20of\x20conditions,\x20including\x20as\x20the\x20<strong>drug\x20of\x20choice\x20for\x20choriocarcinoma</strong>\x20and\x20a\x20<strong>first-line</strong>\x20<strong>DMARD</strong>.\x20It\x20is\x20<strong>essential</strong>\x20to\x20understand\x20that\x20while<strong>\x20methotrexate\x20inhibits\x20DHFRase,</strong>\x20leading\x20to<strong>\x20decreased\x20DNA\x20synthesis\x20</strong>in\x20<strong>proliferating\x20cells,\x20folinic\x20acid\x20</strong>is\x20used\x20to<strong>\x20rescue\x20normal\x20cells\x20</strong>from\x20its<strong>\x20toxic\x20effects,\x20not</strong>\x20enhance\x20its\x20<strong>action.</strong></span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>G2\x20phase</span></span></span></p>','wkMri','4|0|3|2|1|5','yEIoS','SztcU','AZNyx','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Acute\x20Myeloblastic\x20Leukemia\x20(AML)</span></span></span></p>','bQXJs','bottom','includes','FiIRx','aPXQn','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','DWSFB','nQmhz','wYGxl','bIRvT','Svesp','createElement','Q9627413','apply','study','Q8710912','vFgDc','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Procarbazine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20<strong>symptoms</strong>\x20described\x20are\x20consistent\x20with\x20a\x20condition\x20called\x20<strong>disulfiram-like\x20reaction,\x20</strong>which\x20can\x20occur\x20when\x20<strong>alcohol\x20is</strong>\x20<strong>consumed</strong>\x20while\x20taking\x20<strong>certain\x20medication</strong>s.\x20Among\x20the\x20drugs\x20used\x20in<strong>\x20MOPP\x20regimen\x20for\x20Hodgkin&#39;s\x20lymphoma</strong>,\x20the\x20most\x20likely\x20to<strong>\x20cause\x20disulfiram-like\x20reaction\x20with\x20alcohol\x20</strong>is\x20<strong>procarbazine.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Procarbazine\x20</strong>is\x20an<strong>\x20alkylating\x20agent</strong>.\x20It\x20can\x20cause\x20a\x20<strong>disulfiram-like\x20reaction</strong>\x20when\x20<strong>alcohol\x20is\x20consumed,\x20</strong>which\x20can\x20result\x20in\x20symptoms\x20such\x20as<strong>\x20flushing,\x20headache,\x20nausea,\x20vomiting,\x20chest\x20pain,\x20weakness,\x20blurred\x20vision,\x20mental\x20confusion,</strong>\x20s<strong>weating,\x20choking,\x20breathing\x20difficulty,\x20and\x20anxiety</strong>.\x20Patients\x20should\x20be\x20<strong>advised\x20to\x20avoid\x20alcohol</strong>\x20while<strong>\x20taking</strong>\x20<strong>procarbazine\x20to\x20prevent\x20this\x20reaction.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Mechlorethamine:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Also\x20part\x20of\x20the\x20<strong>MOPP\x20regimen,\x20</strong>mechlorethamine\x20is\x20an\x20<strong>alkylating\x20agent\x20</strong>that\x20causes\x20<strong>DNA\x20crosslinks</strong>\x20but<strong>\x20does\x20not\x20</strong>induce\x20a<strong>\x20disulfiram-like\x20reaction\x20with\x20alcohol.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Oncovin\x20(Vincristine):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Vincristine\x20is\x20a\x20<strong>chemotherapeutic\x20agent</strong>\x20that<strong>\x20inhibits\x20microtubule\x20formation</strong>.\x20It\x20<strong>does\x20not</strong>\x20interact\x20with<strong>\x20alcohol\x20</strong>to\x20produce\x20<strong>disulfiram-like\x20reactions.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Prednisone:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20A<strong>\x20corticosteroid</strong>\x20used\x20in\x20various\x20<strong>chemotherapy\x20regimens,</strong>\x20including<strong>\x20MOPP,\x20prednisone\x20</strong>has\x20many\x20effects\x20on\x20<strong>metabolism\x20and\x20the\x20immune\x20system</strong>\x20but\x20<strong>does\x20not</strong>\x20cause<strong>\x20disulfiram-like\x20reactions\x20</strong>when\x20combined\x20with\x20<strong>alcohol.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Procarbazine</strong>\x20can\x20induce\x20a\x20<strong>disulfiram-like\x20reaction</strong>\x20when<strong>\x20taken</strong>\x20with\x20<strong>alcohol,</strong>\x20manifesting\x20as<strong>\x20severe\x20and\x20acute\x20symptoms\x20</strong>shortly\x20after\x20alcohol\x20consumption.\x20It\x20is\x20<strong>crucial\x20for\x20patients</strong>\x20receiving\x20<strong>procarbazine</strong>\x20to\x20<strong>avoid\x20alcohol\x20to\x20prevent</strong>\x20these\x20potentially\x20<strong>distressing</strong>\x20<strong>and\x20dangerous\x20effects.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Drugs\x20causing\x20disulfiram\x20like\x20reaction:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-145325.png\x22\x20style=\x22height:554px;\x20width:800px\x22\x20/></span></strong></span></span></p>','split','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Pembrolizumab\x20</span></span></span></p>','peaIE','WbiNZ','closest','{}.constructor(\x22return\x20this\x22)(\x20)','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Adriamycin</span></span></span></p>','Option\x20','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','selectedAnswer','jRxaE','MOnfL','totalTime','reload','BjRdI','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20less\x20neurotoxic\x20than\x20cyclophosphamide</span></span></span></p>','McapM','wVfpn','Previous\x20progress\x20cleared.','zRlcM','currentMode','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Histone\x20deacetylase\x20inhibitors</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2045-year-old\x20male\x20patient\x20is\x20being\x20treated\x20with\x20ABVD\x20chemotherapy\x20for\x20Hodgkin\x20lymphoma.\x20He\x20presents\x20for\x20cycle\x204\x20of\x20a\x20planned\x206\x20cycles\x20with\x20a\x20new-onset\x20cough.\x20He\x20states\x20it\x20started\x20a\x20week\x20ago\x20and\x20he\x20also\x20feels\x20like\x20he\x20has\x20a\x20little\x20trouble\x20catching\x20his\x20breath.\x20Which\x20drug\x20in\x20the\x20ABVD\x20regimen\x20is\x20the\x20most\x20likely\x20cause\x20of\x20his\x20pulmonary\x20toxicity?</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20IV\x20hydration,\x20mesna,\x20and\x20frequent\x20urinalyses.</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:\x20</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20<strong>chemotherapy\x20drugs</strong>\x20listed\x20<strong>(vincristine,\x20dactinomycin,\x20cyclophosphamide,\x20doxorubicin,\x20and\x20ifosfamide)</strong>\x20can\x20be\x20associated\x20with\x20<strong>potential\x20toxicities</strong>,\x20including<strong>\x20damage\x20to\x20the\x20bladder\x20and\x20kidneys</strong>.\x20Therefore,\x20it\x20is\x20important\x20to\x20include\x20<strong>measures\x20to\x20protect\x20</strong>these\x20<strong>organs\x20</strong>during<strong>\x20treatment.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>IV\x20hydration,\x20mesna,\x20and\x20frequent\x20urinalyses,</strong>\x20which\x20are\x20<strong>commonly\x20used\x20to\x20protect\x20the\x20bladder\x20and\x20kidneys</strong>\x20during\x20<strong>chemotherapy</strong>\x20with\x20<strong>ifosfamide\x20and\x20cyclophosphamide.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>IV\x20hydration</strong>\x20can\x20help\x20<strong>flush\x20out</strong>\x20the\x20drugs\x20and\x20prevent\x20the<strong>\x20buildup\x20of\x20toxic\x20metabolites\x20</strong>in\x20the\x20<strong>kidneys.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Mesna</strong>\x20can\x20<strong>prevent\x20damage\x20to\x20the\x20bladder\x20lining\x20</strong>by\x20<strong>neutralizing\x20metabolites\x20of\x20ifosfamide.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Frequent\x20urinalyses</strong>\x20can<strong>\x20help</strong>\x20<strong>monitor\x20</strong>for\x20<strong>signs\x20of\x20kidney\x20or\x20bladder\x20toxicity.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Leucovorin\x20and\x20frequent\x20urinalyses.\x20</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>Leucovorin</strong>\x20is\x20used\x20in\x20<strong>combination\x20with\x20the\x20methotrexate,</strong>\x20which\x20is<strong>\x20not\x20</strong>included\x20in\x20the\x20<strong>listed\x20chemotherapy\x20drugs.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Allopurinol\x20and\x20frequent\x20urinalyses</span></strong><span\x20style=\x22font-size:12.0pt\x22>.\x20<strong>Allopurinol\x20</strong>is\x20used\x20to<strong>\x20prevent\x20uric\x20acid\x20buildup\x20</strong>during\x20<strong>chemotherapy\x20for\x20lymphoma</strong>\x20but\x20is<strong>\x20not</strong>\x20used\x20for\x20<strong>rhabdomyosarcoma.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20IV\x20hydration,\x20prophylactic\x20antibiotics,\x20and\x20frequent\x20urinalyses</span></strong><span\x20style=\x22font-size:12.0pt\x22>.\x20<strong>Prophylactic\x20antibiotics\x20</strong>may\x20be\x20used\x20to\x20<strong>prevent\x20infections</strong>\x20<strong>during\x20chemotherapy</strong>,\x20but\x20is\x20<strong>not</strong>\x20typically\x20<strong>required\x20for\x20rhabdomyosarcoma\x20chemotherapy.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>For<strong>\x20patients\x20receiving\x20chemotherapy\x20regimens</strong>\x20that\x20include\x20<strong>cyclophosphamide\x20and\x20ifosfamide,</strong>\x20it\x20is\x20crucial\x20to\x20<strong>implement\x20measures</strong>\x20to<strong>\x20prevent\x20bladder\x20toxicity.\x20</strong>This\x20includes\x20the\x20<strong>use\x20of\x20IV\x20hydration\x20to\x20facilitate\x20dilution\x20of\x20urine,\x20mesna\x20to\x20chemically\x20neutralize\x20toxic</strong>\x20<strong>metabolites,</strong>\x20and\x20<strong>regular\x20monitoring\x20of\x20urinary\x20function</strong>\x20through<strong>\x20frequent\x20urinalyses</strong>.\x20These\x20<strong>steps\x20</strong>are<strong>\x20essential\x20to\x20protect\x20</strong>the\x20<strong>patient&rsquo;s\x20urinary\x20tract\x20</strong>and\x20ensure\x20the<strong>\x20safe\x20administration\x20of\x20potentially\x20nephrotoxic\x20chemotherapy\x20agents.</strong></span></span></span></p>','nvyqj','markReviewBtn','qEHzW','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Methotrexate</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate</strong>\x20is\x20a\x20<strong>chemotherapeutic\x20agent\x20</strong>that\x20acts\x20as\x20a<strong>\x20folate\x20analog\x20to\x20inhibit\x20the\x20enzyme\x20dihydrofolate\x20reductase.\x20</strong>This\x20enzyme\x20is<strong>\x20essential\x20for\x20the\x20synthesis\x20of\x20tetrahydrofolate,</strong>\x20a\x20molecule\x20necessary\x20for\x20the<strong>\x20production\x20of\x20thymidine\x20and\x20purine\x20nucleotides,</strong>\x20which\x20are\x20<strong>required\x20for\x20DNA\x20synthesis.</strong>\x20Since\x20DNA\x20synthesis\x20is\x20a\x20critical\x20activity\x20during\x20the<strong>\x20S\x20phase\x20of\x20the\x20cell\x20cycle,</strong>\x20<strong>methotrexate</strong>\x20primarily\x20exerts\x20its<strong>\x20cytotoxic\x20effects\x20in\x20this\x20phase</strong>,\x20making\x20it\x20particularly\x20<strong>effective\x20against\x20rapidly\x20dividing\x20cells</strong>\x20such\x20as\x20those\x20found\x20in\x20<strong>various\x20cancers.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.&nbsp;</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>Chlorambucil</strong>:\x20This\x20is\x20an<strong>\x20</strong><strong>alkylating\x20agent</strong>\x20that\x20<strong>acts</strong>\x20primarily\x20in\x20the\x20<strong>G1\x20and\x20S\x20phases,</strong>\x20but\x20it&#39;s\x20<strong>not\x20as\x20specific\x20</strong>to\x20the<strong>\x20S\x20phase</strong>\x20compared\x20to<strong>\x20some\x20other\x20drugs.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Vincristine</strong>:\x20Vincristine\x20is\x20a<strong>\x20mitotic\x20inhibitor\x20</strong>that\x20primarily\x20<strong>acts</strong>\x20on\x20the\x20<strong>M\x20phase\x20of\x20the\x20cell\x20cycle</strong>.\x20It\x20<strong>inhibits\x20microtubule</strong>\x20<strong>formation,\x20</strong>which\x20is\x20<strong>crucial\x20for\x20cell\x20division.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Paclitaxel</strong>:\x20Paclitaxel\x20is\x20also\x20a<strong>\x20mitotic\x20inhibitor\x20</strong>that\x20<strong>acts\x20</strong>mainly\x20on\x20the<strong>\x20M\x20phase.</strong>\x20It<strong>\x20stabilizes\x20microtubules,</strong>\x20<strong>preventing\x20</strong>their\x20<strong>disassembly,</strong>\x20which\x20is\x20necessary\x20for\x20<strong>cell\x20division.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate&#39;s</strong>\x20specific\x20action\x20of<strong>\x20inhibiting\x20DNA\x20synthesis\x20</strong>during\x20the\x20<strong>S\x20phase.</strong></span></span></span></p>','DpUHu','\x22\x20data-src=\x22','Q3920056','BcfVh','fInas','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','beginner','OXOaX','attachMedia','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vincristine\x20</span></span></span></p>','AGEHM','bOrGP','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Regorafenib</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Oncovin</span></span></span></p>','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>It\x20is\x20a\x20macrolide\x20lactone</span></p>','incorrectResult','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20It\x20is\x20a\x20monoclonal\x20antibody\x20produced\x20by\x20injecting\x20the\x20HER2\x20antigen</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Herceptin\x20(trastuzumab)</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20that\x20specifically\x20targets\x20the<strong>\x20human\x20epidermal\x20growth\x20factor\x20receptor</strong>\x20<strong>2\x20(HER2)\x20protein</strong>,\x20which\x20is\x20<strong>overexpressed\x20</strong>in\x20approximately\x20<strong>25%\x20of\x20breast\x20cancers</strong>.\x20It\x20is\x20produced\x20by\x20<strong>injecting</strong><strong>\x20</strong>the\x20<strong>HER2\x20antigen</strong>\x20into<strong>\x20mice\x20</strong>and\x20then<strong>\x20harvesting\x20the\x20resulting\x20monoclonal\x20antibodies.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>It\x20is\x20an\x20antibody\x20produced\x20entirely\x20from\x20mice\x20containing\x20no\x20human\x20component:</strong>\x20This\x20statement\x20is\x20<strong>incorrect.</strong>\x20<strong>Trastuzumab</strong>\x20is<strong>\x20not</strong>\x20a<strong>\x20fully\x20murine\x20</strong>(<strong>mouse-derived</strong>)\x20<strong>antibody.</strong>\x20It\x20is,\x20in\x20fact,\x20a<strong>\x20humanized\x20monoclonal\x20antibody,\x20</strong>which\x20means\x20it\x20is<strong>\x20predominantly\x20of</strong>\x20<strong>human\x20origin</strong>,\x20but\x20with\x20<strong>mouse-derived\x20antigen-binding\x20regions.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Option\x20C.\x20It\x20is\x20a\x20polyclonal\x20antibody:</strong>\x20This\x20statement\x20is<strong>\x20incorrect.\x20Trastuzumab</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody,</strong>\x20meaning\x20it\x20is\x20made\x20by\x20<strong>identical\x20immune\x20cells</strong>\x20that\x20are\x20all<strong>\x20clones</strong>\x20of\x20a\x20<strong>unique\x20parent\x20cell</strong>,\x20and\x20it\x20<strong>targets\x20a\x20specific\x20epitope</strong>\x20on\x20the\x20<strong>HER2\x20receptor.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>It\x20is\x20a\x20monoclonal\x20antibody\x20containing\x20only\x20human\x20components:\x20</strong>This\x20is\x20<strong>not\x20accurate</strong>.\x20<strong>Trastuzumab\x20</strong>is\x20<strong>humanized,</strong>\x20meaning\x20it\x20<strong>combines\x20both\x20human\x20and\x20mouse\x20antibody\x20components.</strong>\x20The\x20<strong>majority</strong>\x20of\x20the<strong>\x20antibody\x20is\x20human,</strong>\x20with\x20<strong>mouse</strong>\x20<strong>components</strong>\x20in\x20the<strong>\x20antigen-binding\x20region.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22><strong>Trastuzumab\x20(Herceptin)</strong>\x20is\x20a<strong>\x20humanized\x20monoclonal\x20antibody\x20</strong>used\x20in\x20the\x20treatment\x20of\x20<strong>HER2-positive\x20breast\x20cancer.</strong>\x20It\x20is\x20crucial\x20to\x20understand\x20that\x20it<strong>\x20targets\x20the\x20HER2\x20receptor,</strong>\x20which\x20is\x20<strong>overexpressed\x20</strong>in\x20certain\x20<strong>aggressive\x20forms\x20of\x20breast\x20cancer</strong>,\x20helping\x20to<strong>\x20inhibit</strong>\x20the\x20<strong>growth\x20and&nbsp;</strong></span></span><strong><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>spread\x20of\x20cancer\x20cells.\x20</span></span></span></strong></p>','SSaol','gdJho','Q3428289','XiMnZ','xApGJ','rtmsw','yEEuE','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Used\x20in\x20non-small\x20cell\x20carcinoma\x20of\x20lung</span></span></span></p>','Bookmark','TmAjg','UyFaT','click','MukTy','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Methotrexate</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate\x20</strong>is\x20a\x20well-known\x20<strong>chemotherapeutic\x20agent</strong>\x20that\x20specifically\x20targets\x20the<strong>\x20S\x20phase\x20of\x20the\x20cell\x20cycle</strong>,\x20which\x20is\x20the\x20phase\x20in\x20which<strong>\x20DNA\x20synthesis\x20occurs.</strong>\x20It\x20acts\x20by<strong>\x20inhibiting\x20dihydrofolate\x20reductase,</strong>\x20an\x20enzyme\x20critical\x20for\x20the<strong>\x20synthesis\x20of\x20tetrahydrofolate,</strong>\x20necessary\x20for\x20the\x20<strong>production\x20of\x20thymidylate\x20and\x20purine\x20nucleotides</strong>&mdash;both\x20<strong>essential\x20</strong>components\x20for\x20<strong>DNA\x20replication</strong>\x20and\x20<strong>cell</strong>\x20<strong>division</strong>.\x20This\x20specific\x20mechanism\x20makes<strong>\x20Methotrexate</strong>\x20particularly\x20<strong>effective\x20during\x20the\x20S\x20phase,</strong>\x20where\x20it\x20can\x20<strong>inhibit\x20the\x20growth\x20of</strong>\x20<strong>cancer\x20cells\x20</strong>by\x20preventing<strong>\x20DNA\x20replication.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Chlorambucil:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20drug\x20is\x20an\x20<strong>alkylating\x20agent</strong>\x20that\x20is<strong>\x20not\x20</strong>specific\x20to\x20any<strong>\x20particular\x20phase\x20of\x20the\x20cell\x20cycle</strong>.\x20It\x20can\x20form\x20<strong>cross-links\x20in\x20DNA</strong>\x20<strong>at\x20any\x20phase</strong>,\x20thereby\x20causing\x20<strong>damage</strong>\x20that\x20leads\x20to<strong>\x20cell\x20death.</strong>\x20While\x20effective\x20<strong>against\x20various\x20cancers,\x20</strong>it\x20<strong>does</strong>\x20<strong>not</strong>\x20specifically\x20target\x20the<strong>\x20S\x20phase.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Vincristine:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Vincristine\x20is\x20a<strong>\x20vinca\x20alkaloid</strong>\x20that\x20acts\x20predominantly\x20during\x20the\x20<strong>M\x20phase\x20of\x20the\x20cell\x20cycle.\x20</strong>It<strong>\x20inhibits</strong>\x20<strong>microtubule\x20formation</strong>,\x20which\x20is\x20essential\x20for\x20<strong>mitotic\x20spindle</strong>\x20assembly\x20and\x20<strong>chromosome</strong>\x20separation\x20during\x20<strong>mitosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Paclitaxel:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Also\x20acting\x20in\x20the<strong>\x20M\x20phase,</strong>\x20Paclitaxel\x20stabilizes\x20<strong>microtubules\x20</strong>and\x20<strong>prevents\x20</strong>their\x20<strong>disassembly,\x20</strong>thus<strong>\x20inhibiting</strong>\x20the\x20<strong>completion\x20of\x20mitosis\x20</strong>and\x20<strong>leading\x20to\x20cell\x20death.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate</strong>\x20is\x20a<strong>\x20cell\x20cycle-specific\x20anticancer\x20drug\x20</strong>that\x20acts\x20by\x20<strong>inhibiting\x20DNA\x20synthesis</strong>\x20in\x20the<strong>\x20&#39;S&#39;\x20phase</strong>\x20of\x20the\x20cell\x20cycle.\x20</span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Chlorambucil</strong>\x20is\x20a\x20<strong>cell\x20cycle-nonspecific\x20alkylating\x20agent\x20</strong>that\x20can\x20affect\x20cells\x20in\x20<strong>any\x20phase\x20of\x20the\x20cell\x20cycle.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Vincristine\x20and\x20Paclitaxel\x20</strong>are<strong>\x20cell\x20cycle-specific\x20anticancer\x20drug\x20</strong>that\x20acts\x20in\x20the<strong>\x20&#39;M&#39;\x20phase\x20of\x20the\x20cell\x20cycle.</strong></span></span></span></li>\x0d\x0a</ul>','pXyRX','Incorrect','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','answered','CRGMh','dvLQx','KDHeL','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20Dihydrofolate\x20reductase\x20</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Folic\x20acid\x20and\x20vitamin\x20B12</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Pemetrexed\x20</strong>is\x20a\x20<strong>chemotherapy\x20agent\x20</strong>primarily\x20used\x20to\x20<strong>treat\x20lung\x20cancer\x20and\x20mesothelioma.</strong>\x20A\x20<strong>major\x20side\x20effect</strong>\x20of\x20pemetrexed\x20is\x20<strong>myelosuppression</strong>,\x20which\x20can\x20lead\x20to\x20serious<strong>\x20blood-related\x20issues\x20</strong>such\x20as\x20<strong>anemia,\x20neutropenia,\x20and\x20thrombocytopenia.</strong>\x20To\x20<strong>counteract\x20this\x20toxicity</strong>,\x20supplementation\x20with<strong>\x20folic\x20acid\x20and\x20vitamin\x20B12\x20</strong>is\x20recommended.\x20<strong>Folic\x20acid\x20</strong>helps\x20maintain\x20necessary\x20levels\x20of\x20<strong>folate\x20within\x20cells</strong>,\x20aiding\x20in<strong>\x20DNA\x20and\x20RNA\x20synthesis\x20</strong>which\x20are\x20crucial\x20<strong>during\x20cell\x20division.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Pemetrexed\x20interferes</strong>\x20with<strong>\x20folate\x20metabolism\x20by\x20inhibiting</strong>\x20key\x20<strong>enzymes</strong>;\x20therefore,\x20<strong>folic\x20acid\x20supplementation</strong>\x20is\x20vital\x20to\x20<strong>mitigate</strong>\x20this\x20effect.\x20Similarly,<strong>\x20vitamin\x20B12\x20plays\x20a\x20critical\x20role\x20in\x20DNA\x20synthesis\x20</strong>and\x20<strong>red\x20blood\x20cell\x20maturation.\x20Supplementation\x20with\x20vitamin</strong>\x20<strong>B12\x20</strong>helps\x20<strong>prevent\x20deficiencies</strong>\x20that\x20can\x20<strong>exacerbate\x20anemia\x20</strong>and\x20other\x20<strong>hematological\x20issues</strong>\x20caused\x20by\x20<strong>pemetrexed.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Folinic\x20acid\x20and\x20vitamin\x20B6:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20combination\x20is<strong>\x20incorrect\x20as\x20folinic\x20acid,</strong>\x20while\x20related\x20to\x20folate,\x20is\x20<strong>not\x20</strong>used\x20to\x20mitigate\x20the\x20toxicity\x20associated\x20with\x20pemetrexed,\x20and\x20<strong>vitamin\x20B6\x20does\x20not</strong>\x20play\x20a\x20role\x20in\x20<strong>mitigating\x20pemetrexed&#39;s\x20specific\x20toxic\x20effects</strong>.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Vitamin\x20B6\x20and\x20vitamin\x20B12:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Vitamin\x20B12\x20is\x20<strong>correct</strong>\x20in\x20part;\x20however,<strong>\x20vitamin\x20B6</strong>\x20<strong>does\x20not</strong>\x20aid\x20in\x20<strong>ameliorating\x20</strong>the\x20<strong>specific</strong>\x20<strong>toxicities\x20of\x20pemetrexed.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Folic\x20acid\x20and\x20dexamethasone:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While<strong>\x20folic\x20acid\x20</strong>is\x20a\x20<strong>correct\x20component</strong>,<strong>\x20dexamethasone\x20</strong>is\x20primarily\x20used\x20for\x20its\x20<strong>anti-inflammatory\x20properties\x20</strong>and\x20<strong>not\x20for</strong>\x20<strong>mitigating\x20myelosuppression</strong>\x20caused\x20by<strong>\x20pemetrexed.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>For<strong>\x20patients</strong>\x20undergoing<strong>\x20treatment\x20with\x20pemetrexed</strong>,\x20it\x20is\x20<strong>crucial\x20to\x20supplement</strong>\x20with\x20<strong>folic\x20acid\x20and\x20vitamin\x20B12</strong>\x20to\x20<strong>reduce\x20the\x20risk\x20of</strong>\x20<strong>myelosuppression\x20</strong>and\x20related\x20<strong>complications.\x20</strong>This\x20supplementation\x20strategy\x20helps\x20<strong>maintain\x20necessary\x20folate\x20and\x20vitamin\x20B12</strong>\x20<strong>levels</strong>,\x20<strong>supporting\x20DNA\x20synthesis\x20and\x20red\x20blood\x20cell\x20maturation</strong>,\x20thereby<strong>\x20counteracting\x20the\x20drug&#39;s\x20</strong>potential\x20<strong>hematological\x20toxicities.</strong></span></span></span></p>','kDoPj','Correct','stringify','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Tofacitinib\x20is\x20administered\x20by\x20intravenous\x20route</span></span></span></p>','NviTx','nav-btn-incorrect','remove','Q6236379','cHbnB','Mark\x20for\x20Review','PpUtP','EIgwl','QYkxU','mpoTP','wJNXX','nwNVE','zmciT','KrPDj','rfNQF','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Methotrexate\x20</span></span></span></p>','forEach','eAKLY','tFTSR','wZxyT','UGnou','target','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20a\x20monoclonal\x20antibody\x20produced\x20by\x20injecting\x20the\x20HER2\x20antigen</span></span></span></p>','testModeLegend','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Non-proliferative\x20cells\x20are\x20relatively\x20resistant\x20to\x20methotrexate</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Capecitabine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20symptoms\x20described\x20&ndash;\x20<strong>tingling,\x20numbness,\x20pain,\x20and\x20erythema</strong>\x20on\x20the\x20<strong>palms\x20and\x20soles\x20</strong>&ndash;\x20are<strong>\x20indicative\x20</strong>of\x20a\x20condition\x20<strong>known\x20as</strong>\x20<strong>hand-foot\x20syndrome</strong>\x20or\x20<strong>palmar-plantar\x20erythrodysesthesia</strong>.\x20This\x20condition\x20is\x20a\x20<strong>known\x20side\x20effect\x20</strong>of\x20certain\x20<strong>chemotherapy\x20drugs</strong>.\x20Among\x20the\x20options\x20given,\x20the\x20<strong>drug</strong>\x20most\x20likely\x20to\x20<strong>cause</strong>\x20these\x20symptoms\x20in\x20patients<strong>\x20undergoing\x20treatment\x20for\x20colorectal\x20cancer</strong>\x20is\x20<strong>capecitabine</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Capecitabine</strong>\x20is\x20an\x20<strong>oral\x20prodrug\x20of\x205-fluorouracil\x20(5-FU)</strong>\x20and\x20is\x20commonly\x20used\x20in\x20the\x20treatment\x20of\x20<strong>colorectal\x20cancer.</strong>\x20<strong>Hand-foot</strong>\x20<strong>syndrome\x20</strong>is\x20a\x20<strong>well-known\x20</strong>and\x20<strong>relatively\x20common</strong>\x20side\x20effect\x20of\x20<strong>capecitabine,</strong>\x20characterized\x20by\x20<strong>redness,\x20swelling,\x20pain,\x20</strong>and\x20<strong>numbness</strong>\x20in\x20the\x20<strong>palms\x20of\x20the\x20hands\x20and\x20soles\x20of\x20the\x20feet.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Cladribine</strong>:\x20Primarily<strong>\x20used</strong>\x20in<strong>\x20hairy\x20cell\x20leukemia,</strong>\x20<strong>cladribine</strong>\x20can\x20cause\x20<strong>several\x20side\x20effects</strong>\x20but\x20is\x20<strong>not\x20</strong>typically\x20associated\x20with<strong>\x20hand-foot\x20syndrome.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Gemcitabine</strong>:\x20Used\x20in<strong>\x20various\x20cancers</strong>,\x20including\x20<strong>pancreatic,\x20breast,\x20and\x20non-small\x20cell\x20lung\x20cancer</strong>.\x20While\x20<strong>gemcitabine\x20</strong>has\x20many<strong>\x20side\x20effects,</strong>\x20it\x20is<strong>\x20less</strong>\x20commonly\x20associated\x20with<strong>\x20hand-foot\x20syndrome</strong>\x20compared\x20to<strong>\x20capecitabine.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Bleomycin</strong>:\x20Used\x20in\x20the\x20<strong>treatment\x20of\x20Hodgkin&#39;s\x20lymphoma</strong>,\x20<strong>testicular\x20cancer,</strong>\x20and<strong>\x20other\x20types\x20of\x20cancer.\x20Bleomycin</strong>\x20is\x20<strong>more\x20</strong>known\x20for<strong>\x20pulmonary\x20side\x20effects,</strong>\x20and<strong>\x20hand-foot\x20syndrome</strong>\x20is<strong>\x20not</strong>\x20a\x20<strong>typical\x20side\x20effect\x20of\x20this\x20drug.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Capecitabine</strong>\x20is\x20the\x20likely\x20cause\x20of\x20the\x20symptoms\x20due\x20to\x20its\x20<strong>known\x20</strong>association\x20with<strong>\x20hand-foot\x20syndrome</strong>,\x20particularly\x20in\x20patients\x20treated\x20for<strong>\x20colorectal\x20cancer.</strong></span></span></span></p>','MaoQE','WBlyx','jfGNQ','lNgEt','yOmkB','incorrectCount','maopD','questionText','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Bisphosphonates</span></span></span></p>','tpFPG','WnCJs','Not\x20Attempted','lHpRa','qnDIM','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20D)\x20Vemurafenib</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Vemurafenib</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20is\x20a\x20<strong>tyrosine\x20kinase\x20inhibitor</strong>\x20that\x20specifically\x20targets\x20the<strong>\x20BRAF\x20V600E\x20mutation</strong>\x20in\x20<strong>malignant\x20melanoma.</strong>\x20This\x20mutation\x20is\x20<strong>present</strong>\x20in\x20a\x20<strong>significant\x20percentage\x20of\x20melanomas</strong>\x20and\x20contributes\x20to\x20the<strong>\x20growth\x20of\x20cancer\x20cells.</strong>\x20By\x20<strong>inhibiting\x20the\x20mutated\x20BRAF</strong>\x20<strong>kinase,\x20vemurafenib</strong>\x20can<strong>\x20slow\x20or\x20stop\x20</strong>the\x20<strong>growth\x20of\x20the\x20melanoma\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Erlotinib:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Erlotinib\x20is\x20used\x20primarily\x20for\x20<strong>non-small\x20cell\x20lung\x20carcinoma\x20(NSCLC)</strong>\x20and\x20<strong>pancreatic\x20cancer.</strong>\x20It\x20<strong>targets\x20</strong>the\x20<strong>epidermal\x20growth\x20factor\x20receptor\x20(EGFR),</strong>\x20which\x20is<strong>\x20overexpressed\x20or\x20mutated\x20</strong>in\x20these\x20cancers.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Regorafenib:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Regorafenib\x20is\x20used\x20for\x20<strong>colorectal\x20carcinoma\x20and\x20gastrointestinal\x20stromal\x20tumors\x20(GIST).</strong>\x20It\x20<strong>inhibits</strong>\x20multiple\x20<strong>protein\x20kinases</strong>\x20involved\x20in<strong>\x20tumor\x20angiogenesis,\x20oncogenesis,\x20</strong>and\x20the<strong>\x20tumor\x20microenvironment.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Sorafenib:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Sorafenib\x20is\x20used\x20mainly\x20for<strong>\x20hepatocellular\x20carcinoma\x20(HCC)\x20</strong>and\x20also\x20for<strong>\x20renal\x20cell\x20carcinoma\x20(RCC)</strong>.\x20It\x20<strong>targets</strong>\x20<strong>multiple\x20kinases</strong>,\x20including\x20those\x20involved\x20in\x20<strong>angiogenesis\x20and\x20cell\x20proliferation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Vemurafenib</strong>\x20is<strong>\x20used\x20for\x20</strong>the\x20treatment\x20of\x20<strong>malignant\x20melanoma.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Erlotinib\x20</strong>is\x20<strong>used\x20for&nbsp;\x20non-small\x20cell\x20carcinoma\x20of\x20lung\x20and\x20pancreatic\x20carcinoma.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Regorafenib</strong>\x20is\x20used\x20for<strong>\x20colorectal\x20carcinoma\x20and\x20GIST.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Sorafenib\x20</strong>is\x20used\x20for\x20<strong>hepatocellular\x20carcinoma.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Indications\x20of\x20tyrosine\x20kinase\x20inhibitors</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-151648.png\x22\x20style=\x22height:543px;\x20width:900px\x22\x20/></span></strong></span></span></p>','status','push','WmyLC','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Mithramycin</span></span></span></p>','getItem','DBOfL','currentQuestion','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Medulloblastoma</span></span></span></p>','lIbOC','tgyoG','add','eaNHa','textContent','LsgUG','1314474KwEytM','PkhgR','OBMEQ','yzkIf','removeItem','RNIkx','meCdq','yWKeP','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','TacsD','markedForReview','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Pembrolizumab</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Pembrolizumab</strong>:\x20Pembrolizumab\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20that\x20targets\x20the\x20<strong>programmed\x20death\x201\x20(PD-1)\x20receptor\x20on\x20T</strong>\x20<strong>cells</strong>,\x20which\x20helps\x20to\x20<strong>stimulate</strong>\x20an<strong>\x20immune\x20response\x20against\x20cancer\x20cells.</strong>\x20This\x20therapy\x20has\x20been\x20approved\x20by\x20the\x20<strong>FDA\x20to</strong>\x20<strong>treat\x20head\x20and\x20neck\x20cancer,\x20</strong>as\x20well\x20as\x20other\x20types\x20of\x20cancer\x20such\x20as\x20<strong>melanoma,\x20non-small\x20cell\x20lung\x20cancer,\x20and\x20Hodgkin\x20lymphoma.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Trastuzumab</strong>:\x20Trastuzumab\x20is\x20a<strong>\x20monoclonal\x20antibody</strong>\x20that\x20is\x20<strong>used</strong>\x20to\x20treat\x20<strong>HER2-positive\x20breast\x20cancer,\x20</strong>which\x20is\x20a\x20type\x20of\x20<strong>breast\x20cancer</strong>\x20that\x20has\x20<strong>high\x20levels\x20of\x20the\x20protein\x20HER2</strong>\x20on\x20the<strong>\x20surface</strong>\x20of\x20the\x20<strong>cancer\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Rituximab</strong>:\x20Rituximab\x20is\x20a<strong>\x20monoclonal\x20antibody</strong>\x20that\x20is\x20used\x20to\x20treat\x20non-Hodgkin&#39;s\x20lymphoma,\x20<strong>chronic\x20lymphocytic</strong>\x20<strong>leukemia,\x20and\x20rheumatoid\x20arthritis</strong>.\x20It\x20works\x20by\x20<strong>targeting\x20a\x20protein\x20</strong>called\x20<strong>CD20\x20</strong>on\x20the\x20<strong>surface\x20of\x20B\x20cells</strong>,\x20which\x20are\x20a\x20type\x20of\x20<strong>immune\x20cell\x20</strong>that\x20can\x20become<strong>\x20cancerous\x20</strong>in\x20certain\x20conditions.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Ocrelizumab</strong>:\x20Ocrelizumab\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20that\x20is<strong>\x20used\x20to\x20treat\x20multiple\x20sclerosis,\x20a\x20chronic\x20autoimmune\x20disease</strong>\x20that\x20affects\x20the<strong>\x20central\x20nervous\x20system</strong>.\x20It<strong>\x20targets\x20a\x20protein</strong>\x20called<strong>\x20CD20\x20on\x20B\x20cells,</strong>\x20which\x20are\x20thought\x20to\x20play\x20a\x20role\x20in\x20the\x20<strong>development\x20of\x20the\x20disease.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Pembrolizumab\x20</strong>is\x20utilized\x20in\x20the\x20treatment\x20of<strong>\x20head\x20and\x20neck\x20cancer\x20</strong>due\x20to\x20its\x20ability\x20to\x20<strong>enhance\x20</strong>the\x20<strong>immune\x20response\x20</strong>against\x20<strong>cancer\x20cells\x20by\x20inhibiting\x20the\x20PD-1\x20pathway</strong>.\x20This\x20action\x20<strong>helps\x20to\x20counteract\x20the\x20immune\x20evasion\x20tactics\x20</strong>employed\x20by\x20many\x20<strong>cancers,</strong>\x20<strong>highlighting\x20</strong>the\x20importance\x20of<strong>\x20immune\x20checkpoint\x20inhibitors</strong>\x20in\x20<strong>modern\x20oncology.</strong></span></span></span></p>','jNqxP','FzAFE','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Bleomycin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Bleomycin</strong>,\x20an<strong>\x20antineoplastic\x20agent,\x20</strong>is\x20<strong>widely\x20used\x20</strong>to\x20treat\x20<strong>lung\x20cancer,\x20lymphomas,\x20and\x20other\x20cancers.</strong>\x20Its\x20significant<strong>\x20side\x20effect</strong>\x20of\x20<strong>pulmonary\x20toxicity,</strong>\x20which\x20may\x20present\x20as<strong>\x20interstitial\x20pneumonitis\x20or\x20pulmonary\x20fibrosis,\x20</strong>is\x20particularly<strong>\x20dangerous\x20</strong>in\x20patients\x20with\x20<strong>pre-existing\x20lung\x20</strong>conditions\x20such\x20as<strong>\x20COPD\x20and\x20bronchiectasis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Given\x20the\x20patient&#39;s<strong>\x20respiratory\x20history\x20and\x20ongoing\x20lung\x20challenges</strong>,\x20the\x20<strong>risk\x20</strong>of<strong>\x20exacerbating\x20pulmonary\x20symptoms</strong>\x20or\x20inducing\x20further\x20<strong>lung\x20damage</strong>\x20makes\x20<strong>Bleomycin\x20a\x20poor\x20choice.</strong>\x20This<strong>\x20heightened\x20sensitivity</strong>\x20to<strong>\x20lung-related\x20side\x20effects</strong>\x20necessitates\x20the\x20<strong>avoidance\x20of\x20Bleomycin</strong>\x20in\x20favor\x20of\x20other\x20<strong>chemotherapeutic\x20agents</strong>\x20<strong>less\x20likely\x20</strong>to\x20affect\x20<strong>pulmonary\x20function.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Vinblastine:&nbsp;</span></strong><span\x20style=\x22font-size:12.0pt\x22>While\x20Vinblastine\x20can\x20have\x20its\x20own\x20set\x20of\x20<strong>side\x20effect</strong>s,\x20including<strong>\x20bone\x20marrow\x20suppression</strong>\x20and\x20<strong>neurotoxicity</strong>,\x20it\x20<strong>does\x20not\x20</strong>specifically\x20<strong>exacerbate\x20lung\x20</strong></span></span></span><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>conditions</strong>\x20like\x20<strong>COPD\x20or\x20bronchiectasis,</strong>\x20making\x20it\x20a<strong>\x20safer</strong>\x20option\x20than\x20Bleomycin.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Mithramycin:&nbsp;</span></strong><span\x20style=\x22font-size:12.0pt\x22>This\x20drug\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>testicular\x20cancer\x20</strong>and<strong>\x20certain\x20types</strong>\x20of<strong>\x20hypercalcemia</strong>\x20but\x20is<strong>\x20less</strong>\x20commonly\x20associated\x20with\x20<strong>pulmonary\x20complications,</strong>\x20making\x20it\x20a\x20potentially\x20<strong>safer\x20option\x20</strong>for\x20this\x20patient.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Adriamycin\x20(Doxorubicin):&nbsp;</span></strong><span\x20style=\x22font-size:12.0pt\x22>Adriamycin\x20is\x20known\x20for\x20its\x20<strong>cardiotoxicity\x20rather\x20than\x20pulmonary\x20toxicity,</strong>\x20and\x20therefore,\x20it\x20<strong>does\x20not\x20pose</strong>\x20the\x20same\x20specific\x20<strong>risk\x20to\x20patients\x20with\x20pre-existing\x20lung\x20diseases\x20as\x20Bleomycin</strong>.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>In\x20patients\x20with<strong>\x20pre-existing\x20lung\x20</strong>conditions\x20such\x20as\x20<strong>COPD\x20and\x20bronchiectasis,\x20Bleomycin</strong>\x20should\x20be<strong>\x20avoided\x20</strong>due\x20to\x20its<strong>\x20potential\x20to</strong>\x20cause\x20significant\x20<strong>pulmonary\x20toxicity.</strong></span></span></span></p>','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Dacarbazine</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2050-year-old\x20woman\x20named\x20Hema\x20has\x20locally\x20advanced\x20breast\x20cancer\x20and\x20has\x20been\x20recommended\x20for\x20chemotherapy.\x20She\x20has\x20a\x20history\x20of\x20myocardial\x20infarction\x20and\x20congestive\x20heart\x20failure.\x20Which\x20antineoplastic\x20drug\x20should\x20be\x20avoided\x20in\x20her\x20treatment?</span></span></span></p>','iSeEm','reviewQuestionsContainer','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Inhibition\x20of\x20microtubule\x20polymerization</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The<strong>\x20drugs\x20derived</strong>\x20<strong>from</strong>\x20the\x20<strong>periwinkle\x20plant\x20</strong>are\x20<strong>vincristine\x20and\x20vinblastine.</strong>\x20These\x20belongs\x20to\x20the\x20<strong>class\x20of\x20drugs</strong>\x20known\x20as\x20<strong>vinca</strong>\x20<strong>alkaloids</strong>.\x20These\x20act\x20by<strong>\x20inhibiting\x20microtubule\x20polymerization</strong>,\x20which\x20<strong>disrupts\x20the\x20formation\x20of\x20the\x20mitotic\x20spindle</strong>\x20during<strong>\x20cell</strong>\x20<strong>division,</strong>\x20leading\x20to<strong>\x20cell\x20cycle\x20arrest\x20and\x20apoptosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Doxorubicin\x20and\x20etoposide\x20</strong>work\x20by\x20<strong>inhibiting\x20DNA\x20synthesis</strong>\x20and\x20<strong>DNA\x20topoisomerase\x20II,</strong>\x20respectively,\x20they\x20are\x20<strong>not</strong>\x20<strong>derived\x20from\x20the\x20periwinkle\x20plant.\x20</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Inhibition\x20of\x20tyrosine\x20kinase\x20activity</strong>\x20is\x20the<strong>\x20mechanism\x20of\x20action</strong>\x20of\x20drugs\x20such\x20as<strong>\x20imatinib</strong>,\x20which\x20is\x20<strong>drug\x20of\x20choice</strong>\x20for\x20<strong>CML\x20and\x20GIST.\x20</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Inhibition\x20of\x20DNA\x20synthesis:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While\x20some\x20<strong>chemotherapeutic\x20agents\x20</strong>do\x20<strong>inhibit\x20DNA\x20synthesis,</strong>\x20the<strong>\x20drugs\x20derived\x20</strong>from\x20the\x20<strong>periwinkle\x20plan</strong>t<strong>\x20do\x20not</strong>\x20act\x20through\x20this<strong>\x20mechanism.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Inhibition\x20of\x20DNA\x20topoisomerase\x20II:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20the\x20<strong>mechanism\x20of\x20action</strong>\x20for\x20drugs\x20like<strong>\x20etoposide</strong>,\x20not\x20vinca\x20alkaloids.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Inhibition\x20of\x20tyrosine\x20kinase\x20activity:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Drugs\x20like<strong>\x20imatinib\x20inhibit\x20tyrosine\x20kinase\x20activity</strong>\x20and\x20are\x20used\x20for\x20conditions\x20such\x20as\x20<strong>chronic\x20myelogenous\x20leukemia\x20(CML)\x20and\x20gastrointestinal\x20stromal\x20tumors\x20(GIST),\x20</strong>which\x20is\x20<strong>not</strong>\x20the\x20mechanism\x20for\x20<strong>vinca\x20alkaloids.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Vinca\x20alkaloids,</strong>\x20such\x20as<strong>\x20vincristine\x20and\x20vinblastine</strong>,\x20work\x20by<strong>\x20inhibiting\x20microtubule\x20polymerization,\x20</strong>leading\x20to\x20<strong>disruption\x20of\x20mitotic</strong>\x20<strong>spindle\x20formation,</strong>\x20<strong>cell\x20cycle\x20arrest</strong>,\x20and<strong>\x20ultimately\x20apoptosis</strong>.\x20This\x20mechanism\x20is<strong>\x20distinct\x20</strong>and\x20<strong>should\x20no</strong>t\x20be\x20confused\x20with\x20drugs\x20that<strong>\x20inhibit\x20DNA\x20synthesis,\x20DNA\x20topoisomerase\x20II,</strong>\x20or<strong>\x20tyrosine\x20kinase\x20activity.</strong></span></span></span></p>','VYTcX','solutionContainer','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Bleomycin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The<strong>\x20ABVD\x20regimen,</strong>\x20used\x20in\x20the\x20treatment\x20of<strong>\x20Hodgkin\x20lymphoma,\x20</strong>includes\x20four\x20drugs:\x20<strong>Doxorubicin,\x20Bleomycin,\x20Vinblastine,\x20</strong>and\x20<strong>Dacarbazine</strong>.\x20Each\x20of\x20these\x20drugs\x20has\x20<strong>its\x20own\x20side\x20effect\x20profile.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>In\x20the\x20given\x20<strong>patient</strong>\x20who\x20<strong>presents\x20with\x20</strong>a<strong>\x20new-onset\x20cough\x20and\x20shortness\x20of\x20breath,</strong>\x20the\x20drug\x20most\x20likely\x20responsible\x20for\x20these\x20symptoms\x20of\x20<strong>pulmonary\x20toxicity\x20is&nbsp;bleomycin</strong>.\x20The\x20pulmonary\x20toxicity\x20can\x20be\x20manifested\x20as\x20<strong>interstitial\x20pneumonitis\x20and\x20pulmonary</strong>\x20<strong>fibrosis.</strong>\x20Symptoms\x20like<strong>\x20coughing\x20and\x20difficulty\x20breathing</strong>\x20are\x20characteristic\x20of\x20<strong>bleomycin-induced\x20lung\x20damage</strong>.\x20The\x20<strong>risk\x20of</strong>\x20<strong>pulmonary\x20toxicity</strong>\x20<strong>increases\x20</strong>with\x20<strong>higher\x20cumulative\x20doses.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Doxorubicin</strong>:\x20<strong>As\x20part\x20</strong>of\x20the\x20<strong>ABVD\x20regimen,</strong>\x20<strong>doxorubicin&#39;s</strong>\x20primary\x20toxicities\x20are\x20<strong>cardiotoxicity\x20and\x20myelosuppression</strong>.\x20<strong>Pulmonary\x20toxicity</strong>\x20is<strong>\x20not</strong>\x20a\x20common\x20side\x20effect\x20of\x20<strong>doxorubicin.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Vinblastine</strong>:\x20<strong>Another\x20component</strong>\x20of\x20the\x20<strong>ABVD\x20regimen</strong>,\x20vinblastine\x20typically\x20causes\x20side\x20effects\x20such\x20as\x20<strong>neurotoxicity\x20and</strong>\x20<strong>myelosuppression.\x20</strong>It\x20is<strong>\x20not\x20</strong>generally\x20associated\x20with<strong>\x20pulmonary\x20toxicity.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Dacarbazine</strong>:\x20The<strong>\x20final\x20drug</strong>\x20in\x20the\x20<strong>ABVD\x20regimen</strong>,\x20<strong>dacarbazine</strong>\x20can\x20cause\x20<strong>nausea,\x20vomiting,\x20and\x20myelosuppression,</strong>\x20but\x20like\x20the\x20others,\x20it\x20is<strong>\x20not</strong>\x20known\x20for<strong>\x20causing\x20pulmonary\x20toxicity.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>In\x20<strong>patients</strong>\x20<strong>undergoing\x20ABVD\x20chemotherapy</strong>\x20who\x20develop\x20<strong>respiratory\x20symptoms\x20</strong>such\x20as\x20<strong>coughing\x20and\x20shortness\x20of\x20breath,</strong>\x20<strong>Bleomycin\x20</strong>is\x20the<strong>\x20agent</strong>\x20within\x20the\x20regimen\x20<strong>most\x20likely</strong>\x20to\x20be\x20<strong>responsible\x20for\x20pulmonary\x20toxicity.</strong></span></span></span></p>','WsFnj','peMqQ','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>mTOR\x20inhibitor</span></span></span></p>','custom_quiz.html','Hqvmq','nav-btn-correct','PsxXR','ZbPYB','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Deep\x20vein\x20thrombosis</span></span></span></p>','ILWRu','Q9951085','Oevvo','gbfzk','questionIndex','saMGj','none','Q8084760','LGdLD','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','application/vnd.apple.mpegurl','Q6966459','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','EvkNZ','izAYK','KLKDr','exception','timeSpent','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20a\x20polyclonal\x20antibody</span></span></span></p>','tsYhQ','name','return\x20(function()\x20','\x20-\x20Brain\x20And\x20Scalpel','nav-btn-current','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2065-year-old\x20male\x20presents\x20with\x20a\x20cough,\x20shortness\x20of\x20breath,\x20and\x20chest\x20pain.\x20Imaging\x20studies\x20reveal\x20a\x20mass\x20in\x20the\x20lung,\x20and\x20a\x20biopsy\x20confirms\x20the\x20diagnosis\x20of\x20carcinoma\x20lung.\x20The\x20patient\x20has\x20a\x20history\x20of\x20chronic\x20obstructive\x20pulmonary\x20disease\x20(COPD)\x20and\x20bronchiectasis.\x20He\x20is\x20currently\x20on\x20bronchodilators,\x20inhaled\x20corticosteroids,\x20and\x20oxygen\x20therapy.\x20The\x20oncologist\x20recommends\x20chemotherapy\x20for\x20the\x20treatment\x20of\x20the\x20cancer.\x20Which\x20of\x20the\x20following\x20drugs\x20should\x20be\x20avoided\x20in\x20this\x20patient?</span></span></span></p>','isSupported','arGSf','Kpbqw','nPavb','XNtNj','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Ocrelizumab</span></span></span></p>','canPlayType','kyqIr','explanation_video','ktiqX','endsWith','RZzmk','<p><span\x20style=\x22font-size:12.0pt;\x22>Hirsutism\x20is\x20more\x20common\x20than\x20cyclosporine</span></p>','vEZtO','UXFvY','error','uxiMN','odbHZ','navBtn_','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20a\x20small\x20molecule\x20tyrosine\x20kinase\x20inhibitor\x20acting\x20as\x20EGFR\x20antagonist</span></span></span></p>','vrJqs','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>X\x20is\x205-Fluorourcail,\x20and\x20Y\x20is\x20Methotrexate</span></span></span></p>','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','QVNrH','XKpqT','kErZr','JqWTJ','LywoM','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2020-year-old\x20boy\x20presented\x20with\x20slow\x20growing\x20mass\x20on\x20the\x20medial\x20side\x20of\x20thigh.\x20Investigations\x20revealed\x20it\x20to\x20be\x20osteosarcoma\x20and\x20patient\x20was\x20started\x20on\x20methotrexate.\x20Mechanism\x20of\x20action\x20of\x20methotrexate\x20as\x20an\x20anticancer\x20drug\x20is:</span></span></span></p>','GWMNF','AmkZY','Mxkqf','Q4211879','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>5FU</span></span></span></p>','review-question\x20','PKtmN','ZOaEs','HKYFG','solutionAudio','(((.+)+)+)+$','mmosl','accuracyScore','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:14.0pt;\x22>After\x2015\x20days\x20of\x20chemotherapy,\x20a\x20patient\x20develops\x20rash\x20and\x20itching\x20on\x20the\x20back\x20as\x20shown\x20in\x20the\x20image.\x20It\x20can\x20occur\x20as\x20a\x20side\x20effect\x20of\x20which\x20of\x20the\x20following\x20drugs?&nbsp;</span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p><span\x20style=\x22font-size:12.0pt;\x22><img\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/415.jpg\x22\x20alt=\x22\x22\x20width=\x22250\x22\x20height=\x22348\x22></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Carboplatin</span></span></span></p>','bJcwZ','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Bleomycin</span></span></span></p>','qWYwk','HpXwQ','now','map','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20has\x20dose\x20dependent\x20kinetics</span></span></span></p>','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:18px;\x22>Bleomycin</span></p>','Bpyvw','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2045-year-old\x20woman\x20with\x20breast\x20cancer\x20is\x20undergoing\x20chemotherapy.\x20She\x20is\x20currently\x20receiving\x20a\x20drug\x20that\x20acts\x20on\x20the\x20&#39;S&#39;\x20phase\x20of\x20the\x20cell\x20cycle.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20likely\x20being\x20used\x20in\x20her\x20treatment?</span></span></span></p>','difficult','iZqwf','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','tSaNW','totalAttempted','__proto__','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Tofacitinib\x20inhibits\x20Janus\x20kinase\x20(JAK)\x20enzymes</span></span></span></p>','VOkaL','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Bortezomib\x20is\x20a\x20drug\x20used\x20for\x20treatment\x20of\x20multiple\x20myeloma.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?</span></span></p>','getAttribute','Q7815960','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Diarrhea</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Thalidomide</strong>\x20is\x20<strong>notorious\x20</strong>for\x20its<strong>\x20initial\x20use</strong>\x20during<strong>\x20pregnancy\x20</strong>to\x20<strong>treat\x20nausea\x20and\x20vomiting</strong>,\x20but\x20it\x20was\x20<strong>rapidly\x20withdrawn</strong>\x20due\x20to\x20<strong>severe\x20teratogenic\x20effects</strong>\x20that\x20resulted\x20in\x20<strong>substantial\x20birth\x20defects</strong>.\x20It\x20has\x20since\x20been\x20<strong>reintroduced,\x20</strong>especially\x20for\x20the<strong>\x20treatment\x20of</strong>\x20<strong>diseases</strong>\x20such\x20as\x20<strong>multiple\x20myeloma\x20</strong>due\x20to\x20its<strong>\x20immunomodulatory\x20effects.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Thalidomide</strong>\x20is\x20<strong>known\x20to\x20cause\x20constipation</strong>\x20rather\x20than\x20diarrhea,\x20which\x20aligns\x20with\x20its\x20common\x20gastrointestinal\x20side\x20effects,\x20contrasting\x20with\x20the<strong>\x20incorrect\x20option</strong>\x20that\x20suggests\x20it<strong>\x20causes\x20diarrhea.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Other</strong>\x20notable<strong>\x20adverse\x20effects\x20of\x20thalidomide</strong>\x20include\x20<strong>peripheral\x20neuropathy,</strong>\x20where\x20patients\x20experience\x20<strong>sensory\x20changes</strong>\x20like\x20<strong>numbness\x20or\x20tingling\x20in\x20the\x20extremities</strong>.\x20Its<strong>\x20teratogenic</strong>\x20potential\x20is<strong>\x20highly</strong>\x20significant,\x20<strong>leading\x20to\x20severe\x20limb\x20</strong>and\x20<strong>organ\x20deformities</strong>\x20when\x20taken<strong>\x20during\x20pregnancy</strong>.\x20Additionally,<strong>\x20thalidomide\x20increases\x20</strong>the\x20<strong>risk\x20of\x20thromboembolic\x20</strong>events\x20such\x20as\x20<strong>deep\x20vein\x20thrombosis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Peripheral\x20neuropathy:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Accurately\x20listed\x20as\x20a\x20<strong>side\x20effect</strong>,\x20it\x20involves<strong>\x20nerve\x20damage\x20</strong>resulting\x20in<strong>\x20pain,\x20numbness,\x20or\x20tingling</strong>\x20<strong>sensations,\x20</strong>primarily\x20in\x20the<strong>\x20hands\x20and\x20feet.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Teratogenicity:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Correctly</strong>\x20identified\x20as\x20a\x20<strong>side\x20effect</strong>,\x20<strong>thalidomide</strong>\x20causes\x20<strong>severe\x20birth\x20defects,</strong>\x20a\x20major\x20reason\x20for\x20its\x20<strong>initial</strong>\x20<strong>market\x20withdrawal.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Deep\x20vein\x20thrombosis:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20a<strong>\x20valid\x20side\x20effect</strong>,\x20with\x20thalidomide\x20<strong>increasing\x20the\x20risk\x20for\x20blood\x20clots,</strong>\x20necessitating\x20<strong>caution\x20and\x20preventive\x20</strong>measures\x20in\x20</span></span></span><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>its\x20administration.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Major\x20adverse\x20effects\x20of\x20thalidomide:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Teratogenicity:</strong>\x20<strong>Thalidomide</strong>\x20is\x20associated\x20with<strong>\x20severe\x20birth\x20defects</strong>,\x20particularly\x20<strong>limb\x20abnormalities,</strong>\x20when\x20taken\x20<strong>during</strong>\x20<strong>pregnancy.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Peripheral\x20neuropathy</strong>:\x20Thalidomide\x20can\x20cause\x20<strong>nerve\x20damage</strong>\x20that\x20results\x20in\x20<strong>tingling,\x20numbness,\x20or\x20pain\x20</strong>in\x20the\x20<strong>hands</strong>\x20<strong>and\x20feet.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Thromboembolism</strong>:\x20Thalidomide\x20use\x20is\x20associated\x20with\x20an\x20<strong>increased\x20risk\x20of\x20blood\x20clots,</strong>\x20including\x20<strong>deep\x20vein\x20thrombosis</strong>\x20and<strong>\x20pulmonary\x20embolism.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Somnolence</strong>:\x20Thalidomide\x20can\x20cause\x20<strong>drowsiness\x20or\x20sedation</strong>,\x20which\x20may<strong>\x20impair\x20the\x20ability\x20</strong>to\x20<strong>perform\x20tasks</strong>\x20that\x20require\x20<strong>alertness.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Bradycardia:</strong>\x20Thalidomide\x20may\x20<strong>cause\x20a\x20slow\x20heart\x20rate</strong>,\x20which\x20can\x20lead\x20to\x20<strong>dizziness\x20or\x20fainting.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Constipation</strong>:\x20Thalidomide\x20can\x20cause\x20<strong>gastrointestinal\x20symptoms\x20such\x20as\x20constipation,\x20nausea,\x20and\x20vomiting.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Hypersensitivity\x20reactions</strong>:\x20Thalidomide\x20can\x20cause<strong>\x20allergic\x20reactions</strong>,\x20including\x20<strong>rash,\x20itching,\x20and\x20difficulty\x20breathing.</strong></span></span></span></li>\x0d\x0a</ul>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Mitoxantrone\x20</span></span></span></p>','replace','lrzpY','byDeR','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Teratogenicity</span></span></span></p>','quizFile','question_video','studyModeLegend','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Peripheral\x20neuropathy</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>IV\x20hydration,\x20mesna,\x20and\x20frequent\x20urinalyses</span></span></span></p>','join','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','completed','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','getElementById','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20D)\x20Vincristine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Vincristine</strong>\x20can\x20<strong>damage</strong>\x20<strong>peripheral\x20nerves,</strong>\x20leading\x20to\x20a\x20range\x20of\x20<strong>neurological\x20symptoms</strong>\x20such\x20as\x20<strong>numbness,\x20tingling,\x20weakness,\x20and</strong>\x20<strong>difficulty\x20walking</strong>.\x20The<strong>\x20severity\x20of\x20neurotoxicity\x20</strong>is\x20directly\x20related\x20to\x20the\x20<strong>dose\x20of\x20the\x20drug</strong>,\x20and\x20it\x20is\x20a\x20<strong>dose-limiting\x20toxicity.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Etoposide:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Etoposide\x20can\x20cause<strong>\x20myelosuppression</strong>,\x20leading\x20to<strong>\x20low\x20blood\x20cell\x20counts,</strong>\x20which\x20is\x20generally\x20the<strong>\x20dose-limiting</strong>\x20<strong>toxicity\x20</strong>for\x20this\x20drug.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Methotrexate:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While\x20methotrexate\x20can\x20cause\x20various<strong>\x20side\x20effects</strong>\x20including<strong>\x20mucositis\x20and\x20hepatotoxicity,</strong>\x20its\x20<strong>dose-limiting</strong>\x20<strong>toxicity\x20</strong>is\x20often\x20<strong>myelosuppression.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Paclitaxel:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Paclitaxel\x20can\x20cause\x20<strong>myelosuppression\x20and\x20neuropathy</strong>,\x20but\x20the\x20<strong>primary\x20dose-limiting\x20toxicity\x20</strong>is\x20typically\x20<strong>bone</strong>\x20<strong>marrow\x20suppression.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Vincristine&#39;s\x20dose-limiting\x20toxicity</strong>\x20is<strong>\x20neurotoxicity,</strong>\x20which\x20necessitates\x20careful\x20<strong>monitoring\x20of\x20neurological\x20symptoms</strong>\x20and\x20<strong>adjustment</strong>\x20of\x20<strong>dosing\x20</strong>to<strong>\x20prevent\x20severe\x20peripheral\x20neuropathy.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Myelosuppression\x20</strong>is\x20<strong>dose\x20limiting\x20</strong>for<strong>\x20paclitaxel,\x20etoposide,\x20and\x20methotrexate.</strong></span></span></span></p>','HjaIv','Q1775454','28230FjrUnC','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Bleomycin\x20</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20DNA\x20topoisomerase\x20II\x20</span></span></span></p>','progressBar','LWCOk','Q9876037','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>All\x20the\x20following\x20statements\x20are\x20true\x20regarding\x20ifosfamide\x20except?</span></span></span></p>','video[data-src]','KDLHf','crZEC','NuLWA','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x207-year-old\x20child\x20is\x20started\x20on\x20chemotherapy.\x20One\x20of\x20the\x20medications\x20used\x20in\x20the\x20treatment\x20is\x20L-asparaginase.\x20This\x20drug\x20works\x20by\x20depleting\x20asparagine,\x20an\x20amino\x20acid\x20that\x20is\x20required\x20for\x20the\x20growth\x20and\x20survival\x20of\x20leukemia\x20cells.\x20Which\x20of\x20the\x20following\x20cancers\x20is\x20L-asparaginase\x20commonly\x20used\x20to\x20treat?</span></span></span></p>','VcwXM','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Chlorambucil</span></span></span></p>','rKctt','PiKKW','xPCUa','acNlT','432669SvtnCo','vhkSt','akkrl','No\x20questions\x20available\x20for\x20this\x20quiz.','CfOqM','Xvdhg','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Acute\x20lymphoblastic\x20leukemia\x20(ALL)</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>L-asparaginase\x20</strong>is\x20an\x20enzyme\x20that\x20is\x20<strong>used\x20in\x20the\x20treatment\x20of\x20acute\x20lymphoblastic\x20leukemia\x20(ALL)</strong>.\x20<strong>ALL</strong>\x20is\x20a\x20cancer\x20of\x20the\x20<strong>blood\x20and\x20bone\x20marrow</strong>\x20that\x20affects\x20<strong>white\x20blood\x20cells.</strong>\x20The\x20drug\x20works\x20by<strong>\x20depleting\x20the\x20level\x20of\x20the\x20amino\x20acid</strong>\x20<strong>asparagine</strong>,\x20which\x20is\x20required\x20for\x20the<strong>\x20growth\x20and\x20survival\x20of\x20leukemia\x20cells.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Normal\x20cells</strong>\x20can\x20<strong>synthesize\x20asparagine</strong>,\x20but\x20<strong>leukemia\x20cells</strong>\x20are\x20<strong>unable</strong>\x20to\x20do\x20so\x20and\x20rely\x20on\x20an\x20<strong>external\x20source\x20</strong>of\x20<strong>asparagine\x20for\x20survival</strong>.\x20<strong>L-asparaginase</strong>\x20works\x20by\x20<strong>breaking\x20down\x20asparagine</strong>\x20in\x20the\x20blood,\x20thus\x20<strong>depriving</strong>\x20the\x20<strong>leukemia</strong>\x20<strong>cells\x20of\x20the\x20amino\x20acid</strong>\x20that\x20they\x20need\x20to<strong>\x20survive.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>L-asparaginase\x20</strong>is\x20typically\x20used\x20in\x20<strong>combination\x20with\x20other\x20chemotherapeutic\x20agents</strong>\x20in\x20the\x20treatment\x20of<strong>\x20ALL</strong>.\x20While\x20it\x20is\x20generally\x20<strong>well\x20tolerated,</strong>\x20it\x20can\x20cause\x20a<strong>\x20few\x20side\x20effects,</strong>\x20including\x20<strong>hypersensitivity\x20reactions</strong>,\x20<strong>coagulation\x20disorders</strong>,\x20and\x20<strong>liver\x20dysfunction.\x20</strong>In\x20addition,<strong>\x20L-asparaginase</strong>\x20can\x20also\x20deplete\x20other\x20<strong>essential\x20amino\x20acids</strong>,\x20which\x20can\x20<strong>lead\x20</strong>to\x20a\x20range\x20of\x20<strong>adverse\x20effects,</strong>\x20including\x20<strong>pancreatitis,\x20hyperglycaemia,\x20and\x20neurological\x20complications.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Acute\x20Myeloblastic\x20Leukemia\x20(AML):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20AML\x20is\x20another\x20<strong>type\x20of\x20leukemia</strong>\x20but\x20primarily\x20affects\x20<strong>different\x20lineages\x20of\x20cells</strong>\x20within\x20the<strong>\x20bone\x20marrow</strong>.<strong>\x20L-asparaginase</strong>\x20is\x20<strong>not</strong>\x20typically<strong>\x20used</strong>\x20in\x20the\x20treatment\x20of<strong>\x20AML.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Chronic\x20lymphocytic\x20leukemia\x20(CLL):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20CLL\x20<strong>progresses</strong>\x20<strong>more\x20slowly\x20than\x20ALL\x20</strong>and\x20generally\x20affects<strong>\x20older\x20adults.</strong>\x20It\x20is\x20<strong>not</strong>\x20treated\x20with<strong>\x20L-asparaginase.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Chronic\x20Myelocytic\x20Leukemia\x20(CML):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20CML\x20is\x20a<strong>\x20chronic\x20form\x20of\x20leukemia\x20</strong>affecting\x20primarily\x20<strong>adults</strong>.<strong>\x20L-asparaginase</strong>\x20is\x20<strong>not</strong>\x20effective<strong>\x20against\x20CML\x20cells</strong>\x20as\x20they<strong>\x20do\x20not</strong>\x20rely\x20on<strong>\x20external\x20sources\x20of\x20asparagine</strong>\x20like<strong>\x20ALL\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>L-asparaginase</strong>\x20is\x20particularly\x20significant\x20in\x20the\x20<strong>treatment\x20of\x20acute\x20lymphoblastic\x20leukemia\x20(ALL)\x20</strong>due\x20to\x20its\x20unique\x20mechanism\x20of\x20<strong>depleting\x20asparagine</strong>,\x20which\x20is\x20<strong>essential\x20for\x20the\x20survival\x20of\x20ALL\x20cells</strong>.\x20This\x20makes\x20it\x20a\x20<strong>key\x20component</strong>\x20of\x20<strong>chemotherapy\x20regimens</strong>\x20for\x20<strong>ALL,</strong>\x20especially\x20in<strong>\x20pediatric\x20patients</strong>,\x20where\x20it\x20can\x20be\x20<strong>combined\x20with\x20other\x20drugs</strong>\x20to\x20enhance\x20<strong>treatment\x20efficacy\x20and\x20</strong>manage\x20the\x20<strong>disease\x20effectively.</strong></span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Basiliximab\x20promotes\x20the\x20activation\x20of\x20B-cells</span></span></span></p>','SJPia','qQoAd','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Chronic\x20Myelocytic\x20Leukemia\x20(CML)</span></span></span></p>','hAjGb','ckDTV','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Platinum\x20compounds\x20</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2052-year-old\x20male\x20with\x20a\x20history\x20of\x20chronic\x20lymphocytic\x20leukemia\x20(CLL)\x20is\x20seen\x20in\x20the\x20oncology\x20clinic\x20for\x20a\x20routine\x20follow-up.\x20His\x20treatment\x20regimen\x20includes\x20a\x20purine\x20analog,\x20and\x20his\x20latest\x20lab\x20tests\x20show\x20a\x20good\x20response\x20to\x20the\x20therapy.&nbsp;Which\x20of\x20the\x20following\x20statements\x20is\x20NOT\x20true\x20about\x20purine\x20analogs?</span></span></span></p>','agAlt','correct_choice_id','DiZgx','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Pulmonary\x20fibrosis\x20is\x20an\x20adverse\x20effect\x20of\x20which\x20of\x20the\x20following\x20anti-cancer\x20drugs?</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Bleomycin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Bleomycin</strong>\x20is\x20a\x20<strong>chemotherapeutic\x20agent</strong>\x20that\x20is\x20known\x20to\x20cause\x20a\x20<strong>distinctive\x20pattern\x20of\x20skin\x20pigmentation</strong>\x20called\x20<strong>&quot;flagellate\x20pigmentation.</strong>&quot;\x20This\x20pattern\x20is\x20characterized\x20by<strong>\x20linear\x20streaks\x20of\x20hyperpigmentation</strong>\x20that\x20resemble\x20the\x20tracks\x20<strong>left\x20by\x20a\x20whip,\x20or\x20flagellum</strong>.\x20This\x20reaction\x20is<strong>\x20more\x20</strong>commonly<strong>\x20seen\x20in\x20women\x20</strong>and\x20can\x20occur\x20<strong>several\x20weeks\x20to\x20months</strong>\x20after<strong>\x20starting\x20therapy</strong>.\x20The\x20<strong>pigmentation\x20</strong>usually<strong>\x20resolves\x20spontaneously,</strong>\x20but\x20in\x20some\x20cases,\x20it\x20can\x20<strong>persist\x20for\x20several\x20months\x20to\x20years\x20after\x20stopping\x20the\x20medication.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/409.jpg\x22\x20style=\x22height:446px;\x20width:300px\x22\x20/></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Minocycline:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20an\x20<strong>antibiotic</strong>\x20that\x20can\x20cause\x20various\x20types\x20of\x20<strong>skin\x20hyperpigmentation</strong>,\x20but\x20these\x20usually\x20take\x20the\x20form\x20of<strong>\x20blue-gray\x20spots\x20or\x20diffuse\x20pigmentation,\x20particularly\x20</strong>in\x20areas\x20of\x20<strong>previous\x20inflammation\x20or\x20sun\x20exposure</strong>.\x20It\x20is\x20<strong>not\x20</strong>known\x20to\x20cause\x20the<strong>\x20flagellate\x20or\x20whip-like\x20streaking\x20pattern\x20</strong>associated\x20<strong>with\x20Bleomycin.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Vincristine:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While<strong>\x20Vincristine</strong>\x20is\x20a<strong>\x20chemotherapeutic\x20agent</strong>\x20used\x20in\x20the\x20<strong>same\x20types\x20of\x20cancer\x20</strong>as<strong>\x20Bleomycin</strong>,\x20its\x20<strong>side\x20effect</strong>\x20profile\x20includes<strong>\x20neurological\x20symptoms</strong>\x20such\x20as\x20<strong>peripheral\x20neuropathy,</strong>\x20rather\x20than\x20<strong>dermatological\x20condition</strong>s\x20like\x20<strong>flagellate</strong>\x20<strong>pigmentation.</strong>\x20The<strong>\x20presentation\x20</strong>of\x20such\x20a\x20<strong>specific\x20skin\x20reaction\x20does\x20not</strong>\x20align\x20with\x20the\x20<strong>known\x20adverse\x20effects\x20of\x20Vincristine.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Daunorubicin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20As\x20an<strong>\x20anthracycline\x20chemotherapeutic</strong>,\x20<strong>Daunorubicin</strong>\x20can\x20cause\x20a<strong>\x20variety\x20of\x20side\x20effects,</strong>\x20with\x20the\x20most\x20<strong>prominent\x20being\x20myelosuppression.</strong>\x20It\x20can\x20also<strong>\x20lead\x20to\x20cardiotoxicity\x20</strong>with\x20<strong>long-term\x20use</strong>.\x20However,\x20it\x20is\x20<strong>not\x20</strong>implicated\x20in\x20causing\x20the\x20characteristic\x20<strong>flagellate\x20pigmentation\x20</strong>that\x20is\x20<strong>seen\x20with\x20Bleomycin\x20therapy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Bleomycin</strong>\x20can\x20lead\x20to\x20<strong>flagellate\x20pigmentation</strong>,\x20a\x20<strong>distinct\x20dermatologic\x20reaction\x20</strong>characterized\x20by\x20<strong>whip-like\x20hyperpigmented\x20streaks</strong>.\x20This\x20<strong>adverse\x20effect\x20</strong>should\x20be\x20recognized\x20by<strong>\x20healthcare\x20providers</strong>\x20as\x20a<strong>\x20potential\x20delayed\x20side\x20effect\x20of\x20the\x20drug,</strong>\x20particularly\x20in\x20<strong>patients\x20with\x20a\x20history\x20of\x20cancer\x20</strong>treatment\x20including<strong>\x20Bleomycin.</strong></span></span></span></p>','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','border-red-500','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Chlorambucil</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Chlorambucil</strong>\x20is\x20an<strong>\x20alkylating\x20agent</strong>\x20typically\x20used\x20in\x20the\x20treatment\x20of\x20<strong>chronic\x20lymphocytic\x20leukemia</strong>\x20and\x20other\x20<strong>hematological</strong>\x20<strong>malignancies.</strong>\x20Compared\x20to\x20the\x20other\x20drugs\x20listed,\x20<strong>chlorambucil</strong>\x20has\x20a<strong>\x20lower\x20emetogenic\x20potential</strong>,\x20meaning\x20it\x20is\x20<strong>less\x20likely</strong>\x20to\x20cause\x20<strong>nausea\x20and\x20vomiting.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Cisplatin\x20and\x20cyclophosphamide\x20</strong>have\x20v<strong>ery\x20high\x20emetogenic\x20potential\x20</strong>whereas\x20<strong>chlorambucil\x20and\x20busulfan</strong>\x20have\x20the\x20<strong>least.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Cisplatin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Known\x20for\x20its<strong>\x20high\x20emetogenic\x20potential,</strong>\x20cisplatin\x20is\x20a\x20<strong>platinum-based\x20drug\x20</strong>that\x20often\x20requires\x20<strong>premedication</strong>\x20<strong>with\x20antiemetics\x20</strong>to\x20manage\x20its\x20<strong>severe\x20nausea\x20and\x20vomiting</strong>\x20side\x20effects.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Doxorubicin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20As\x20an<strong>\x20anthracycline,\x20doxorubicin</strong>\x20has\x20a\x20<strong>moderate\x20to\x20high\x20emetogenic\x20potential</strong>,\x20necessitating\x20the\x20<strong>use\x20of</strong>\x20<strong>antiemetics</strong>\x20for\x20patient\x20<strong>comfort\x20during\x20treatment.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Daunorubicin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Similar</strong>\x20in\x20class\x20to\x20<strong>doxorubicin</strong>,\x20<strong>daunorubicin</strong>\x20also\x20has\x20a<strong>\x20moderate\x20to\x20high\x20emetogenic\x20risk,\x20</strong>which\x20can\x20affect\x20patient<strong>\x20quality\x20of\x20life\x20and\x20treatment\x20adherence.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>When\x20considering\x20the\x20<strong>side\x20effect\x20</strong>profile\x20of\x20<strong>chemotherapeutic\x20agents,</strong>\x20especially\x20regarding\x20<strong>emesis,</strong>\x20<strong>chlorambucil\x20</strong>is\x20noted\x20for\x20its\x20<strong>lower\x20likelihood\x20</strong>of\x20causing\x20<strong>nausea\x20and\x20vomiting\x20</strong>relative\x20to\x20other\x20agents\x20like\x20<strong>cisplatin,\x20doxorubicin,\x20and\x20daunorubicin.\x20</strong></span></span></span></p>','OQgfw','solutionText','KyFOa','LqDIm','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Folic\x20acid\x20and\x20dexamethasone</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Less\x20neurotoxic\x20than\x20cyclophosphamide</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20<strong>correct</strong>\x20statement\x20that\x20is\x20<strong>false</strong>\x20about\x20<strong>ifosfamide</strong>\x20is\x20that\x20it\x20is\x20<strong>less\x20neurotoxic\x20than\x20cyclophosphamide.</strong>\x20In\x20fact,<strong>\x20ifosfamide</strong>\x20is\x20associated\x20with<strong>\x20greater\x20neurotoxicity</strong>\x20compared\x20<strong>to\x20cyclophosphamide.</strong>\x20This\x20is\x20a\x20critical\x20consideration\x20in\x20clinical\x20settings,\x20as\x20<strong>ifosfamide&#39;s\x20neurotoxic\x20effects</strong>\x20can<strong>\x20limit\x20its\x20dosage\x20</strong>and\x20r<strong>equire\x20careful\x20monitoring.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong><u>\x20</u></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20It\x20is\x20metabolized\x20by\x20cytochrome\x20p450\x20enzymes:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20statement\x20is\x20<strong>true.</strong>\x20<strong>Ifosfamide</strong>,\x20like\x20many\x20other\x20<strong>alkylating\x20agents</strong>\x20including\x20<strong>cyclophosphamide</strong>,\x20is\x20metabolized\x20by<strong>\x20cytochrome\x20p450\x20enzymes,\x20</strong>which\x20play\x20a\x20key\x20role\x20in\x20its<strong>\x20activation\x20and\x20detoxification.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Chloroacetaldehyde\x20is\x20the\x20metabolite\x20of\x20ifosfamide:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20also<strong>\x20true</strong>.\x20The\x20metabolism\x20of<strong>\x20ifosfamide</strong>\x20involves\x20the\x20<strong>production\x20of\x20chloroacetaldehyde</strong>,\x20a\x20<strong>metabolite</strong>\x20that\x20contributes\x20to<strong>\x20its\x20nephrotoxic\x20effects.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20It\x20is\x20an\x20alkylating\x20agent:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20statement\x20is\x20<strong>correct</strong>.\x20<strong>Ifosfamide</strong>\x20belongs\x20to\x20the\x20<strong>nitrogen\x20mustard\x20group\x20of\x20alkylating\x20agents,</strong>\x20which\x20are\x20used\x20in\x20<strong>cancer\x20chemotherapy</strong>\x20to\x20<strong>alkylate\x20the\x20DNA\x20of\x20cancer\x20cells</strong>,\x20leading\x20to\x20<strong>cell\x20death.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Ifosfamide,\x20</strong>while\x20being\x20a\x20valuable\x20<strong>chemotherapeutic\x20alkylating\x20agent</strong>,\x20carries\x20a\x20significant\x20<strong>risk\x20of\x20neurotoxicity</strong>\x20that\x20is\x20<strong>greater\x20than</strong>\x20that\x20of\x20<strong>cyclophosphamide.\x20</strong>This\x20fact\x20must\x20be\x20<strong>carefully\x20considered\x20</strong>when\x20<strong>prescribing\x20and\x20managing\x20treatment\x20with\x20ifosfamide\x20</strong>in\x20clinical\x20practice.</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Ustekinumab</span></span></span></p>','BSxUT','display','zYqjX','border-gray-600','Bookmarked','bind','DiagnosisBased','https://media.cerebellumacademy.com/media/public/question_media/solution/video/10933/FMGE_20_Sep_2025_PHARMACOLOGY_Question_13.mp4','test','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2040-year-old\x20male\x20was\x20on\x20treatment\x20with\x20MOPP\x20regimen\x20for\x20Hodgkin&rsquo;s\x20lymphoma.\x20He\x20recently\x20attended\x20a\x20party\x20and\x20had\x20bouts\x20of\x20alcohol\x20with\x20his\x20friends.\x20Soon\x20after,\x20he\x20started\x20experiencing\x20flushing\x20of\x20the\x20face,\x20headache,\x20nausea,\x20vomiting,\x20chest\x20pain,\x20weakness,\x20blurred\x20vision,\x20mental\x20confusion,\x20sweating,\x20choking,\x20breathing\x20difficulty,\x20and\x20anxiety.\x20These\x20effects\x20began\x20about\x2010\x20minutes\x20after\x20drinking\x20and\x20lasted\x20for\x201\x20hour.\x20What\x20drug\x20is\x20likely\x20to\x20cause\x20this\x20presentation?</span></span></span></p>','Q6098509','bqYtb','filter','iwGmV','data-option-index','tnCJA','lGsMj','quizSidebar','Q9284368','tXApS','Q1287108','jtEqT','xCtxB','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Cladribine\x20is\x20degraded\x20by\x20adenosine\x20deaminase</span></span></span></p>','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Chloroacetaldehyde\x20is\x20the\x20metabolite\x20of\x20ifosfamide</span></span></span></p>','fromCharCode','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x206\x20mercaptopurine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>6-Mercaptopurine\x20(6-MP):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Allopurinol</strong>\x20is\x20a<strong>\x20xanthine\x20oxidase\x20inhibitor\x20</strong>used\x20to<strong>\x20decrease\x20the\x20production\x20of\x20uric\x20acid.</strong>\x20Because\x20<strong>xanthine\x20oxidase</strong>\x20is\x20also\x20involved\x20in\x20the<strong>\x20catabolism\x20of\x206-MP,</strong>\x20<strong>co-administration\x20with\x20allopurinol</strong>\x20leads\x20to\x20<strong>increased\x20levels\x20of\x206-MP.</strong>\x20This\x20can\x20result\x20in\x20<strong>excessive\x20myelosuppression</strong>.\x20Therefore,\x20when<strong>\x20allopurinol\x20is\x20administered\x20concurrently\x20with\x206-MP,\x20</strong>the\x20<strong>dose\x20of\x206-MP</strong>\x20must\x20be<strong>\x20reduced\x20(commonly\x20to\x20one-third\x20or\x20one-fourth\x20of\x20its\x20standard\x20dose)\x20</strong>to\x20<strong>prevent</strong>\x20potentially\x20<strong>life-threatening\x20toxicity.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Methotrexate:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While\x20methotrexate\x20is\x20<strong>metabolized\x20by\x20the\x20liver</strong>\x20and\x20<strong>excreted\x20by\x20the\x20kidneys,\x20</strong>a<strong>llopurinol</strong>\x20<strong>does\x20not</strong>\x20significantly\x20affect<strong>\x20its\x20plasma\x20levels.</strong>\x20However,\x20<strong>close\x20monitoring</strong>\x20is\x20still\x20warranted\x20due\x20to\x20the<strong>\x20potential\x20for\x20increased\x20toxicity,</strong>\x20but\x20<strong>specific\x20dose\x20reduction\x20</strong>due\x20to<strong>\x20allopurinol</strong>\x20is\x20<strong>not\x20a\x20standard\x20practice.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x206-Thioguanine:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Like<strong>\x206-MP,\x206-thioguanine\x20is\x20a\x20purine\x20analog</strong>,\x20and\x20though\x20it\x20has\x20a\x20<strong>similar\x20mechanism\x20of\x20action</strong>,\x20the\x20effect\x20of\x20<strong>allopurinol</strong>\x20on<strong>\x20its\x20metabolism</strong>\x20<strong>does\x20not</strong>\x20usually\x20require\x20a<strong>\x20dose\x20adjustment.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Capecitabine:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Capecitabine,\x20an\x20<strong>oral\x20prodrug</strong>\x20that\x20is<strong>\x20metabolized\x20into\x205-fluorouracil,</strong>\x20is\x20<strong>not</strong>\x20primarily\x20<strong>affected</strong>\x20by\x20<strong>allopurinol,</strong>\x20and\x20<strong>dose\x20adjustments</strong>\x20are\x20typically<strong>\x20not\x20</strong>necessary\x20when\x20these<strong>\x20drug</strong>s\x20are<strong>\x20used\x20concurrently.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>When\x20<strong>prescribing\x206-Mercaptopurine</strong>\x20in<strong>\x20conjunction\x20with\x20allopurinol,\x20</strong>it&#39;s\x20essential\x20to\x20<strong>reduce\x20the\x20dosage\x20of\x206-MP\x20to\x20prevent</strong>\x20<strong>increased\x20drug\x20levels\x20</strong>and<strong>\x20potential\x20toxicity\x20</strong>due\x20to\x20the<strong>\x20inhibition\x20of\x20xanthine\x20oxidase\x20by\x20allopurinol.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>This<strong>\x20drug\x20interaction</strong>\x20<strong>underscores\x20</strong>the\x20importance\x20of\x20understanding\x20the\x20<strong>metabolic\x20pathways\x20of\x20chemotherapeutic\x20agents</strong>\x20and\x20the\x20<strong>impact\x20of\x20concomitant\x20medications</strong>\x20on\x20these\x20pathways.</span></span></span></p>','qpxUN','ZhBAa','nGHEc','TreatmentBased','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Folic\x20acid\x20and\x20vitamin\x20B12</span></span></span></p>','EgUUQ','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','daqSN','jirOR','qBank','yzkeq','jofCF','EnKWh','nAoEq','ooOHR','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Cisplatin</span></span></span></p>','DIFDt','eZMzB','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20D)\x20M\x20phase</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Vinblastine</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20is\x20a\x20<strong>chemotherapeutic\x20agent</strong>\x20classified\x20under\x20the<strong>\x20vinca\x20alkaloids,</strong>\x20which\x20are\x20known\x20for\x20their<strong>\x20ability\x20to\x20inhibit\x20microtubule</strong>\x20<strong>formation.</strong>\x20This\x20action<strong>\x20disrupts\x20the\x20mitotic\x20spindle\x20formation</strong>\x20necessary\x20for\x20<strong>chromosome\x20separation</strong>\x20during\x20the\x20<strong>M</strong>\x20<strong>phase\x20(mitosis)\x20of\x20the\x20cell\x20cycle</strong>.\x20Therefore,\x20<strong>vinblastine\x20effectively\x20halts</strong>\x20the\x20<strong>cell\x20cycle\x20in\x20the\x20M\x20phase,\x20preventing\x20cells</strong>\x20<strong>from\x20properly</strong>\x20<strong>completing\x20mitosis</strong>,<strong>\x20leading\x20to\x20cell\x20death.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20G1\x20phase:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20phase\x20involves\x20the<strong>\x20preparation\x20of\x20the\x20cell\x20to\x20enter\x20the\x20S\x20phase\x20</strong>but\x20is<strong>\x20not\x20</strong>affected\x20by\x20<strong>vinblastine.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20S\x20phase:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20The\x20phase\x20where\x20<strong>DNA\x20replication\x20occurs</strong>;\x20<strong>vinblastine\x20does\x20not</strong>\x20directly\x20affect\x20<strong>DNA\x20synthesis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20G2\x20phase:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20The\x20phase\x20where\x20the\x20<strong>cell\x20prepares\x20for\x20mitosis</strong>;\x20although\x20important\x20for\x20<strong>cell\x20cycle\x20progression,</strong>\x20<strong>vinblastine</strong>\x20specifically<strong>\x20targets\x20and\x20disrupts</strong>\x20the<strong>\x20mitotic\x20phase\x20rather\x20</strong>than\x20<strong>this\x20preparatory\x20phase.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-153051.png\x22\x20style=\x22height:408px;\x20width:1000px\x22\x20/></span></u></strong></span></span></p>','Q5725673','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Its\x20most\x20common\x20adverse\x20effect\x20is\x20infusion\x20related\x20reactions</span></span></span></p>','questions','YMBDj','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20dir=\x22ltr\x22\x20lang=\x22PT-BR\x22\x20style=\x22font-size:12.0pt\x22>Pertuzumab</span></span></span></p>','iTNMX','userHistory','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Actinomycin\x20D\x20</span></span></span></p>','xTtpL','aqtUg','xfWlQ','8850110jlOMIO','scoreCircle','explanation_audio_hin','VdRGC','timeDisplay','ArrowLeft','dQtwu','submitSection','.option-button','solutionVideo','ImageBased','VsHZy','Pharmacology','gboWM','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Basal\x20cell\x20Ca</span></span></span></p>','MJFph','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Paclitaxel</span></span></span></p>','6FxkwIX','Factual','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vinblastine\x20inhibits\x20which\x20phase\x20of\x20cell\x20cycle?\x20</span></span></span></p>','ArrowRight','Prbcn','XvKDD','referrer','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Endometrial\x20carcinoma</span></span></span></p>','LKQpX','incorrect','Q9845125','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Allopurinol\x20and\x20frequent\x20urinalyses</span></span></span></p>','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Bromodeoxyuridine</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20N5\x20tetrahydro\x20folate\x20reductase\x20</span></span></span></p>','<div\x20class=\x22mt-4\x22><img\x20src=\x22','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','cpsLU','DSvpF','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Tocilizumab\x20is\x20approved\x20for\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis</span></span></span></p>','49wWbubm','jZPSd','DfRPD','padStart','cCRhi','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Sorafenib</span></span></span></p>','paTvi','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Daunorubicin</span></span></span></p>','querySelectorAll','Q8034663','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','PlZAz','yoPRX','round','pmAxU','lAekt','EbmEH','appendChild','Fyryh','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Alkylating\x20agents\x20</span></span></span></p>','OzPbG','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Chlorambucil\x20</span></span></span></p>','incorrectAnswers','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Crosslinking\x20of\x20DNA\x20</span></span></span></p>','ldujk','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Monoclonal\x20antibody\x20used\x20in\x20Head\x20and\x20Neck\x20cancer\x20is?\x20</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20is\x20a\x20US-FDA\x20approved\x20anti-CD\x2020\x20monoclonal\x20antibody\x20for\x20primary\x20progressive\x20multiple\x20sclerosis?\x20</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vitamin\x20B6\x20and\x20vitamin\x20B12</span></span></span></p>','gYAFu','GJIoA','fill','explanation_audio_eng','zygrR','No\x20question\x20text\x20available','green','HWGiC','HEzOa','statsBar','hgOvN','FdeBo','Dehsy','RVPdS','SPDpA','KHJrV','xfOQS','No\x20solution\x20provided','OXUUj','Aouiv','href','toISOString','dEAgh','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Rituximab</span></span></span></p>','pEOjO','solutionImages','\x22\x20data-option-index=\x22','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20statements\x20best\x20describes\x20the\x20mechanism\x20of\x20action\x20of\x20basiliximab?</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Cladribine</span></span></span></p>','EFqWf','Q2317996','DPAhA','nzYiO','log','Echoy','dataset','hierarchy','kpRwo','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Doxorubicin</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20clinical\x20picture\x20shows\x20<strong>&lsquo;radiation\x20recall\x20syndrome&rsquo;</strong>.\x20The\x20<strong>causative\x20agent\x20is\x20Doxorubicin</strong>.</span></span></span>\x0d\x0a\x0d\x0a\x09<ul\x20style=\x22list-style-type:circle\x22>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Radiation\x20recall\x20syndrome\x20(RRS)</strong>\x20is\x20characterized\x20by\x20an\x20<strong>acute\x20inflammatory\x20reaction</strong>\x20in\x20previously<strong>\x20irradiated</strong>\x20<strong>areas\x20of\x20the\x20body,</strong>\x20usually\x20<strong>occurring\x20within\x20days\x20to\x20weeks</strong>\x20of\x20<strong>administration\x20of\x20anticancer\x20drugs.</strong>\x20The\x20hallmark\x20of\x20<strong>RRS\x20is\x20erythema</strong>,\x20which\x20can\x20<strong>progress\x20to\x20blistering,\x20ulceration,\x20and\x20desquamation.</strong></span></span></span></li>\x0d\x0a\x09\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The<strong>\x20exact\x20</strong>cause\x20of<strong>\x20RRS</strong>\x20is<strong>\x20not\x20well\x20understood,</strong>\x20but\x20it\x20is\x20thought\x20to\x20be\x20related\x20to\x20an\x20<strong>interaction\x20between</strong>\x20the\x20<strong>chemotherapy\x20drugs\x20</strong>and\x20the\x20<strong>radiation\x20therapy.</strong>\x20<strong>Radiation\x20therapy\x20can</strong>\x20cause<strong>\x20damage\x20to\x20the\x20DNA\x20of\x20cells</strong>\x20in\x20the<strong>\x20target\x20area,</strong>\x20and\x20this\x20<strong>damage\x20can\x20persist\x20</strong>for\x20some\x20time.\x20<strong>If\x20chemotherapy</strong>\x20is<strong>\x20administered\x20</strong>after<strong>\x20radiation</strong>\x20<strong>therapy,</strong>\x20it\x20may\x20<strong>interact</strong>\x20with\x20this\x20<strong>residual\x20radiation\x20damage,\x20triggering\x20an\x20inflammatory\x20response</strong>\x20in\x20the\x20<strong>previously\x20irradiated\x20tissue</strong>\x20and\x20causing\x20the\x20symptoms\x20of\x20<strong>RRS.</strong></span></span></span></li>\x0d\x0a\x09</ul>\x0d\x0a\x09</li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Carboplatin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While\x20<strong>Carboplatin</strong>\x20can\x20have\x20a\x20<strong>variety\x20of\x20side\x20effects,</strong>\x20it\x20is\x20<strong>less\x20</strong>commonly\x20associated\x20with\x20<strong>radiation\x20recall</strong>\x20<strong>syndrome.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Methotrexate:</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20Methotrexate</strong>\x20can\x20cause<strong>\x20mucositis\x20and\x20skin\x20reactions\x20</strong>but\x20is<strong>\x20not\x20</strong>typically\x20associated\x20with<strong>\x20radiation\x20recall.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Cetuximab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Cetuximab</strong>,\x20a\x20<strong>monoclonal\x20antibody\x20targeting\x20EGFR,</strong>\x20is\x20associated\x20with\x20<strong>skin\x20reactions;</strong>\x20however,\x20it\x20is\x20<strong>not</strong>\x20<strong>typically</strong>\x20cited\x20as\x20a<strong>\x20cause\x20of\x20radiation\x20recall\x20syndrome.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20<strong>most\x20common\x20drugs</strong>\x20associated\x20with<strong>\x20RRS\x20are\x20anthracyclines</strong>\x20(such\x20a<strong>s\x20doxorubicin</strong>),\x20<strong>taxanes</strong>\x20(such\x20as\x20<strong>paclitaxel</strong>),\x20and\x20<strong>gemcitabine.\x20</strong></span></span></span></li>\x0d\x0a</ul>','YHbDc','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>M\x20phase</span></span></span></p>','YPIGC','warn','key','optionsContainer','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','UvZKO','SyIep','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Proteasome\x20inhibitor</span></span></span></p>','selected','OgSOY','border-green-500','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Pharyngolaryngeal\x20dysesthesia\x20is\x20a\x20peculiar\x20side\x20effect\x20of\x20which\x20of\x20the\x20following\x20drugs?\x20</span></span></span></p>','cslot','xOcuV','nav-btn-answered','argVP','PtiQc','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Adamantinoma</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Colorectal\x20Ca</span></span></span></p>','vMFcB','<p\x20style=\x22margin-right:-1px\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Durvalumab</span></span></span></p>','mCFzg','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','hYUYI','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2032-year-old\x20female\x20presents\x20to\x20the\x20clinic\x20with\x20a\x20complaint\x20of\x20a\x20rash\x20on\x20her\x20arms\x20and\x20legs\x20that\x20has\x20been\x20present\x20for\x20the\x20past\x20few\x20weeks.\x20She\x20reports\x20feeling\x20fatigued\x20and\x20has\x20been\x20experiencing\x20intermittent\x20fevers.\x20The\x20patient\x20has\x20a\x20history\x20of\x20Hodgkin&#39;s\x20lymphoma\x20and\x20underwent\x20chemotherapy\x20treatment\x20approximately\x20two\x20months\x20ago.\x20Her\x20chemotherapy\x20regimen\x20included\x20daunorubicin,\x20bleomycin,\x20and\x20vincristine.\x20On\x20physical\x20examination,\x20the\x20patient\x20is\x20noted\x20to\x20have\x20multiple\x20erythematous,\x20linear\x20lesions\x20on\x20her\x20arms\x20and\x20legs\x20that\x20appear\x20to\x20be\x20hyperpigmented\x20in\x20a\x20flagellate\x20pattern.\x20The\x20remainder\x20of\x20her\x20examination\x20is\x20unremarkable.\x20Based\x20on\x20the\x20patient&#39;s\x20clinical\x20history\x20and\x20examination,\x20which\x20drug\x20is\x20most\x20likely\x20responsible\x20for\x20her\x20skin\x20pigmentation?</span></span></span></p>','search','title','iRuFr','Marked','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Inhibition\x20of\x20Dihydrofolate\x20reductase</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Methotrexate</strong>\x20is\x20an\x20<strong>antimetabolite</strong>\x20that\x20interferes\x20with\x20the<strong>\x20synthesis\x20of\x20nucleic\x20acids\x20</strong>in\x20<strong>rapidly\x20dividing\x20cells</strong>\x20such\x20as\x20<strong>cancer\x20cells.</strong>\x20It\x20<strong>inhibits\x20the\x20activity\x20of\x20DHFR</strong>,\x20which\x20is\x20an\x20enzyme\x20that\x20is\x20necessary\x20for\x20the\x20<strong>synthesis\x20of\x20tetrahydrofolate,\x20</strong>a\x20<strong>coenzyme</strong>\x20that\x20is\x20involved\x20in\x20the\x20<strong>synthesis\x20of\x20nucleotides</strong>.\x20By<strong>\x20inhibiting\x20DHFR,\x20methotrexate\x20reduces\x20the\x20availability\x20of\x20tetrahydrofolate,</strong>\x20which\x20in\x20turn<strong>\x20inhibits</strong>\x20the<strong>\x20synthesis\x20of\x20nucleotides</strong>,\x20ultimately\x20leading\x20to\x20<strong>decreased\x20DNA\x20synthesis\x20and\x20cell\x20division.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Inhibition\x20of\x20N5\x20tetrahydro\x20folate\x20reductase:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20option\x20is<strong>\x20incorrect\x20</strong>because\x20there\x20is<strong>\x20no\x20enzyme</strong>\x20named\x20<strong>N5\x20tetrahydro</strong>\x20<strong>folate\x20reductase</strong>\x20that<strong>\x20methotrexate</strong>\x20is\x20known\x20to\x20<strong>inhibit.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Inhibition\x20of\x20tyrosine\x20kinase:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20the\x20<strong>action\x20of\x20</strong>drugs\x20like\x20<strong>imatinib,</strong>\x20<strong>not\x20methotrexate.\x20Tyrosine\x20kinase\x20inhibitors</strong>\x20are\x20<strong>used</strong>\x20in\x20the\x20treatment\x20of\x20certain\x20<strong>types\x20of\x20leukemia.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Inhibition\x20of\x20purine\x20metabolism:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20While\x20<strong>methotrexate</strong>\x20can\x20<strong>impact\x20purine\x20metabolism\x20indirectly\x20</strong>by\x20<strong>its\x20action</strong>\x20on\x20<strong>DHFR</strong>,\x20the\x20<strong>direct\x20inhibition\x20of\x20purine\x20metabolism\x20</strong>is\x20characteristic\x20of\x20drugs\x20like\x20<strong>6-mercaptopurine,\x20not\x20methotrexate.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20key\x20<strong>mechanism\x20of\x20action</strong>\x20of<strong>\x20methotrexate</strong>\x20in\x20the\x20treatment\x20of\x20<strong>cancer</strong>,\x20including\x20<strong>osteosarcoma,</strong>\x20is\x20the<strong>\x20inhibition\x20of\x20dihydrofolate</strong>\x20<strong>reductase.</strong>\x20This\x20action\x20results\x20in\x20<strong>decreased\x20nucleotide\x20biosynthesis</strong>,\x20which\x20is<strong>\x20vital\x20for\x20DNA\x20replication\x20</strong>and\x20<strong>cell\x20division\x20in\x20rapidly</strong>\x20<strong>dividing\x20cancer\x20cells.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Understanding\x20this\x20<strong>mechanism</strong>\x20is\x20critical\x20when\x20<strong>using\x20methotrexate</strong>\x20as\x20an\x20<strong>anticancer\x20agent</strong>,\x20as\x20it\x20informs<strong>\x20both\x20its\x20therapeutic\x20effects</strong>\x20<strong>and\x20its\x20toxicity\x20profile.</strong></span></span></span></p>','toString','aGhqn','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20dir=\x22ltr\x22\x20lang=\x22PT-BR\x22\x20style=\x22font-size:12.0pt\x22>Alemtuzumab</span></span></span></p>','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','TtNvP','parse','quizPerformanceData','FjMpq','zQLqh','cZObc','Q8755280','ePRlK','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>6-mercaptopurine</span></span></span></p>','NaoSE','5|1|0|2|4|3','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Anthracyclines\x20</span></span></span></p>','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','hOmkJ','CBWkR','zwliL','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2050-year-old\x20woman\x20presents\x20with\x20a\x20diagnosis\x20of\x20non-Hodgkin&#39;s\x20lymphoma.\x20She\x20is\x20started\x20on\x20chemotherapy,\x20which\x20includes\x20a\x20drug\x20derived\x20from\x20the\x20periwinkle\x20plant\x20(Image\x20shown\x20below).\x20Which\x20of\x20the\x20following\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/406.jpg\x22\x20style=\x22height:239px;\x20width:300px\x22\x20/></span></span></span></p>','VgXAB','Cerebellum','oWDuO','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>6\x20Thioguanine</span></span></span></p>','reduce','944848OuaDzp','qjpzL','floor','bmSPr','vQvKT','toLowerCase','QaYHM','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Methotrexate\x20acts\x20by\x20inhibiting\x20dihydrofolate\x20reductase</span></span></span></p>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','sohur','Q4902967','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x20patient\x20with\x20head\x20and\x20neck\x20cancer\x20was\x20given\x20radiotherapy.\x20After\x206\x20months\x20of\x20radiotherapy,\x20chemotherapy\x20was\x20started\x20but\x20patient\x20presented\x20with\x20the\x20clinical\x20picture\x20as\x20shown\x20after\x20start\x20of\x20chemotherapy.\x20What\x20is\x20the\x20likely\x20drug\x20responsible\x20for\x20this?</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/405.jpg\x22\x20style=\x22height:271px;\x20width:300px\x22\x20/></span></span></span></p>','pathname','hcZBW','YrFlY','XnyjU','bTkml','HknEP','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20an\x20alkylating\x20agent</span></span></span></p>','ylehM','UHiCt','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Cisplatin</span></span></span></p>','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20purine\x20metabolism</span></span></span></p>','bookmarkedQuestions','LtTvG','CnnRW','info','sKJfS','performanceModal','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2056-year-old\x20female\x20presents\x20with\x20breast\x20carcinoma,\x20and\x20she\x20was\x20prescribed\x20Herceptin\x20(trastuzumab).\x20Which\x20of\x20the\x20following\x20statements\x20regarding\x20this\x20drug\x20is\x20true?</span></span></span></p>','customQuizData','FBFeB','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Ans.\x20D)\x20Obtained\x20from\x20E.\x20coli</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20D:</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><ul><li><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Paclitaxel\x20</strong>is\x20a<strong>\x20chemotherapy\x20</strong>drug\x20that<strong>\x20stabilizes\x20microtubules\x20</strong>and\x20<strong>prevents\x20their\x20depolymerization,</strong>\x20leading\x20to<strong>\x20cell</strong>\x20<strong>cycle\x20arrest\x20and\x20apoptosis.</strong></span></p></li><li><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>It\x20is\x20<strong>commonly\x20used</strong>\x20in\x20the\x20treatment\x20of<strong>\x20ovarian,\x20cervical,\x20and\x20breast\x20cancer</strong>,\x20among\x20others.</span></p></li><li><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>Like\x20<strong>most\x20cytotoxic\x20drugs,\x20Paclitaxel</strong>\x20is\x20also\x20known\x20to\x20cause\x20<strong>myelosuppression\x20and\x20alopecia\x20(hair\x20loss)</strong>\x20as\x20common\x20side\x20effects.</span></p></li><li><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>However,\x20<strong>Paclitaxel</strong>\x20is\x20<strong>not</strong>\x20obtained\x20from<strong>\x20E.\x20coli</strong>.\x20It\x20is\x20originally\x20derived\x20from\x20the\x20<strong>bark\x20of\x20the\x20Pacific\x20yew\x20tree,</strong>\x20<strong>Taxus</strong>\x20<strong>brevifolia</strong>,\x20and\x20is\x20now\x20produced<strong>\x20synthetically\x20or\x20through\x20semi-synthesis.</strong></span></p></li></ul><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong><u>Explanation:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20A.\x20Stabilizes\x20microtubules\x20and\x20prevent\x20polymerization:</strong>\x20The\x20statement\x20is\x20almost\x20<strong>correct</strong>\x20but\x20has\x20a\x20<strong>crucial\x20error.\x20Paclitaxel</strong>\x20<strong>actually\x20stabilizes\x20microtubules</strong>\x20but\x20<strong>prevents\x20</strong>their\x20<strong>depolymerization,\x20not\x20polymerization.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20B.\x20Used\x20in\x20ovarian,\x20cervix\x20and\x20breast\x20cancer:</strong>\x20This\x20is\x20<strong>true.</strong>\x20<strong>Paclitaxel</strong>\x20is<strong>\x20used\x20</strong>in\x20the\x20treatment\x20of\x20these\x20<strong>cancers</strong>\x20due\x20to\x20its\x20<strong>effectiveness\x20in\x20inhibiting\x20cell\x20division.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Option\x20C.\x20Most\x20commonly\x20causes\x20myelosuppression\x20and\x20alopecia:</strong>\x20Also\x20<strong>true.</strong>\x20These\x20are\x20<strong>common\x20side\x20effects</strong>\x20of\x20<strong>many</strong>\x20<strong>chemotherapeutic\x20agents</strong>,\x20including<strong>\x20paclitaxel.</strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong><u>Educational\x20objective:</u></strong></span></p><p\x20style=\x22text-align:justify;\x22>&nbsp;</p><p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22><strong>Paclitaxel</strong>,\x20a\x20<strong>chemotherapeutic\x20agent</strong>\x20that\x20is<strong>\x20known</strong>\x20for\x20its\x20<strong>ability\x20to\x20stabilize\x20microtubules\x20</strong>and\x20thereby\x20<strong>prevent\x20their</strong>\x20<strong>depolymerization</strong>,\x20leading\x20to\x20<strong>inhibition\x20of\x20cell\x20division</strong>\x20in\x20<strong>cancer\x20treatment.\x20</strong>It\x20is\x20associated\x20with<strong>\x20side\x20effects</strong>\x20such\x20as\x20<strong>myelosuppression\x20and\x20alopecia;</strong>\x20and\x20it\x20was<strong>\x20originally</strong>\x20obtained\x20from\x20the\x20<strong>bark\x20of\x20the\x20Pacific\x20yew\x20tree</strong>\x20and\x20now\x20can\x20be\x20<strong>produced</strong>\x20<strong>synthetically.</strong></span></p>','qiOSl','iOgnf','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Ribociclib</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Ribociclib</strong>\x20is\x20a\x20<strong>selective\x20inhibitor\x20of\x20cyclin-dependent\x20kinases\x204\x20and\x206\x20(CDK4/6),</strong>\x20which\x20are\x20<strong>enzymes\x20</strong>that\x20play\x20a\x20critical\x20<strong>role\x20in\x20cell\x20cycle\x20progression.\x20</strong>These\x20<strong>kinases</strong>\x20<strong>promote\x20cell\x20proliferation\x20by\x20phosphorylating</strong>\x20and\x20<strong>inactivating</strong>\x20the\x20<strong>retinoblastoma\x20protein\x20(Rb),\x20</strong>which\x20in\x20turn\x20allows\x20the\x20<strong>cell\x20to\x20pass\x20</strong>through\x20the<strong>\x20G1\x20checkpoint</strong>\x20and\x20<strong>enter\x20S\x20phase</strong>\x20of\x20the\x20<strong>cell\x20cycle.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Inhibition\x20of\x20CDK4/6\x20</strong>by\x20<strong>Ribociclib</strong>\x20results\x20in<strong>\x20cell\x20cycle\x20arrest\x20in\x20the\x20G1\x20phase</strong>,\x20leading\x20to\x20<strong>inhibition\x20of\x20cell\x20proliferation.</strong>\x20This\x20<strong>mechanism\x20of\x20action\x20</strong>is\x20particularly<strong>\x20relevant\x20in\x20cancer\x20cells</strong>,\x20which\x20often\x20have\x20<strong>aberrant\x20regulation\x20of\x20the\x20cell\x20cycle\x20and\x20increased\x20reliance\x20on\x20CDK4/6\x20activity\x20to\x20drive\x20proliferation.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Ribociclib</strong>\x20is\x20approved\x20for\x20<strong>use\x20in\x20combination</strong>\x20with\x20other\x20therapies\x20for\x20the\x20treatment\x20of<strong>\x20estrogen\x20receptor-positive</strong>,\x20<strong>human\x20epidermal\x20growth\x20factor\x20receptor\x202-negative\x20(HR+/HER2-)</strong>\x20<strong>advanced\x20</strong>or\x20<strong>metastatic\x20breast\x20cancer.\x20</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Erlotinib</strong>:\x20<strong>Erlotinib\x20</strong>is\x20a\x20<strong>tyrosine\x20kinase\x20inhibitor</strong>\x20that\x20<strong>targets\x20the\x20epidermal\x20growth\x20factor\x20receptor\x20(EGFR)\x20pathway</strong>.\x20It\x20works\x20by\x20<strong>blocking\x20the\x20activity\x20of\x20the\x20EGFR\x20protein,\x20</strong>which\x20is\x20often\x20<strong>overexpressed\x20</strong>in\x20certain\x20types\x20of\x20<strong>cancer\x20cells</strong>\x20and\x20contributes\x20to\x20<strong>tumor\x20growth\x20and\x20spread</strong>.\x20<strong>Erlotinib\x20</strong>is\x20primarily\x20<strong>used\x20</strong>to\x20treat<strong>\x20non-small\x20cell\x20lung\x20cancer\x20and\x20pancreatic\x20cancer.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Dabrafenib</strong>:<strong>\x20Dabrafenib\x20</strong>is\x20a<strong>\x20selective\x20inhibitor\x20of\x20the\x20BRAF\x20protein</strong>,\x20which\x20is\x20a\x20key\x20component\x20of\x20the<strong>\x20MAP\x20kinase\x20signalling</strong>\x20<strong>pathway</strong>.\x20This\x20pathway\x20is<strong>\x20frequently\x20mutated\x20in\x20certain\x20types\x20of\x20cancer</strong>,\x20including<strong>\x20melanoma,\x20and\x20drives\x20tumor\x20growth</strong>\x20<strong>and\x20survival</strong>.\x20Dabrafenib\x20is<strong>\x20used\x20to\x20treat\x20advanced\x20melanoma</strong>\x20with<strong>\x20BRAF\x20V600E\x20or\x20V600K\x20mutations</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Nilotinib</strong>:\x20Nilotinib\x20is\x20a<strong>\x20tyrosine\x20kinase\x20inhibitor</strong>\x20that\x20targets\x20the\x20<strong>BCR-ABL\x20protein,</strong>\x20which\x20is\x20a\x20<strong>fusion\x20protein</strong>\x20that\x20drives\x20the\x20<strong>growth\x20of\x20chronic\x20myelogenous\x20leukemia\x20(CML)\x20cells.\x20</strong>It\x20works\x20by<strong>\x20blocking\x20the\x20activity</strong>\x20of\x20the<strong>\x20BCR-ABL\x20protein</strong>,\x20leading\x20to\x20<strong>inhibition</strong>\x20of\x20<strong>cell\x20proliferation\x20and\x20induction\x20of\x20cell\x20death</strong>.\x20<strong>Nilotinib\x20</strong>is\x20taken\x20<strong>orally</strong>\x20and\x20is\x20primarily\x20used\x20to\x20treat<strong>\x20CML.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Ribociclib\x20</strong>is\x20a<strong>\x20targeted\x20anticancer</strong>\x20therapy\x20that\x20<strong>inhibits\x20CDK4/6</strong>,\x20key\x20enzymes\x20in\x20<strong>cell\x20cycle\x20regulation</strong>.\x20It\x20is\x20<strong>used\x20to\x20</strong>halt\x20the\x20<strong>progression\x20of\x20certain\x20cancers</strong>\x20by<strong>\x20inducing\x20cell\x20cycle\x20arrest\x20at\x20the\x20G1\x20phase,</strong>\x20thereby\x20<strong>impeding\x20the\x20cancer\x20cells</strong>\x20<strong>from\x20multiplying.</strong></span></span></span></p>','UPTqh','KoDri','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>All\x20are\x20true\x20about\x20Erlotinib\x20except?</span></span></span></p>','XhEfG','toggle','block','nav-btn-bookmarked','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20an\x20antibody\x20produced\x20entirely\x20from\x20mice\x20containing\x20no\x20human\x20component</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>G1\x20phase</span></span></span></p>','mHDly','hidden','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20D)\x20Tofacitinib\x20is\x20administered\x20by\x20intravenous\x20route</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>This\x20statement\x20is\x20<strong>false</strong>.\x20<strong>Tofacitinib</strong>\x20is\x20<strong>not</strong>\x20administered\x20<strong>intravenously</strong>;\x20it\x20is\x20an\x20<strong>orally\x20administered\x20</strong>medication.\x20This\x20<strong>distinguishes\x20it</strong>\x20<strong>from</strong>\x20many\x20<strong>other\x20biologic\x20drugs\x20</strong>used\x20in\x20the\x20treatment\x20of\x20conditions\x20like\x20<strong>rheumatoid\x20arthritis</strong>,\x20which\x20are\x20often\x20<strong>administered\x20via\x20injection\x20or\x20infusion.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Tofacitinib\x20inhibits\x20Janus\x20kinase\x20(JAK)\x20enzymes.</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20True.</strong>\x20<strong>Tofacitinib\x20functions\x20</strong>as\x20a\x20<strong>Janus\x20kinase\x20inhibitor,</strong>\x20<strong>targeting</strong>\x20and\x20<strong>inhibiting\x20these\x20enzymes</strong>,\x20which\x20are\x20<strong>crucial\x20in\x20the\x20signaling\x20pathways</strong>\x20for\x20various<strong>\x20inflammatory\x20processes.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Tocilizumab\x20is\x20a\x20monoclonal\x20antibody\x20against\x20interleukin-6\x20(IL-6)\x20receptor\x20-\x20</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>True.</strong>\x20<strong>Tocilizumab\x20</strong>is\x20a<strong>\x20monoclonal\x20antibody</strong>\x20that\x20<strong>specifically\x20binds</strong>\x20to\x20and\x20<strong>inhibits\x20the\x20IL-6\x20receptor,</strong>\x20thereby\x20impacting\x20the\x20<strong>action\x20of\x20interleukin-6,\x20</strong>a\x20<strong>cytokine</strong>\x20involved\x20in\x20<strong>inflammation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Tocilizumab\x20is\x20approved\x20for\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis\x20-\x20</span></strong><span\x20style=\x22font-size:12.0pt\x22>&nbsp;<strong>True.\x20Tocilizumab\x20</strong>has\x20been\x20<strong>approved\x20for</strong>\x20the\x20treatment\x20of<strong>\x20rheumatoid\x20arthritis</strong>,\x20particularly\x20for\x20patients\x20who\x20<strong>have\x20not\x20</strong>responded\x20<strong>adequately\x20to\x20other\x20treatments.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-122248.png\x22\x20style=\x22height:434px;\x20width:1000px\x22\x20/></span></u></strong></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>A\x2056-year-old\x20man\x20presents\x20to\x20the\x20oncology\x20clinic\x20with\x20a\x206-month\x20history\x20of\x20progressively\x20worsening\x20headaches\x20and\x20nausea.\x20He\x20has\x20no\x20significant\x20past\x20medical\x20history.\x20MRI\x20reveals\x20a\x20large,\x20heterogeneously\x20enhancing\x20mass\x20in\x20the\x20right\x20frontal\x20lobe.\x20Biopsy\x20confirms\x20the\x20diagnosis\x20of\x20glioblastoma\x20multiforme.\x20The\x20patient\x20is\x20started\x20on\x20temozolomide.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20temozolomide?\x20</span></span></span></p>','WlHUb','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Dabrafenib\x20</span></span></span></p>','pSBnR','ubxGn','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Basiliximab\x20enhances\x20the\x20differentiation\x20of\x20dendritic\x20cells</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Amifostine</span></span></span></p>','BBdkt','mfVVD','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20anticancer\x20drugs\x20act\x20at\x20the\x20target\x20shown\x20in\x20figure?\x20</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/407.jpg\x22\x20style=\x22height:226px;\x20width:400px\x22\x20/></span></span></span></p>','yTuTA','not_attempted','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20is\x20false\x20about\x20tofacitinib\x20and\x20tocilizumab?</span></span></span></p>','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>All\x20the\x20following\x20statements\x20are\x20true\x20about\x20tacrolimus\x20except:</span></p>','Q1912153','MGhYf','Jocld','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Proteosome\x20inhibition</span></span></span></p>','length','xtabz','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Methotrexate\x20can\x20be\x20used\x20in\x20the\x20treatment\x20of\x20psoriasis</span></span></span></p>','className','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>All\x20the\x20following\x20are\x20true\x20about\x20paclitaxel\x20except:</span></p>','qbkFZ','LAfWp','Wibhi','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20tyrosine\x20kinase</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20D)\x20Sarilumab</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20<strong>monoclonal\x20antibodies</strong>\x20approved\x20for\x20use\x20in\x20<strong>psoriasis</strong>\x20are\x20<strong>Ustekinumab,\x20Brodalumab,\x20and\x20Secukinumab.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Sarilumab</strong>\x20is\x20a<strong>\x20monoclonal\x20antibody</strong>\x20that\x20targets\x20the<strong>\x20interleukin-6\x20(IL-6)\x20receptor</strong>\x20and\x20is\x20approved\x20for\x20the\x20treatment\x20of\x20<strong>rheumatoid\x20arthritis,</strong>\x20but\x20it\x20is<strong>\x20not\x20</strong>approved\x20for\x20use\x20in<strong>\x20psoriasis.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Ustekinumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20<strong>monoclonal\x20antibody\x20</strong>targets\x20both\x20<strong>interleukin-12\x20(IL-12)\x20and\x20interleukin-23\x20(IL-23).</strong>\x20It\x20is\x20approved\x20for\x20the\x20treatment\x20of<strong>\x20psoriasis,\x20psoriatic\x20arthritis,\x20and\x20Crohn&#39;s\x20disease.</strong>\x20It\x20works\x20by<strong>\x20modulating\x20the\x20immune\x20response\x20</strong>that\x20contributes\x20to\x20the<strong>\x20inflammation</strong>\x20characteristic\x20of\x20these\x20conditions.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Brodalumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Targets</strong>\x20the<strong>\x20interleukin-17\x20(IL-17)\x20receptor,</strong>\x20approved\x20for\x20the\x20treatment\x20of<strong>\x20psoriasis.</strong>\x20By\x20<strong>blocking\x20IL-17,</strong>\x20<strong>Brodalumab</strong>\x20helps\x20<strong>reduce\x20inflammation\x20</strong>and\x20the<strong>\x20rapid\x20skin\x20cell\x20</strong>turnover\x20associated\x20with\x20<strong>psoriasis.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Secukinumab:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20<strong>antibody\x20targets\x20interleukin-17A\x20(IL-17A)\x20</strong>and\x20is\x20approved\x20for\x20<strong>psoriasis,\x20psoriatic\x20arthritis,</strong>\x20and\x20<strong>ankylosing\x20spondylitis</strong>.\x20It\x20works\x20similarly\x20to<strong>\x20Brodalumab\x20</strong>by\x20targeting\x20a\x20key<strong>\x20cytokine</strong>\x20involved\x20in<strong>\x20inflammatory\x20processes</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>While<strong>\x20Ustekinumab,\x20Brodalumab,\x20and\x20Secukinumab</strong>\x20are\x20<strong>approved\x20</strong>and\x20<strong>effective\x20</strong>treatments\x20for<strong>\x20psoriasis</strong>\x20through\x20their<strong>\x20targeting\x20</strong>of\x20<strong>specific\x20interleukins</strong>\x20involved\x20in\x20<strong>inflammatory\x20pathways,</strong>\x20<strong>Sarilumab,</strong>\x20though\x20a\x20<strong>monoclonal\x20antibody</strong>,\x20is\x20<strong>not</strong>\x20used\x20for\x20<strong>psoriasis</strong>\x20as\x20it\x20<strong>targets\x20IL-6</strong>,\x20<strong>relevant\x20primarily</strong>\x20in\x20the\x20context\x20of<strong>\x20rheumatoid\x20arthritis.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Monoclonal\x20antibodies\x20for\x20psoriasis:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-150951.png\x22\x20style=\x22height:541px;\x20width:700px\x22\x20/></span></strong></span></span></p>','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','eBAPJ','red','LBwlj','text','aznJa','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20drugs\x20acts\x20specifically\x20on\x20the\x20M\x20phase\x20of\x20the\x20cell\x20cycle?</span></span></span></p>','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','VrHAz','KuQBV','Q4625536','YOWYu','Q9739289','oEHro','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>It\x20inhibits\x20the\x20gene\x20transcription\x20of\x20interleukin\x202</span></p>','jxiVu','jZNxw','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>All\x20the\x20following\x20statements\x20about\x20methotrexate\x20are\x20correct\x20except:</span></span></span></p>','BdarN','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Methotrexate</span></span></span></p>','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Crohn&rsquo;s\x20disease</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Paclitaxel</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Paclitaxel\x20</strong>is\x20a\x20<strong>chemotherapy\x20agent</strong>\x20that\x20falls\x20under\x20the<strong>\x20category\x20of\x20taxanes,</strong>\x20which\x20are\x20known\x20for\x20their\x20ability\x20to<strong>\x20inhibit\x20the</strong>\x20<strong>depolymerization\x20of\x20tubulin</strong>.\x20<strong>Tubulin\x20</strong>is\x20a\x20key<strong>\x20protein</strong>\x20involved\x20in\x20<strong>spindle\x20formation</strong>\x20during\x20the<strong>\x20M\x20phase\x20of\x20the\x20cell\x20cycle.</strong>\x20By\x20<strong>stabilizing\x20tubulin\x20polymers,</strong>\x20<strong>paclitaxel\x20effectively\x20</strong>prevents\x20the<strong>\x20spindle\x20fibers\x20from\x20breaking\x20down,</strong>\x20which\x20is\x20essential\x20for<strong>\x20cell</strong>\x20<strong>division.</strong>\x20This\x20<strong>inhibition\x20locks\x20the\x20cells\x20</strong>in\x20the<strong>\x20M\x20phase</strong>,\x20<strong>preventing\x20</strong>them\x20from\x20<strong>successfully\x20completing\x20mitosis</strong>,\x20thus<strong>\x20inhibiting\x20cell</strong>\x20<strong>division\x20and\x20proliferation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Mitoxantrone:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20drug\x20is\x20a\x20<strong>type\x20of\x20antitumor\x20antibiotic\x20</strong>that\x20interferes\x20with<strong>\x20DNA\x20replication\x20and\x20RNA\x20synthesis</strong>\x20but\x20<strong>does</strong>\x20<strong>not\x20</strong>specifically\x20act\x20on\x20the<strong>\x20M\x20phase</strong>.\x20It\x20is\x20classified\x20among<strong>\x20topoisomerase\x20inhibitors</strong>\x20and\x20is\x20used\x20primarily\x20for\x20<strong>its\x20action</strong>\x20in\x20various\x20<strong>phases\x20of\x20the\x20cell\x20cycle,</strong>\x20but\x20<strong>not\x20</strong>specifically\x20the\x20<strong>M\x20phase.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Topotecan:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20As\x20a<strong>\x20topoisomerase\x20inhibitor,\x20</strong>Topotecan\x20<strong>interferes</strong>\x20with\x20the\x20<strong>ability\x20of\x20topoisomerases</strong>\x20to\x20<strong>relieve\x20torsional</strong>\x20<strong>strain\x20on\x20DNA\x20during\x20replication\x20</strong>and<strong>\x20transcription</strong>.\x20It\x20is\x20<strong>primarily\x20active</strong>\x20in\x20the<strong>\x20S\x20phase\x20of\x20the\x20cell\x20cycle</strong>,\x20not\x20the\x20M\x20phase.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Daunorubicin:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Another\x20antitumor\x20antibiotic,<strong>\x20Daunorubicin</strong>\x20is\x20involved\x20in\x20<strong>intercalating\x20DNA</strong>\x20and<strong>\x20inhibiting\x20the\x20enzyme</strong>\x20<strong>topoisomerase\x20II,</strong>\x20which\x20<strong>prevents\x20the\x20relaxation\x20of\x20supercoiled\x20DNA\x20and\x20promotes\x20DNA\x20breakage\x20</strong>during\x20<strong>replication</strong>.\x20Like\x20<strong>Mitoxantrone</strong>,\x20it\x20<strong>does\x20not</strong>\x20specifically\x20<strong>target\x20the\x20M\x20phase.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-121414.png\x22\x20style=\x22height:454px;\x20width:1000px\x22\x20/></span></u></strong></span></span></p>','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20C)\x20Colorectal\x20Ca</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Cetuximab</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20that\x20targets\x20the\x20<strong>epidermal\x20growth\x20factor\x20receptor\x20(EGFR)</strong>,\x20which\x20is\x20<strong>overexpressed</strong>\x20in\x20many\x20<strong>types\x20of\x20cancers</strong>,\x20including\x20a\x20<strong>significant\x20proportion\x20of\x20colorectal\x20cancers</strong>.\x20By<strong>\x20binding\x20to\x20EGFR,\x20cetuximab\x20inhibits</strong>\x20the\x20<strong>receptor&#39;s</strong>\x20<strong>function</strong>,\x20which\x20is\x20to\x20<strong>trigger\x20pathways</strong>\x20that\x20lead\x20to<strong>\x20cell\x20growth\x20and\x20proliferation</strong>.\x20This\x20<strong>inhibition</strong>\x20helps<strong>\x20to\x20control\x20the\x20growth\x20</strong>of\x20<strong>cancer\x20cells,\x20</strong>making\x20<strong>cetuximab\x20an\x20effective\x20treatment</strong>\x20for<strong>\x20colorectal\x20cancer,\x20</strong>particularly\x20in\x20<strong>tumors</strong>\x20that\x20express\x20<strong>high\x20levels\x20of\x20EGFR.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.\x20Adamantinoma:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20a<strong>\x20rare</strong>\x20type\x20of<strong>\x20tumor</strong>\x20that\x20typically<strong>\x20arises\x20in\x20the\x20bones,</strong>\x20specifically\x20the\x20<strong>tibia\x20and\x20the\x20jawbone.</strong>\x20<strong>Cetuximab</strong>\x20is<strong>\x20not</strong>\x20indicated\x20for\x20the<strong>\x20treatment\x20of\x20adamantinoma.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Basal\x20cell\x20Ca\x20(Carcinoma):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Basal\x20cell\x20carcinoma\x20is\x20primarily<strong>\x20treated</strong>\x20with\x20<strong>surgical\x20methods,\x20topical\x20treatments,\x20</strong>or\x20<strong>radiation</strong>\x20<strong>therapy.</strong>\x20<strong>Cetuximab</strong>\x20is<strong>\x20not</strong>\x20used\x20for\x20<strong>basal\x20cell\x20carcinoma</strong>\x20as\x20it\x20generally\x20<strong>does\x20not\x20</strong>express<strong>\x20EGFR\x20</strong>to\x20a\x20significant\x20extent.</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Crohn&rsquo;s\x20disease:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20an\x20<strong>inflammatory\x20bowel\x20disease</strong>;\x20treatment\x20typically\x20involves\x20<strong>immunosuppressive\x20</strong>and\x20<strong>anti-inflammatory\x20agents</strong>\x20such\x20as\x20<strong>TNF&alpha;\x20inhibitors\x20(e.g.,\x20infliximab).\x20Cetuximab</strong>\x20has\x20<strong>no</strong>\x20role\x20in\x20the\x20<strong>treatment\x20of\x20Crohn&#39;s\x20disease.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>MONOCLONAL\x20ANTIBODIES</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-130406.png\x22\x20style=\x22height:713px;\x20width:1000px\x22\x20/></span></strong></span></span></p>','ClinicalVignette','hqSWv','kydVn','qVaPD','NKGIm','intermediate','iOURu','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>S\x20phase</span></span></span></p>','incomplete','klgZc','MNxEi','CPpwk','question_audio','\x20>\x20','htevR','constructor','Q9245504','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Basiliximab\x20directly\x20inhibits\x20the\x20proliferation\x20of\x20T-cells</span></span></span></p>','pop','xZpZS','xWBsA','JKOmO','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','ycFfF','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Folinic\x20acid\x20enhances\x20the\x20action\x20of\x20methotrexate</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:12.0pt\x22><span\x20style=\x22font-family:&quot;Calibri&quot;,sans-serif\x22>Which\x20is\x20not\x20a\x20radiosensitizer?</span></span></p>','keydown','FlzXn','655972zpszud','wZIbO','twWIf','HuOho','OEpAk','gxdtX','rVFab','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Capacitabine</span></span></span></p>','XLfpS','ZDmYR','HbJmF','Q7237449','CDAvO','bDbKS','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Atezolizumab</span></span></span></p>','YFvHm','testModeReviewLegend','gMOHE','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Nivolumab\x20is\x20used\x20in\x20the\x20treatment\x20of?</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Doxorubicin</span></span></span></p>','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vincristine</span></span></span></p>','hieve','VGxud','lmWnF','nKqsm','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Retinoblastoma</span></span></span></p>','Q8140329','BxkNw','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>X\x20is\x20Vincristine\x20and\x20Y\x20is\x20Methotrexate</span></span></span></p>','XILZH','nrLxQ','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Hydroxyurea</span></span></span></p>','pAaxc','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Vincristine</span></span></span></p>','BJxQa','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Amifostine</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>&nbsp;Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Amifostine\x20</strong>is\x20classified\x20as\x20a\x20<strong>radioprotective\x20agent</strong>\x20rather\x20than\x20a<strong>\x20radiosensitizer.</strong>\x20It\x20<strong>works</strong>\x20by\x20<strong>protecting\x20normal\x20tissues</strong>\x20from\x20the<strong>\x20toxic</strong>\x20<strong>effects\x20of\x20radiation</strong>.\x20<strong>Amifostine</strong>\x20is\x20a\x20<strong>cytoprotective\x20prodrug</strong>\x20that,\x20<strong>once\x20activated,</strong>\x20has\x20<strong>free\x20radical\x20scavenging\x20properties,</strong>\x20thus\x20<strong>protecting\x20cells</strong>\x20from\x20the\x20<strong>damaging\x20effects\x20of\x20radiation\x20therapy.</strong>\x20It\x20selectively\x20<strong>accumulates\x20in\x20normal\x20cells</strong>\x20over<strong>\x20tumor\x20cells\x20</strong>and,\x20<strong>upon\x20activation</strong>,\x20it\x20<strong>detoxifies\x20reactive\x20oxygen\x20species</strong>\x20and<strong>\x20other\x20radicals</strong>\x20generated\x20by\x20<strong>radiation\x20in\x20normal\x20tissues.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Hydroxyurea:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20Hydroxyurea\x20acts\x20as\x20a<strong>\x20radiosensitizer</strong>\x20by<strong>\x20inhibiting\x20the\x20enzyme\x20ribonucleotide\x20reductase,</strong>\x20which\x20leads\x20to\x20a\x20<strong>depletion\x20of\x20deoxyribonucleotides</strong>\x20and\x20thereby<strong>\x20enhances\x20the\x20effects\x20of\x20radiation\x20on\x20cancer\x20cells.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x205FU\x20(5-Fluorouracil):</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>5FU\x20</strong>is\x20a\x20<strong>chemotherapy\x20agent</strong>\x20that\x20also\x20functions\x20as\x20a\x20<strong>radiosensitizer.</strong>\x20It\x20is\x20<strong>incorporated\x20</strong>into<strong>\x20RNA\x20</strong>and\x20<strong>DNA\x20</strong>and<strong>\x20interfere</strong>s\x20with\x20the\x20<strong>synthesis</strong>\x20and<strong>\x20function\x20of\x20nucleic\x20acids</strong>,\x20<strong>enhancing\x20radiation\x20therapy&#39;s\x20efficacy.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Bromodeoxyuridine:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20This\x20is\x20a\x20<strong>thymidine\x20analog\x20</strong>that\x20is<strong>\x20incorporated\x20into\x20DNA\x20</strong>during\x20the\x20<strong>S-phase\x20of\x20the\x20cell\x20cycle</strong>,\x20making\x20<strong>DNA\x20more\x20</strong>susceptible\x20to<strong>\x20damage\x20by\x20radiation.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>key\x20differences\x20between\x20radiosensitizers\x20and\x20radioprotectors:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-143815.png\x22\x20style=\x22height:547px;\x20width:1000px\x22\x20/></span></strong></span></span></p>','</span><span>','36qYABFk','FdFsj','qYMJj','eWXpq','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>All\x20the\x20platinum\x20compounds</span></span></span></p>','EJfVL','top','CztGF','TCDNK','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>The\x20most\x20common\x20side\x20effect\x20of\x20cancer\x20chemotherapy\x20is\x20nausea\x20with\x20or\x20without\x20vomiting.\x20The\x20anticancer\x20drugs\x20vary\x20is\x20their\x20ability\x20to\x20cause\x20nausea\x20and\x20vomiting.\x20Which\x20of\x20the\x20following\x20anti-cancer\x20drugs\x20is\x20least\x20likely\x20to\x20cause\x20nausea\x20and\x20vomiting?</span></span></span></p>','markReviewText','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Gemcitabine</span></span></span></p>','wQSiK','lnmuq','EnPop','kosla','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Cetuximab</span></span></span></p>','not-attempted','choices','flex','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Cetuximab</span></span></span></p>','timed_exam','accuracy','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Mechlorethamine</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20dir=\x22ltr\x22\x20lang=\x22PT-BR\x22\x20style=\x22font-size:12.0pt\x22>Ocrelizumab</span></span></span></p>','correctAnswers','location','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','fYKra','VBdXV','notAttemptedResult','nQDNZ','XvRjy','Q6952089','RkvWV','timed_study','startAt','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Mitomycin\x20C</span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20A)\x20Hodgkin&rsquo;s\x20lymphoma</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Nivolumab</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20is\x20a<strong>\x20checkpoint\x20inhibitor</strong>\x20that\x20targets\x20the\x20<strong>PD-1\x20(programmed\x20cell\x20death\x20protein\x201)\x20on\x20T\x20cells</strong>.\x20It\x20is<strong>\x20used</strong>\x20in\x20the\x20treatment\x20of\x20<strong>various\x20cancers,\x20including\x20Hodgkin&rsquo;s\x20lymphoma.</strong>\x20<strong>Nivolumab\x20</strong>works\x20by\x20<strong>blocking\x20PD-1,\x20enhancing\x20the\x20immune\x20system&#39;s\x20response</strong>\x20<strong>against\x20cancer\x20cells.\x20</strong>It\x20has\x20been\x20particularly\x20<strong>effective</strong>\x20in\x20treating\x20<strong>classical\x20Hodgkin&#39;s\x20lymphoma,</strong>\x20especially\x20in<strong>\x20cases\x20</strong>that\x20are\x20<strong>refractory</strong>\x20to<strong>\x20other\x20treatments.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B.\x20Medulloblastoma:</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20Not</strong>\x20a\x20primary\x20indication\x20for\x20<strong>nivolumab.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.\x20Retinoblastoma:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Not</strong>\x20treated\x20with\x20<strong>nivolumab.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.\x20Endometrial\x20carcinoma:</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Pembrolizumab</strong>\x20is\x20more\x20commonly\x20associated\x20with\x20<strong>endometrial\x20carcinoma,\x20not\x20nivolumab.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Important<strong>\x20indications</strong>\x20of\x20<strong>Immune\x20Check\x20Point\x20Inhibitors</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/416.jpg\x22\x20style=\x22height:742px;\x20width:1000px\x22\x20/></span></span></span></p>','PyxdA','button','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>Stabilizes\x20microtubules\x20and\x20prevent\x20depolymerization</span></p>','SXgTb','<p><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Inhibition\x20of\x20tyrosine\x20kinase\x20activity</span></span></span></p>','isArray','BriTU','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>It\x20is\x20a\x20chimeric\x20monoclonal\x20antibody\x20against\x20CD-20</span></span></span></p>','JXpIY','correct','svKKL','addEventListener','setItem','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Folinic\x20acid\x20and\x20vitamin\x20B6</span></span></span></p>','notAttempted','question_images','nSIaC','yKgmf','Zupls','bookmarked','yMgMd','totalQuestions','CYkQr','quizHierarchy','JQWzO','src','DDqvz','style','VoXhI','<p\x20style=\x22text-align:justify;\x22><span\x20style=\x22font-size:12.0pt;\x22>It\x20acts\x20by\x20binding\x20to\x20immunophilins</span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Which\x20of\x20the\x20following\x20is\x20an\x20inhibitor\x20of\x20DNA\x20replication?\x20</span></span></span></p>','vrDsA','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>X\x20is\x20Methotrexate\x20and\x20Y\x20is\x205-Fluorouracil</span></span></span></p>','xQGzL','console','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Ans.\x20B)\x20Proteasome\x20inhibitor</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20B:</span></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<ul>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Bortezomib</strong>\x20is\x20used\x20to\x20treat\x20<strong>multiple\x20myeloma.</strong>\x20It\x20works\x20by<strong>\x20inhibiting\x20the\x20activity\x20of\x20the\x20proteasome,</strong>\x20a\x20<strong>large\x20protein</strong>\x20<strong>complex</strong>\x20that\x20is\x20responsible\x20for\x20the<strong>\x20degradation\x20of\x20many\x20cellular\x20proteins.\x20</strong>Specifically,<strong>\x20Bortezomib\x20</strong>targets\x20the<strong>\x2026S</strong>\x20<strong>proteasome,\x20</strong>which\x20is\x20involved\x20in\x20the<strong>\x20degradation\x20of\x20ubiquitinated\x20proteins.</strong></span></span></span></li>\x0d\x0a\x09<li\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>By<strong>\x20inhibiting\x20proteasome\x20activity,\x20Bortezomib</strong>\x20interferes\x20with\x20the<strong>\x20normal\x20process\x20of\x20protein\x20degradation</strong>\x20and\x20leads\x20to\x20the\x20<strong>accumulation\x20of\x20misfolded\x20or\x20damaged\x20proteins\x20within\x20the\x20cell.</strong>\x20This\x20can\x20cause<strong>\x20cell\x20cycle\x20arrest,\x20activation\x20of</strong>\x20<strong>apoptotic\x20pathways,</strong>\x20and\x20ultimately,\x20<strong>cell\x20death.</strong></span></span></span></li>\x0d\x0a</ul>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Explanation:</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20A.</span></strong><span\x20style=\x22font-size:12.0pt\x22><strong>\x20mTOR\x20inhibitor</strong>:\x20The\x20<strong>mammalian\x20target\x20of\x20rapamycin\x20(mTOR)</strong>\x20is\x20a\x20<strong>protein\x20kinase</strong>\x20that\x20plays\x20a\x20key\x20role\x20in\x20<strong>regulating\x20cell</strong>\x20<strong>growth\x20and\x20proliferation.</strong>\x20<strong>Inhibition\x20of\x20mTOR\x20activity\x20</strong>can\x20<strong>slow\x20down</strong>\x20or\x20<strong>stop\x20the\x20growth\x20of\x20cancer\x20cells.</strong>\x20<strong>mTOR\x20inhibitors</strong>\x20such\x20as\x20<strong>temsirolimus\x20and\x20everolimus</strong>\x20are\x20used\x20to\x20<strong>treat\x20renal\x20cell\x20carcinoma\x20</strong>and\x20<strong>breast\x20cancer.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20C.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Histone\x20deacetylase\x20inhibitors</strong>:\x20HDAC\x20enzymes\x20are\x20involved\x20in\x20the\x20<strong>regulation\x20of\x20gene\x20expression</strong>.\x20By\x20<strong>altering</strong>\x20the\x20<strong>acetylation\x20status\x20of\x20histone\x20proteins</strong>,\x20<strong>HDAC\x20inhibitors</strong>\x20can\x20induce\x20changes\x20in\x20<strong>gene\x20expression</strong>\x20that\x20can\x20lead\x20to\x20<strong>cell\x20cycle\x20arrest,</strong>\x20<strong>differentiation,\x20or\x20apoptosis.</strong>\x20These\x20drugs\x20are<strong>\x20used\x20</strong>to\x20treat\x20various\x20types\x20of\x20<strong>cancer,\x20</strong>including<strong>\x20lymphoma\x20and\x20leukaemia.</strong>\x20Examples\x20of\x20<strong>HDAC\x20inhibitors\x20</strong>include<strong>\x20vorinostat,\x20romidepsin,\x20and\x20belinostat.\x20</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><span\x20style=\x22font-size:12.0pt\x22>Option\x20D.</span></strong><span\x20style=\x22font-size:12.0pt\x22>\x20<strong>Protein\x20tyrosine\x20kinase\x20inhibitor</strong>:<strong>\x20Protein\x20tyrosine\x20kinases\x20(PTKs)</strong>\x20are\x20enzymes\x20that\x20play\x20a\x20role\x20in<strong>\x20cell\x20signaling\x20pathways</strong>\x20and\x20are\x20often\x20<strong>overexpressed\x20or\x20mutated\x20in\x20cancer\x20cells</strong>.\x20<strong>PTK\x20inhibitors</strong>\x20such\x20as<strong>\x20imatinib,\x20dasatinib,\x20and\x20erlotinib</strong>\x20<strong>target\x20specific</strong>\x20<strong>tyrosine\x20kinases\x20</strong>and\x20<strong>inhibit\x20their\x20activity,\x20</strong>leading\x20to<strong>\x20decreased\x20cell\x20proliferation\x20and\x20survival</strong>.\x20These\x20drugs\x20are\x20<strong>used\x20to\x20treat\x20</strong>various\x20<strong>types\x20of\x20cancer,</strong>\x20including\x20<strong>chronic\x20myelogenous\x20leukemia\x20(CML)\x20</strong>and\x20some\x20forms\x20of<strong>\x20lung\x20cancer.</strong></span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><strong><u><span\x20style=\x22font-size:12.0pt\x22>Educational\x20Objective:\x20</span></u></strong></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><strong>Bortezomib&#39;s\x20</strong>role\x20as\x20a\x20<strong>proteasome\x20inhibitor</strong>\x20makes\x20it\x20an<strong>\x20effective\x20drug\x20</strong>in\x20the\x20treatment\x20of\x20<strong>multiple\x20myeloma,</strong>\x20by\x20<strong>disrupting</strong>\x20the\x20<strong>regulated\x20degradation\x20of\x20proteins</strong>\x20and\x20causing\x20a\x20<strong>build-up\x20that\x20is\x20toxic\x20to\x20cancer\x20cells.</strong></span></span></span></p>','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>6\x20Mercaptopurine</span></span></span></p>','tHtUK','<p><span\x20style=\x22font-size:12.0pt;\x22>Obtained\x20from\x20E.\x20coli</span></p>','jmFET','contains','Q3499495','classList','AdwCS','HuzUF','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Some\x20of\x20these\x20drugs\x20are\x20activated\x20by\x20hypoxanthine\x20guanine\x20phosphoribosyl\x20transferase\x20(HGPRTase)</span></span></span></p>','ywLaV','OJdVO','549775WyAUoR','trace','WbftY','totalQuestionsResult','shpbA','DLKJY','ktwxv','gTGWS','currentQuestionIndex','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Q3479799','DOava','explanationVideoPlayer','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Patients\x20undergoing\x20treatment\x20for\x20colorectal\x20cancer\x20have\x20developed\x20symptoms\x20such\x20as\x20tingling,\x20numbness,\x20pain,\x20and\x20erythema\x20on\x20the\x20palms\x20and\x20soles\x20of\x20their\x20feet\x20as\x20shown\x20in\x20the\x20figure\x20below.\x20Which\x20of\x20the\x20following\x20chemotherapy\x20drugs\x20could\x20be\x20the\x20causative\x20agent?</span></span></span></p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22>&nbsp;</p>\x0d\x0a\x0d\x0a<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22><img\x20alt=\x22\x22\x20src=\x22https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/403_RU0SYwK.jpg\x22\x20style=\x22height:280px;\x20width:500px\x22\x20/></span></span></span></p>','iwIsX','<p\x20style=\x22text-align:justify\x22><span\x20style=\x22font-size:11pt\x22><span\x20style=\x22font-family:Calibri,sans-serif\x22><span\x20style=\x22font-size:12.0pt\x22>Thalidomide\x20was\x20once\x20used\x20for\x20treating\x20the\x20emesis\x20of\x20pregnancy.\x20Later,\x20it\x20was\x20withdrawn\x20from\x20the\x20market\x20due\x20to\x20its\x20side\x20effects.\x20However,\x20it\x20was\x20reintroduced\x20for\x20certain\x20indications\x20like\x20multiple\x20myelomA.\x20Which\x20of\x20the\x20following\x20is\x20not\x20a\x20side\x20effect\x20of\x20thalidomide?</span></span></span></p>'];_0x5eeb=function(){return _0x272373;};return _0x5eeb();}function selectMode(_0x5d524c){const _0x33da4c=_0x164193,_0x29b602={'kpRwo':_0x33da4c(0x2d6),'AGEHM':_0x33da4c(0x3ad),'dKhik':function(_0x6671d7){return _0x6671d7();}};currentMode=_0x5d524c,document[_0x33da4c(0x410)](_0x29b602[_0x33da4c(0x184)])['style'][_0x33da4c(0x445)]=_0x29b602[_0x33da4c(0x32e)],_0x29b602['dKhik'](initializeQuiz);}function initializeQuiz(){const _0x523ad9=_0x164193,_0x575da7={'MNxEi':_0x523ad9(0x2d7),'ylehM':_0x523ad9(0x321),'jirOR':_0x523ad9(0x253),'VgXAB':function(_0x14bbd7,_0xf54bdc){return _0x14bbd7===_0xf54bdc;},'SSaol':function(_0x2f57af,_0x15b359){return _0x2f57af===_0x15b359;},'maopD':_0x523ad9(0x27d),'JKOmO':_0x523ad9(0x168),'KoDri':_0x523ad9(0x3ad),'KuQBV':_0x523ad9(0x1eb),'HxYKg':_0x523ad9(0x367),'nwNVE':_0x523ad9(0x484),'SJPia':_0x523ad9(0x27b),'daqSN':_0x523ad9(0x28b),'xfOQS':function(_0x3f42d9,_0x267357){return _0x3f42d9(_0x267357);},'LDSsB':function(_0x4bbb1a,_0x366ada){return _0x4bbb1a<_0x366ada;},'DLKJY':function(_0x37591e){return _0x37591e();},'VlMeC':function(_0x1e5740){return _0x1e5740();}};quizStartTime=Date[_0x523ad9(0x3f0)]();const _0x58bd8a=document[_0x523ad9(0x410)](_0x575da7[_0x523ad9(0x230)]),_0xc2faf0=document[_0x523ad9(0x410)](_0x575da7[_0x523ad9(0x1d5)]),_0x7b38f2=document[_0x523ad9(0x410)](_0x575da7[_0x523ad9(0x467)]),_0xd4f80d=_0x575da7['VgXAB'](currentMode,'test')||_0x575da7[_0x523ad9(0x335)](currentMode,_0x575da7[_0x523ad9(0x370)]);document[_0x523ad9(0x410)](_0x575da7[_0x523ad9(0x23b)])[_0x523ad9(0x2aa)][_0x523ad9(0x445)]=_0xd4f80d?_0x575da7[_0x523ad9(0x1e7)]:_0x575da7[_0x523ad9(0x217)],document[_0x523ad9(0x410)](_0x523ad9(0x409))[_0x523ad9(0x2aa)][_0x523ad9(0x445)]=_0xd4f80d?_0x575da7[_0x523ad9(0x1e7)]:'block',document[_0x523ad9(0x410)](_0x575da7['HxYKg'])[_0x523ad9(0x2aa)][_0x523ad9(0x445)]=_0xd4f80d?_0x523ad9(0x1eb):_0x575da7[_0x523ad9(0x1e7)],document[_0x523ad9(0x410)](_0x575da7[_0x523ad9(0x35b)])[_0x523ad9(0x2aa)]['display']=_0xd4f80d?_0x575da7[_0x523ad9(0x217)]:_0x575da7[_0x523ad9(0x1e7)],_0x58bd8a[_0x523ad9(0x2aa)]['display']=_0xd4f80d?_0x575da7[_0x523ad9(0x1e7)]:_0x523ad9(0x27b),_0xc2faf0[_0x523ad9(0x2aa)][_0x523ad9(0x445)]=_0xd4f80d?_0x575da7[_0x523ad9(0x42e)]:_0x575da7['KoDri'],_0x7b38f2[_0x523ad9(0x2aa)][_0x523ad9(0x445)]=_0xd4f80d?_0x523ad9(0x27b):_0x575da7[_0x523ad9(0x1e7)],(_0x575da7[_0x523ad9(0x1bc)](currentMode,_0x575da7[_0x523ad9(0x466)])||_0x575da7[_0x523ad9(0x335)](currentMode,'timed_exam'))&&document[_0x523ad9(0x410)](_0x523ad9(0x2d4))[_0x523ad9(0x2ba)][_0x523ad9(0x352)](_0x523ad9(0x1f0)),!_0x575da7[_0x523ad9(0x16f)](isNaN,startAt)&&startAt>=0x0&&_0x575da7['LDSsB'](startAt,questionsData[_0x523ad9(0x204)])&&(currentQuestionIndex=startAt),_0x575da7[_0x523ad9(0x2c5)](loadBookmarkedQuestions),_0x575da7['VlMeC'](generateQuestionNav),_0x575da7[_0x523ad9(0x2c5)](updateStats),_0x575da7['VlMeC'](displayQuestion);}function generateQuestionNav(){const _0x5516a9=_0x164193,_0xdb18={'yzkIf':'questionNav','rtmsw':function(_0x2d441f,_0x5c177a){return _0x2d441f<_0x5c177a;},'pmAxU':_0x5516a9(0x290),'yWKeP':function(_0x5efaf4,_0x1e3395){return _0x5efaf4+_0x1e3395;},'PlZAz':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','XvRjy':function(_0x2b965d){return _0x2b965d();}},_0x26bd7c=document[_0x5516a9(0x410)](_0xdb18[_0x5516a9(0x38a)]);_0x26bd7c[_0x5516a9(0x2d2)]='';for(let _0x496749=0x0;_0xdb18[_0x5516a9(0x33a)](_0x496749,questionsData['length']);_0x496749++){const _0x53818b=document[_0x5516a9(0x301)](_0xdb18[_0x5516a9(0x151)]);_0x53818b[_0x5516a9(0x385)]=_0xdb18[_0x5516a9(0x38e)](_0x496749,0x1),_0x53818b[_0x5516a9(0x207)]=_0xdb18[_0x5516a9(0x14e)],_0x53818b['onclick']=()=>jumpToQuestion(_0x496749),_0x53818b['id']=_0x5516a9(0x3d2)+_0x496749,_0x26bd7c['appendChild'](_0x53818b);}_0xdb18[_0x5516a9(0x288)](updateQuestionNav);}function _0x2ee7(_0x483db9,_0x2bc582){const _0x5cf2aa=_0x5eeb();return _0x2ee7=function(_0x167b6e,_0x56fa08){_0x167b6e=_0x167b6e-0x140;let _0x12d0bc=_0x5cf2aa[_0x167b6e];return _0x12d0bc;},_0x2ee7(_0x483db9,_0x2bc582);}function updateQuestionNav(){const _0x598510=_0x164193,_0x3f25ab={'gUCdi':function(_0x25245d,_0x601680){return _0x25245d-_0x601680;},'jtEqT':function(_0x46aa5b,_0x501145){return _0x46aa5b<_0x501145;},'gboWM':function(_0x10bf16,_0x54fdd0){return _0x10bf16!==_0x54fdd0;},'sJSkq':_0x598510(0x2ab),'jZPSd':function(_0x5ce207,_0xce9e91){return _0x5ce207===_0xce9e91;},'CnnRW':'nav-btn-marked-review','NviTx':function(_0x52e041,_0x423d48){return _0x52e041===_0x423d48;},'qiOSl':_0x598510(0x304),'jRxaE':function(_0x1148cb,_0x496bb5){return _0x1148cb===_0x496bb5;},'SNAmJ':'timed_study','QaYHM':_0x598510(0x25a),'McapM':'zVkrR','VOkaL':_0x598510(0x298),'ktwxv':_0x598510(0x497),'MOnfL':_0x598510(0x2b2),'gbfzk':_0x598510(0x269),'FlzXn':_0x598510(0x196)};for(let _0x5ecb00=0x0;_0x3f25ab[_0x598510(0x459)](_0x5ecb00,questionsData[_0x598510(0x204)]);_0x5ecb00++){if(_0x3f25ab[_0x598510(0x48a)](_0x598510(0x17f),_0x3f25ab[_0x598510(0x2eb)])){const _0x19a8fa=document[_0x598510(0x410)](_0x598510(0x3d2)+_0x5ecb00),_0x5aa825=questionStates[_0x5ecb00];let _0x43bb82='';if(_0x3f25ab['jZPSd'](_0x5ecb00,currentQuestionIndex))_0x43bb82=_0x598510(0x3be);else{if(_0x5aa825[_0x598510(0x2a2)])_0x43bb82=_0x598510(0x1ec);else{if(_0x5aa825[_0x598510(0x391)])_0x43bb82=_0x3f25ab[_0x598510(0x1db)];else{if(_0x3f25ab[_0x598510(0x350)](currentMode,_0x3f25ab[_0x598510(0x1e3)])||_0x3f25ab[_0x598510(0x312)](currentMode,_0x3f25ab['SNAmJ'])){if(_0x3f25ab[_0x598510(0x48a)](_0x3f25ab[_0x598510(0x1c7)],_0x3f25ab[_0x598510(0x318)])){if(_0x3f25ab[_0x598510(0x144)](_0x5aa825[_0x598510(0x379)],_0x3f25ab[_0x598510(0x3fd)]))_0x43bb82=_0x598510(0x3a3);else{if(_0x3f25ab[_0x598510(0x144)](_0x5aa825[_0x598510(0x379)],_0x3f25ab[_0x598510(0x2c6)]))_0x43bb82=_0x598510(0x351);else _0x43bb82=_0x3f25ab[_0x598510(0x313)];}}else _0x4ed83a[_0x16c6d5[_0x598510(0x3ab)]][_0x598510(0x2a2)]=!![];}else{if(_0x598510(0x269)!==_0x3f25ab[_0x598510(0x3aa)])_0x4da640[_0x598510(0x29e)][_0x598510(0x360)](_0x57357c=>{const _0x32bcfd=_0x598510;if(_0x57357c)_0xe04eed+=_0x32bcfd(0x250)+_0x57357c+_0x32bcfd(0x1b7);});else{if(_0x5aa825[_0x598510(0x311)]!==null)_0x43bb82=_0x3f25ab[_0x598510(0x241)];else _0x43bb82=_0x3f25ab[_0x598510(0x313)];}}}}}_0x19a8fa[_0x598510(0x207)]=_0x598510(0x310)+_0x43bb82;}else _0x5fffa0[_0x62bf70][_0x598510(0x3b8)]+=_0x3f25ab['gUCdi'](_0x5bab4c['now'](),_0x22ff17),_0x41604b=_0x1a8581[_0x598510(0x3f0)]();}}function jumpToQuestion(_0x1c6e5d){const _0x19d555=_0x164193,_0x1aba44={'ubxGn':function(_0x177584){return _0x177584();},'sKJfS':function(_0x1d3649,_0x433ace){return _0x1d3649(_0x433ace);},'Qhjgw':function(_0x5a2073,_0x55d8c3){return _0x5a2073===_0x55d8c3;},'hbMOY':_0x19d555(0x27d),'hHSeu':function(_0x560fd8,_0x3f9e58){return _0x560fd8+_0x3f9e58;},'eBAPJ':function(_0x15287e,_0x74c9bb){return _0x15287e===_0x74c9bb;},'rVFab':_0x19d555(0x2dc),'YOWYu':_0x19d555(0x190),'nQDNZ':function(_0x181117,_0x10afe0){return _0x181117+_0x10afe0;},'LBwlj':function(_0x223c31,_0x55bb29){return _0x223c31>=_0x55bb29;},'ldujk':function(_0x5390bf,_0x925354){return _0x5390bf===_0x925354;},'tguoS':_0x19d555(0x35e),'AezKx':_0x19d555(0x2f0),'QWhdt':_0x19d555(0x258),'GpDGk':function(_0x5ad563,_0x44372b){return _0x5ad563-_0x44372b;},'zygrR':function(_0x5573a3){return _0x5573a3();}};if(_0x1aba44[_0x19d555(0x211)](_0x1c6e5d,0x0)&&_0x1c6e5d<questionsData[_0x19d555(0x204)]){if(_0x1aba44[_0x19d555(0x15b)](_0x1aba44['tguoS'],_0x1aba44['AezKx']))_0x36e09e--,_0x1aba44[_0x19d555(0x1f6)](_0x209300),_0x13bdbe<=0x0&&(_0x1aba44[_0x19d555(0x1dd)](_0x3a8e2f,_0x11a6b0),_0x1aba44[_0x19d555(0x2e8)](_0x3d00e9,_0x1aba44['hbMOY'])?_0x1aba44[_0x19d555(0x1f6)](_0x24439b):_0x3ab17e());else{if(questionStartTime){if(_0x1aba44[_0x19d555(0x20f)](_0x1aba44['QWhdt'],'hieve'))questionStates[currentQuestionIndex][_0x19d555(0x3b8)]+=_0x1aba44['GpDGk'](Date[_0x19d555(0x3f0)](),questionStartTime);else{const _0x1b71d5=_0x3b781a['fromCharCode'](_0x1aba44['hHSeu'](0x41,_0x476eeb)),_0x14859d=_0x1aba44['eBAPJ'](_0x32362f,_0x3366eb),_0x414903=_0xad3434[_0x19d555(0x301)](_0x1aba44[_0x19d555(0x248)]);_0x414903[_0x19d555(0x2d2)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x14859d?_0x1aba44[_0x19d555(0x219)]:'')+_0x19d555(0x179)+_0x45a657+_0x19d555(0x465)+_0x1b71d5+_0x19d555(0x329)+(_0x2c2ea9[_0x19d555(0x212)]||_0x1aba44['nQDNZ']('Option\x20',_0x1aba44[_0x19d555(0x287)](_0x1b6d0e,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x3eb744[_0x19d555(0x154)](_0x414903);}}currentQuestionIndex=_0x1c6e5d,_0x1aba44['ubxGn'](displayQuestion),_0x1aba44[_0x19d555(0x163)](saveProgress);}}}function updateStats(){const _0x172bdc=_0x164193,_0x55f22d={'iwGmV':function(_0x9b32f,_0x14ca59){return _0x9b32f===_0x14ca59;},'XiMnZ':'timed_study','BBdkt':'correctCount','klgZc':_0x172bdc(0x3fa),'akkrl':function(_0x1bf246,_0x3be426){return _0x1bf246*_0x3be426;},'TmAjg':function(_0x1cc32e,_0x1012ff){return _0x1cc32e/_0x1012ff;},'UOQRV':function(_0x1241e4,_0x514d92){return _0x1241e4/_0x514d92;},'uqFhH':function(_0x86493,_0x1ebc96){return _0x86493/_0x1ebc96;},'acNlT':function(_0x1d1024,_0x56f360){return _0x1d1024+_0x56f360;}};if(_0x55f22d[_0x172bdc(0x451)](currentMode,_0x172bdc(0x304))||_0x55f22d['iwGmV'](currentMode,_0x55f22d[_0x172bdc(0x338)])){document[_0x172bdc(0x410)](_0x55f22d[_0x172bdc(0x1f9)])[_0x172bdc(0x385)]=stats[_0x172bdc(0x281)],document['getElementById'](_0x172bdc(0x36f))[_0x172bdc(0x385)]=stats[_0x172bdc(0x159)],document[_0x172bdc(0x410)](_0x55f22d[_0x172bdc(0x22f)])[_0x172bdc(0x385)]=stats[_0x172bdc(0x3fa)];const _0xb7a1a4=stats[_0x172bdc(0x3fa)]>0x0?Math[_0x172bdc(0x150)](_0x55f22d[_0x172bdc(0x428)](_0x55f22d[_0x172bdc(0x33e)](stats[_0x172bdc(0x281)],stats[_0x172bdc(0x3fa)]),0x64)):0x0;document[_0x172bdc(0x410)](_0x172bdc(0x27e))[_0x172bdc(0x385)]=_0xb7a1a4+'%',stats[_0x172bdc(0x314)]=questionStates[_0x172bdc(0x1c0)]((_0x355077,_0x453589)=>_0x355077+_0x453589['timeSpent'],0x0);const _0x16f039=Math[_0x172bdc(0x1c3)](_0x55f22d[_0x172bdc(0x2de)](stats['totalTime'],0x3e8)),_0x26c39e=Math[_0x172bdc(0x1c3)](_0x55f22d['uqFhH'](_0x16f039,0x3c)),_0x111bf9=_0x16f039%0x3c;document['getElementById']('timeSpent')[_0x172bdc(0x385)]=_0x55f22d[_0x172bdc(0x425)](_0x26c39e+':',_0x111bf9[_0x172bdc(0x1a6)]()[_0x172bdc(0x146)](0x2,'0'));}}function setupVideo(_0x473d59,_0x17c647){const _0x4c6cd7=_0x164193,_0xd8a643={'kErZr':_0x4c6cd7(0x478),'qbkFZ':_0x4c6cd7(0x31a),'cCRhi':function(_0xa1dc59,_0x5c5410){return _0xa1dc59===_0x5c5410;},'yOmkB':_0x4c6cd7(0x45a),'lnmuq':_0x4c6cd7(0x3b1)};if(Hls[_0x4c6cd7(0x3c0)]()){if(_0xd8a643[_0x4c6cd7(0x147)](_0x4c6cd7(0x457),_0xd8a643[_0x4c6cd7(0x36e)]))delete _0x190f97[_0x5dddc4],_0x3013f['setItem'](_0xd8a643[_0x4c6cd7(0x3d9)],_0x422ebe[_0x4c6cd7(0x34e)](_0x13d5de)),_0x17e831['log'](_0xd8a643[_0x4c6cd7(0x209)]);else{const _0x47f43d=new Hls();_0x47f43d['loadSource'](_0x17c647),_0x47f43d[_0x4c6cd7(0x32c)](_0x473d59);}}else _0x473d59[_0x4c6cd7(0x3c6)](_0xd8a643[_0x4c6cd7(0x275)])&&(_0x473d59['src']=_0x17c647);}function displayQuestion(){const _0x1b62c1=_0x164193,_0x5e1dba={'BdarN':'0|5|4|2|3|1','mmosl':function(_0x443fc7,_0x3a1d2e){return _0x443fc7+_0x3a1d2e;},'IcHyw':_0x1b62c1(0x3bd),'coMFM':_0x1b62c1(0x2a4),'WbiNZ':function(_0x4b5971,_0x5b3815){return _0x4b5971!==_0x5b3815;},'wZxyT':_0x1b62c1(0x2a3),'joruS':_0x1b62c1(0x349),'UXFvY':_0x1b62c1(0x344),'UPTqh':function(_0x502948,_0x1cf634){return _0x502948===_0x1cf634;},'hcZBW':_0x1b62c1(0x298),'RNIkx':_0x1b62c1(0x3a3),'kosla':function(_0x489907,_0x1f47de){return _0x489907===_0x1f47de;},'SyIep':_0x1b62c1(0x497),'FTFyj':_0x1b62c1(0x351),'BriTU':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','DiZgx':function(_0xa63486,_0x20ef63){return _0xa63486!==_0x20ef63;},'DmNzA':_0x1b62c1(0x3b4),'BJxQa':'yJcvK','gRSFk':function(_0xe29785,_0x1416bc){return _0xe29785===_0x1416bc;},'KAnzB':_0x1b62c1(0x2dc),'sNsLV':_0x1b62c1(0x30f),'ZDmYR':function(_0x2c6c4f,_0x664b9d){return _0x2c6c4f+_0x664b9d;},'xApGJ':function(_0x2cc397,_0x54ca56){return _0x2cc397(_0x54ca56);},'BcfVh':_0x1b62c1(0x3f8),'GLfMg':function(_0xb4dcb7){return _0xb4dcb7();},'wJNXX':_0x1b62c1(0x2cb),'xOcuV':'HvPYi','CDYLY':_0x1b62c1(0x485),'AZNyx':'OKUVH','aPXQn':_0x1b62c1(0x452),'nPavb':function(_0x2435de,_0x478852){return _0x2435de===_0x478852;},'saMGj':_0x1b62c1(0x371),'ePRlK':_0x1b62c1(0x429),'XLfpS':function(_0x3efd81,_0x40d59a){return _0x3efd81*_0x40d59a;},'izAYK':function(_0xe15875,_0x1caf12){return _0xe15875/_0x1caf12;},'lDrlv':function(_0x4f6691,_0x3e99ac){return _0x4f6691+_0x3e99ac;},'AeBAX':_0x1b62c1(0x417),'qjpzL':_0x1b62c1(0x37f),'GvGSc':function(_0x563cb9,_0x43f8ca){return _0x563cb9+_0x43f8ca;},'PxCWy':function(_0xe72737){return _0xe72737();},'SztcU':'prevBtn','vMFcB':function(_0x42e2f1,_0x203a78){return _0x42e2f1===_0x203a78;},'NaoSE':_0x1b62c1(0x1f0),'Ukudg':_0x1b62c1(0x164),'gdJho':function(_0x33d16b,_0x3115c3){return _0x33d16b===_0x3115c3;},'hYUYI':_0x1b62c1(0x492),'inVEZ':_0x1b62c1(0x18b),'XILZH':_0x1b62c1(0x346),'OvuEh':_0x1b62c1(0x28b),'jNqxP':function(_0xca23d4,_0x214669){return _0xca23d4===_0x214669;},'JrjYF':_0x1b62c1(0x27d),'lPvso':_0x1b62c1(0x454),'LrMtN':'vnFVy'};if(!questionsData||_0x5e1dba[_0x1b62c1(0x3c3)](questionsData[_0x1b62c1(0x204)],0x0)){document[_0x1b62c1(0x410)](_0x5e1dba[_0x1b62c1(0x3ac)])[_0x1b62c1(0x2d2)]=_0x5e1dba[_0x1b62c1(0x1b1)];return;};const _0x2fae79=questionsData[currentQuestionIndex];questionStartTime=Date[_0x1b62c1(0x3f0)](),selectedOption=questionStates[currentQuestionIndex][_0x1b62c1(0x311)];const _0x5409b4=_0x5e1dba[_0x1b62c1(0x24a)](_0x5e1dba[_0x1b62c1(0x3b5)](_0x5e1dba['lDrlv'](currentQuestionIndex,0x1),questionsData[_0x1b62c1(0x204)]),0x64);document[_0x1b62c1(0x410)](_0x5e1dba['AeBAX'])[_0x1b62c1(0x2aa)]['width']=_0x5e1dba[_0x1b62c1(0x3e8)](_0x5409b4,'%'),document[_0x1b62c1(0x410)](_0x5e1dba[_0x1b62c1(0x1c2)])['textContent']=_0x5e1dba['GvGSc'](currentQuestionIndex,0x1),_0x5e1dba['PxCWy'](updateQuestionNav),document[_0x1b62c1(0x410)](_0x5e1dba[_0x1b62c1(0x2f3)])['disabled']=_0x5e1dba['vMFcB'](currentQuestionIndex,0x0),document[_0x1b62c1(0x410)](_0x1b62c1(0x39c))[_0x1b62c1(0x2ba)][_0x1b62c1(0x383)](_0x5e1dba[_0x1b62c1(0x1b4)]),document[_0x1b62c1(0x410)](_0x5e1dba['saMGj'])[_0x1b62c1(0x2d2)]=_0x2fae79[_0x1b62c1(0x212)]||_0x5e1dba['Ukudg'];let _0x51b805='';if(_0x2fae79[_0x1b62c1(0x232)])_0x51b805+=_0x1b62c1(0x1b2)+_0x2fae79[_0x1b62c1(0x232)]+_0x1b62c1(0x1cc);if(_0x2fae79[_0x1b62c1(0x408)])_0x51b805+=_0x1b62c1(0x38f)+_0x2fae79[_0x1b62c1(0x408)]+_0x1b62c1(0x1a9);_0x2fae79[_0x1b62c1(0x29e)]&&(_0x5e1dba[_0x1b62c1(0x336)](_0x5e1dba[_0x1b62c1(0x19f)],_0x5e1dba[_0x1b62c1(0x19f)])?_0x2fae79[_0x1b62c1(0x29e)]['forEach'](_0x33b0a5=>{const _0xcc5d94=_0x1b62c1;if(_0x5e1dba[_0xcc5d94(0x30b)](_0x5e1dba[_0xcc5d94(0x363)],_0x5e1dba['joruS'])){if(_0x33b0a5)_0x51b805+=_0xcc5d94(0x250)+_0x33b0a5+_0xcc5d94(0x1b7);}else{const _0x798fb5=_0x5e1dba[_0xcc5d94(0x220)][_0xcc5d94(0x308)]('|');let _0x4ac441=0x0;while(!![]){switch(_0x798fb5[_0x4ac441++]){case'0':_0x48040c=_0x3ab260[_0xcc5d94(0x474)];continue;case'1':_0x2c6b9b['getElementById'](_0xcc5d94(0x2a6))[_0xcc5d94(0x385)]=_0x3f253e[_0xcc5d94(0x40c)]('\x20>\x20');continue;case'2':_0x22b757[_0xcc5d94(0x1a2)]=_0x5e1dba[_0xcc5d94(0x3e8)](_0x35f2f8,_0x5e1dba['IcHyw']);continue;case'3':_0x57828f[_0xcc5d94(0x410)](_0x5e1dba['coMFM'])[_0xcc5d94(0x385)]=_0x85e755[_0xcc5d94(0x204)];continue;case'4':_0x53f51f=_0x23af7e[_0xcc5d94(0x183)];continue;case'5':_0x3f03cb=_0x3d7aea[_0xcc5d94(0x3bb)];continue;}break;}}}):(_0xa7e458=_0x1b62c1(0x497),_0x16f43e=_0x5e1dba[_0x1b62c1(0x3ce)]));document['getElementById']('questionMedia')[_0x1b62c1(0x2d2)]=_0x51b805;const _0x5c3fc8=document[_0x1b62c1(0x410)](_0x5e1dba['inVEZ']);_0x5c3fc8['innerHTML']='',_0x5c3fc8[_0x1b62c1(0x2ba)][_0x1b62c1(0x352)](_0x5e1dba[_0x1b62c1(0x260)]);_0x2fae79[_0x1b62c1(0x27a)]&&Array[_0x1b62c1(0x294)](_0x2fae79[_0x1b62c1(0x27a)])&&(_0x2fae79[_0x1b62c1(0x27a)][_0x1b62c1(0x360)]((_0x3374ef,_0x282a1b)=>{const _0x5cd11b=_0x1b62c1;if(_0x5e1dba[_0x5cd11b(0x437)](_0x5e1dba['DmNzA'],_0x5e1dba[_0x5cd11b(0x265)])){const _0x456add=String[_0x5cd11b(0x45d)](0x41+_0x282a1b),_0x5e7d24=_0x5e1dba['gRSFk'](selectedOption,_0x282a1b),_0x24aca8=document['createElement'](_0x5e1dba['KAnzB']);_0x24aca8['innerHTML']=_0x5cd11b(0x49d)+(_0x5e7d24?_0x5cd11b(0x190):'')+_0x5cd11b(0x179)+_0x282a1b+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x456add+_0x5cd11b(0x329)+(_0x3374ef[_0x5cd11b(0x212)]||_0x5e1dba[_0x5cd11b(0x3e8)](_0x5e1dba['sNsLV'],_0x5e1dba[_0x5cd11b(0x24b)](_0x282a1b,0x1)))+_0x5cd11b(0x2c9),_0x5c3fc8[_0x5cd11b(0x154)](_0x24aca8);}else{if(_0x5e1dba[_0x5cd11b(0x1e6)](_0x3c8751[_0x5cd11b(0x379)],_0x5e1dba[_0x5cd11b(0x1cf)]))_0x1de1d6=_0x5e1dba[_0x5cd11b(0x38c)];else{if(_0x5e1dba['kosla'](_0x119a03[_0x5cd11b(0x379)],_0x5e1dba[_0x5cd11b(0x18e)]))_0x1b6272=_0x5e1dba['FTFyj'];else _0xdf48b9=_0x5e1dba[_0x5cd11b(0x295)];}}}),_0x5c3fc8[_0x1b62c1(0x29a)](_0x1b62c1(0x340),function(_0x1c6403){const _0x3bf2f2=_0x1b62c1,_0x4f1bdf={'GzxXJ':function(_0x330d05,_0x26a205){const _0x4f862f=_0x2ee7;return _0x5e1dba[_0x4f862f(0x339)](_0x330d05,_0x26a205);},'XOKyM':_0x5e1dba[_0x3bf2f2(0x327)],'lNgEt':function(_0x843048){return _0x5e1dba['GLfMg'](_0x843048);}};if(_0x5e1dba[_0x3bf2f2(0x35a)]===_0x5e1dba[_0x3bf2f2(0x195)])_0x4f1bdf['GzxXJ'](_0x32123c,_0x4f1bdf['XOKyM'])&&(_0x5aafe4=0x0,_0x239e26(),_0x4f1bdf[_0x3bf2f2(0x36d)](_0xfb473b));else{const _0x208e00=_0x1c6403['target'][_0x3bf2f2(0x30c)](_0x5e1dba['CDYLY']);if(_0x208e00){if(_0x5e1dba[_0x3bf2f2(0x30b)](_0x5e1dba[_0x3bf2f2(0x2f4)],_0x5e1dba[_0x3bf2f2(0x2f4)])){if(_0x359bbe){const _0x4e52e1=_0x55f4f8[_0x3bf2f2(0x303)](_0x28182e,arguments);return _0x116ed3=null,_0x4e52e1;}}else{const _0x12c7b0=parseInt(_0x208e00[_0x3bf2f2(0x3ff)](_0x5e1dba[_0x3bf2f2(0x2fa)]));selectOption(_0x12c7b0);}}}}));updateBookmarkButton(),updateMarkReviewButton();if((_0x5e1dba[_0x1b62c1(0x277)](currentMode,_0x5e1dba['OvuEh'])||_0x5e1dba[_0x1b62c1(0x393)](currentMode,_0x5e1dba['JrjYF']))&&!isQuizCompleted){if(_0x5e1dba[_0x1b62c1(0x19b)](_0x5e1dba[_0x1b62c1(0x2dd)],_0x5e1dba['LrMtN'])){const _0x137e4c=_0x541d8f[_0x1b62c1(0x303)](_0x2d70a7,arguments);return _0x337ba5=null,_0x137e4c;}else startTimer();}}function selectOption(_0x138144){const _0x3aa579=_0x164193,_0x468edc={'svKKL':_0x3aa579(0x1f0),'qQoAd':function(_0x31534a,_0x2b552c){return _0x31534a!==_0x2b552c;},'PsxXR':'pGLYS','gMOHE':_0x3aa579(0x190),'tFTSR':function(_0xe4a8b7,_0x36e5ae){return _0xe4a8b7===_0x36e5ae;},'tnCJA':function(_0x40a202,_0x4bb1ac){return _0x40a202+_0x4bb1ac;},'twWIf':_0x3aa579(0x30f),'MTgRE':function(_0x622c9f,_0x4f8183){return _0x622c9f+_0x4f8183;},'dEAgh':_0x3aa579(0x485),'WqXPr':function(_0x44ae88,_0x867f15){return _0x44ae88(_0x867f15);},'nSIaC':_0x3aa579(0x452),'vrDsA':'click','EnPop':_0x3aa579(0x18b),'yzkeq':_0x3aa579(0x346),'FzAFE':function(_0x7280dd,_0x1d4717){return _0x7280dd!==_0x1d4717;},'WBlyx':function(_0x36fb98,_0x5b72a6){return _0x36fb98-_0x5b72a6;},'omnWI':_0x3aa579(0x304),'WbftY':function(_0x5a3c12){return _0x5a3c12();},'TtNvP':'bKWPh','ckDTV':function(_0x42170e){return _0x42170e();}},_0x3c375d=document[_0x3aa579(0x410)](_0x468edc[_0x3aa579(0x276)]);if(_0x3c375d[_0x3aa579(0x2ba)]['contains'](_0x468edc[_0x3aa579(0x469)]))return;if(questionStartTime){if(_0x468edc[_0x3aa579(0x394)](_0x3aa579(0x364),_0x3aa579(0x364))){if(_0x4beee3){const _0x46035a=_0x86e004[_0x3aa579(0x303)](_0x48be91,arguments);return _0xca8973=null,_0x46035a;}}else questionStates[currentQuestionIndex][_0x3aa579(0x3b8)]+=_0x468edc[_0x3aa579(0x36b)](Date['now'](),questionStartTime),questionStartTime=Date[_0x3aa579(0x3f0)]();}selectedOption=_0x138144,questionStates[currentQuestionIndex]['selectedAnswer']=_0x138144,document[_0x3aa579(0x14b)](_0x468edc[_0x3aa579(0x175)])[_0x3aa579(0x360)]((_0x173e44,_0x136fd5)=>{const _0x33e1d2=_0x3aa579,_0x57ebc4={'eaNHa':_0x468edc[_0x33e1d2(0x299)]};_0x468edc[_0x33e1d2(0x42f)](_0x468edc[_0x33e1d2(0x3a4)],_0x468edc['PsxXR'])?_0x3fc053[_0x33e1d2(0x2ba)]['add'](_0x57ebc4[_0x33e1d2(0x384)]):_0x173e44[_0x33e1d2(0x2ba)][_0x33e1d2(0x1ea)](_0x468edc['gMOHE'],_0x468edc[_0x33e1d2(0x362)](_0x136fd5,_0x138144));}),_0x468edc['tFTSR'](currentMode,_0x468edc['omnWI'])||currentMode===_0x3aa579(0x28b)?_0x468edc[_0x3aa579(0x2c2)](processAnswer):_0x468edc[_0x3aa579(0x394)](_0x468edc[_0x3aa579(0x1aa)],_0x3aa579(0x42a))?(_0x468edc['tFTSR'](questionStates[currentQuestionIndex][_0x3aa579(0x379)],_0x3aa579(0x1fd))&&(questionStates[currentQuestionIndex][_0x3aa579(0x379)]=_0x3aa579(0x346),stats['totalAttempted']++,stats[_0x3aa579(0x29d)]--),_0x468edc[_0x3aa579(0x2c2)](updateQuestionNav)):(_0x55867d[_0x3aa579(0x27a)][_0x3aa579(0x360)]((_0x10d07c,_0x50c3dc)=>{const _0x349e85=_0x3aa579,_0x314517=_0x32d58b[_0x349e85(0x45d)](_0x468edc[_0x349e85(0x453)](0x41,_0x50c3dc)),_0x4a13c6=_0x468edc[_0x349e85(0x362)](_0x2dc2c4,_0x50c3dc),_0x3e5bd9=_0xcd7bb8['createElement'](_0x349e85(0x2dc));_0x3e5bd9[_0x349e85(0x2d2)]=_0x349e85(0x49d)+(_0x4a13c6?_0x468edc[_0x349e85(0x254)]:'')+_0x349e85(0x179)+_0x50c3dc+_0x349e85(0x465)+_0x314517+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x10d07c[_0x349e85(0x212)]||_0x468edc[_0x349e85(0x453)](_0x468edc[_0x349e85(0x244)],_0x468edc['MTgRE'](_0x50c3dc,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x54a0ab[_0x349e85(0x154)](_0x3e5bd9);}),_0x58f37c['addEventListener'](_0x468edc[_0x3aa579(0x2ae)],function(_0x15e5fb){const _0x687eeb=_0x3aa579,_0x22fdaf=_0x15e5fb[_0x687eeb(0x365)][_0x687eeb(0x30c)](_0x468edc[_0x687eeb(0x175)]);if(_0x22fdaf){const _0x1aa775=_0x468edc['WqXPr'](_0x10482d,_0x22fdaf[_0x687eeb(0x3ff)](_0x468edc[_0x687eeb(0x29f)]));_0x4e8b0a(_0x1aa775);}})),_0x468edc[_0x3aa579(0x432)](saveProgress);}function processAnswer(){const _0x37bcee=_0x164193,_0x50e734={'pAAql':function(_0x32b3d8){return _0x32b3d8();},'iZqwf':'modeModal','Jocld':_0x37bcee(0x27b),'vhkSt':function(_0x4c5bf9,_0x20c280){return _0x4c5bf9===_0x20c280;},'ZhBAa':_0x37bcee(0x1fd),'PpUtP':function(_0x3cb049,_0x7c4461){return _0x3cb049===_0x7c4461;},'dvLQx':function(_0x3264d7){return _0x3264d7();},'zmciT':function(_0x1fcd3e,_0xf1f526){return _0x1fcd3e(_0xf1f526);}},_0x534c97=questionsData[currentQuestionIndex],_0x49c63f=_0x534c97['correct_choice_id'];if(_0x50e734[_0x37bcee(0x427)](selectedOption,null))return;const _0x4549a7=_0x534c97[_0x37bcee(0x27a)][selectedOption],_0x4a2ff7=_0x4549a7['id']===_0x49c63f;if(questionStates[currentQuestionIndex][_0x37bcee(0x379)]===_0x50e734[_0x37bcee(0x460)]){if(_0x50e734[_0x37bcee(0x356)](_0x37bcee(0x140),'Fxrdk'))_0x50e734['pAAql'](_0x4eaef0),_0x1e2773[_0x37bcee(0x410)](_0x50e734[_0x37bcee(0x3f7)])[_0x37bcee(0x2aa)]['display']=_0x50e734[_0x37bcee(0x202)];else{stats[_0x37bcee(0x3fa)]++,stats[_0x37bcee(0x29d)]--;if(_0x4a2ff7)stats[_0x37bcee(0x281)]++;else stats['incorrectAnswers']++;}}questionStates[currentQuestionIndex][_0x37bcee(0x379)]=_0x4a2ff7?_0x37bcee(0x298):_0x37bcee(0x497),_0x50e734[_0x37bcee(0x348)](updateStats),_0x50e734[_0x37bcee(0x35c)](showInlineFeedback,_0x4a2ff7),updateQuestionNav();}function showInlineFeedback(_0x29c991){const _0x1f64e4=_0x164193,_0x23faaa={'yLiJS':_0x1f64e4(0x190),'fInas':function(_0x49e007,_0x2bbb12){return _0x49e007===_0x2bbb12;},'inwhC':'correct','mHDly':_0x1f64e4(0x497),'OgSOY':function(_0x2fcccf,_0x1024b1){return _0x2fcccf!==_0x1024b1;},'jmFET':_0x1f64e4(0x304),'pAaxc':_0x1f64e4(0x28b),'HpXwQ':_0x1f64e4(0x18b),'JYPue':'.option-button','BxkNw':function(_0x575926){return _0x575926();}};if(_0x23faaa['OgSOY'](currentMode,_0x23faaa[_0x1f64e4(0x2b7)])&&_0x23faaa[_0x1f64e4(0x191)](currentMode,_0x23faaa[_0x1f64e4(0x263)]))return;const _0x5de002=document[_0x1f64e4(0x410)](_0x23faaa[_0x1f64e4(0x3ef)]),_0x128e91=_0x5de002[_0x1f64e4(0x14b)](_0x23faaa['JYPue']),_0x5e9570=questionsData[currentQuestionIndex],_0x4be1cf=_0x5e9570[_0x1f64e4(0x436)];let _0x278fe2=_0x5e9570[_0x1f64e4(0x27a)]['findIndex'](_0x48b25a=>_0x48b25a['id']===_0x4be1cf);_0x5de002[_0x1f64e4(0x2ba)][_0x1f64e4(0x383)](_0x1f64e4(0x346)),_0x128e91[_0x1f64e4(0x360)]((_0x1825c7,_0x194070)=>{const _0x18ed32=_0x1f64e4;_0x1825c7[_0x18ed32(0x2ba)]['remove'](_0x23faaa['yLiJS']);if(_0x23faaa[_0x18ed32(0x328)](_0x194070,_0x278fe2))_0x1825c7[_0x18ed32(0x2ba)]['add'](_0x23faaa['inwhC']);else{if(_0x194070===selectedOption&&!_0x29c991)_0x1825c7[_0x18ed32(0x2ba)]['add'](_0x23faaa[_0x18ed32(0x1ef)]);}}),_0x23faaa[_0x1f64e4(0x25e)](showSolution);}function showSolution(){const _0x875fd7=_0x164193,_0x398e38={'bmqOo':_0x875fd7(0x3e7),'RVPdS':'selected','MeQUu':function(_0x10fce4,_0x1cb7c8){return _0x10fce4===_0x1cb7c8;},'hAgPK':_0x875fd7(0x298),'crxAn':function(_0x235f94,_0x482ab0){return _0x235f94!==_0x482ab0;},'KDLHf':function(_0x24987d,_0x49bd03){return _0x24987d===_0x49bd03;},'BMjmX':function(_0x29335d,_0x58e01d){return _0x29335d!==_0x58e01d;},'ywLaV':'timed_study','JGvEC':_0x875fd7(0x43e),'kDoPj':_0x875fd7(0x170),'BTHQB':_0x875fd7(0x486),'aznJa':_0x875fd7(0x2cc),'qVaPD':'.m3u8','YrFlY':function(_0x120dc2,_0x29fe87,_0x40c53a){return _0x120dc2(_0x29fe87,_0x40c53a);},'WmyLC':_0x875fd7(0x3c1),'RkvWV':_0x875fd7(0x3e6),'WsFnj':function(_0x6f38f0,_0x49c496){return _0x6f38f0!==_0x49c496;},'DKSFF':_0x875fd7(0x14f),'yEIoS':_0x875fd7(0x178),'qYMJj':'ZXVqe','tHyGi':_0x875fd7(0x39c),'CztGF':_0x875fd7(0x1f0)};if(_0x398e38['BMjmX'](currentMode,_0x875fd7(0x304))&&currentMode!==_0x398e38[_0x875fd7(0x2be)])return;const _0x3acfb4=questionsData[currentQuestionIndex];document[_0x875fd7(0x410)](_0x398e38['JGvEC'])[_0x875fd7(0x2d2)]=_0x3acfb4['solution']||_0x398e38[_0x875fd7(0x34c)];const _0x2695eb=document[_0x875fd7(0x410)](_0x398e38['BTHQB']),_0x3463c2=document['getElementById'](_0x398e38[_0x875fd7(0x213)]),_0xdb675e=_0x3acfb4[_0x875fd7(0x3c8)];if(_0xdb675e){_0x2695eb['classList']['remove']('hidden');if(_0xdb675e[_0x875fd7(0x2f8)](_0x398e38[_0x875fd7(0x229)]))_0x398e38[_0x875fd7(0x1d0)](setupVideo,_0x3463c2,_0xdb675e);else _0x3463c2[_0x875fd7(0x2a8)]=_0xdb675e;}else{if(_0x398e38[_0x875fd7(0x41c)](_0x398e38[_0x875fd7(0x37b)],_0x875fd7(0x2a0)))return _0x12c99e[_0x875fd7(0x1a6)]()[_0x875fd7(0x1a1)](XJeEHQ['bmqOo'])['toString']()[_0x875fd7(0x235)](_0x28af50)[_0x875fd7(0x1a1)](_0x875fd7(0x3e7));else _0x2695eb[_0x875fd7(0x2ba)][_0x875fd7(0x383)](_0x875fd7(0x1f0));}const _0x546567=document[_0x875fd7(0x410)](_0x398e38[_0x875fd7(0x28a)]);_0x546567['innerHTML']='';_0x3acfb4[_0x875fd7(0x162)]&&(_0x398e38[_0x875fd7(0x39e)](_0x875fd7(0x201),_0x398e38['DKSFF'])?_0x546567[_0x875fd7(0x2d2)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x3acfb4[_0x875fd7(0x162)]+_0x875fd7(0x1cc):_0x3a6a89());_0x3acfb4['explanation_audio_hin']&&(_0x546567[_0x875fd7(0x2d2)]+=_0x875fd7(0x345)+_0x3acfb4['explanation_audio_hin']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');const _0x558035=document['getElementById'](_0x398e38[_0x875fd7(0x2f2)]);_0x558035['innerHTML']='',_0x3acfb4[_0x875fd7(0x2d0)]&&(_0x398e38[_0x875fd7(0x26a)]===_0x398e38[_0x875fd7(0x26a)]?_0x3acfb4[_0x875fd7(0x2d0)][_0x875fd7(0x360)](_0xdb2122=>{const _0x216fc4=_0x875fd7;if(_0x398e38['crxAn'](_0x216fc4(0x418),_0x216fc4(0x1b8))){if(_0xdb2122)_0x558035[_0x216fc4(0x2d2)]+=_0x216fc4(0x49c)+_0xdb2122+_0x216fc4(0x40f);}else{_0x4f20dc[_0x216fc4(0x2ba)][_0x216fc4(0x352)](_0x398e38['RVPdS']);if(_0x398e38['MeQUu'](_0x1e9596,_0x6ca2f2))_0x1ad68b[_0x216fc4(0x2ba)][_0x216fc4(0x383)](_0x398e38['hAgPK']);else{if(_0x398e38['MeQUu'](_0x2b63d3,_0x873f29)&&!_0x137735)_0x664d3b[_0x216fc4(0x2ba)][_0x216fc4(0x383)](_0x216fc4(0x497));}}}):_0x360834[_0x875fd7(0x2ba)]['toggle'](_0x398e38[_0x875fd7(0x16c)],_0x398e38[_0x875fd7(0x41c)](_0x45e2ef,_0x34331b))),document[_0x875fd7(0x410)](_0x398e38['tHyGi'])[_0x875fd7(0x2ba)][_0x875fd7(0x352)](_0x398e38[_0x875fd7(0x26f)]);}function submitQuiz(){const _0x1d3a0c=_0x164193,_0x1d4f66={'vFgDc':function(_0x357b14,_0x5651fe){return _0x357b14===_0x5651fe;},'bJcwZ':_0x1d3a0c(0x1f5),'wUqeM':function(_0x2669c9,_0x342206){return _0x2669c9===_0x342206;},'lJGtU':'correct','Echoy':function(_0x35443d,_0x52ac84){return _0x35443d(_0x52ac84);},'DWSFB':_0x1d3a0c(0x20e),'zQLqh':function(_0x3ba3cf,_0x403d89){return _0x3ba3cf-_0x403d89;},'EbmEH':_0x1d3a0c(0x1ac),'iwIsX':function(_0x5c6398,_0x42644e,_0x5a1347,_0x28ae91,_0x343812){return _0x5c6398(_0x42644e,_0x5a1347,_0x28ae91,_0x343812);}};if(timer)clearInterval(timer);if(!_0x1d4f66[_0x1d3a0c(0x181)](confirm,_0x1d4f66[_0x1d3a0c(0x2fc)]))return;isQuizCompleted=!![];let _0xbf9991=0x0,_0x5f29be=0x0;const _0x4d0196=_0x1d4f66[_0x1d3a0c(0x1ae)](Date['now'](),quizStartTime);questionsData[_0x1d3a0c(0x360)]((_0x33742a,_0x17c65d)=>{const _0x3e9929=_0x1d3a0c,_0x27f80c=questionStates[_0x17c65d];_0x27f80c['selectedAnswer']!==null&&(_0x1d4f66[_0x3e9929(0x306)](_0x1d4f66[_0x3e9929(0x3ec)],_0x1d4f66[_0x3e9929(0x3ec)])?_0x1d4f66['wUqeM'](_0x33742a[_0x3e9929(0x27a)][_0x27f80c['selectedAnswer']]['id'],_0x33742a[_0x3e9929(0x436)])?(_0xbf9991++,_0x27f80c[_0x3e9929(0x379)]=_0x1d4f66['lJGtU']):(_0x5f29be++,_0x27f80c[_0x3e9929(0x379)]='incorrect'):_0x25b43c['explanation_images'][_0x3e9929(0x360)](_0x5461c9=>{const _0x5aae64=_0x3e9929;if(_0x5461c9)_0x53bd08['innerHTML']+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x5461c9+_0x5aae64(0x40f);}));});const _0x5df813=JSON[_0x1d3a0c(0x1ab)](localStorage[_0x1d3a0c(0x37d)](_0x1d4f66[_0x1d3a0c(0x153)]))||[];_0x5df813[_0x1d3a0c(0x37a)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x1d3a0c(0x3f0)](),'totalTime':_0x4d0196,'stats':{'correct':_0xbf9991,'incorrect':_0x5f29be,'notAttempted':_0x1d4f66['zQLqh'](questionsData[_0x1d3a0c(0x204)],_0xbf9991+_0x5f29be)}}),localStorage[_0x1d3a0c(0x29b)](_0x1d4f66[_0x1d3a0c(0x153)],JSON[_0x1d3a0c(0x34e)](_0x5df813)),stats[_0x1d3a0c(0x281)]=_0xbf9991,stats['incorrectAnswers']=_0x5f29be,markQuizAsCompleted(),_0x1d4f66[_0x1d3a0c(0x2ce)](showPerformanceAnalysis,_0xbf9991,_0x5f29be,_0x1d4f66[_0x1d3a0c(0x1ae)](questionsData[_0x1d3a0c(0x204)],_0xbf9991+_0x5f29be),_0x4d0196);}function showPerformanceAnalysis(_0x20e395,_0x515824,_0x3f731a,_0x571836){const _0x377c32=_0x164193,_0x291332={'PKtmN':function(_0x449e13,_0x4a25de){return _0x449e13>_0x4a25de;},'sohur':function(_0x4772e7,_0x1e946f){return _0x4772e7+_0x1e946f;},'BSxUT':function(_0x30630d,_0x285f4a){return _0x30630d*_0x285f4a;},'lrzpY':function(_0x250761,_0x21d12c){return _0x250761/_0x21d12c;},'SXjQd':_0x377c32(0x47e),'MesLs':function(_0x3ac994,_0x12f7d8){return _0x3ac994-_0x12f7d8;},'crZEC':_0x377c32(0x3e9),'DPAhA':_0x377c32(0x2c3),'Iifmd':_0x377c32(0x2e0),'srGDO':_0x377c32(0x333),'vQvKT':_0x377c32(0x286),'lHpRa':function(_0x1edc6b,_0xff28b){return _0x1edc6b%_0xff28b;},'Aouiv':'totalTimeResult','Bpyvw':function(_0xd4e66e,_0x2a4ca1){return _0xd4e66e/_0x2a4ca1;},'fktYF':'avgTimeResult','UYiRL':_0x377c32(0x1f0)},_0x40c03e=document['getElementById'](_0x377c32(0x1de)),_0x47815b=_0x291332[_0x377c32(0x3e3)](_0x291332[_0x377c32(0x1ca)](_0x20e395,_0x515824),0x0)?Math[_0x377c32(0x150)](_0x291332[_0x377c32(0x444)](_0x291332[_0x377c32(0x404)](_0x20e395,_0x291332['sohur'](_0x20e395,_0x515824)),0x64)):0x0,_0x7b94db=_0x291332[_0x377c32(0x444)](_0x291332['BSxUT'](0x2,Math['PI']),0x41),_0x30958e=document[_0x377c32(0x410)](_0x291332['SXjQd']);_0x30958e[_0x377c32(0x2aa)]['strokeDasharray']=_0x7b94db+'\x20'+_0x7b94db,_0x30958e[_0x377c32(0x2aa)]['strokeDashoffset']=_0x291332['MesLs'](_0x7b94db,_0x291332['BSxUT'](_0x291332[_0x377c32(0x404)](_0x47815b,0x64),_0x7b94db)),document[_0x377c32(0x410)](_0x291332[_0x377c32(0x41d)])[_0x377c32(0x385)]=_0x47815b+'%',document['getElementById'](_0x291332[_0x377c32(0x17e)])[_0x377c32(0x385)]=questionsData[_0x377c32(0x204)],document[_0x377c32(0x410)](_0x291332['Iifmd'])[_0x377c32(0x385)]=_0x20e395,document[_0x377c32(0x410)](_0x291332['srGDO'])[_0x377c32(0x385)]=_0x515824,document[_0x377c32(0x410)](_0x291332[_0x377c32(0x1c5)])[_0x377c32(0x385)]=_0x3f731a;const _0x5792c0=Math[_0x377c32(0x1c3)](_0x291332[_0x377c32(0x404)](_0x571836,0xea60)),_0x11847c=Math[_0x377c32(0x1c3)](_0x291332[_0x377c32(0x376)](_0x571836,0xea60)/0x3e8);document[_0x377c32(0x410)](_0x291332[_0x377c32(0x172)])[_0x377c32(0x385)]=_0x5792c0+':'+_0x11847c[_0x377c32(0x1a6)]()[_0x377c32(0x146)](0x2,'0');const _0x1aaf39=_0x291332['lrzpY'](_0x571836,questionsData[_0x377c32(0x204)]),_0x468221=Math[_0x377c32(0x1c3)](_0x291332[_0x377c32(0x3f4)](_0x1aaf39,0xea60)),_0x455207=Math[_0x377c32(0x1c3)](_0x291332['lrzpY'](_0x291332[_0x377c32(0x376)](_0x1aaf39,0xea60),0x3e8));document[_0x377c32(0x410)](_0x291332['fktYF'])[_0x377c32(0x385)]=_0x468221+':'+_0x455207['toString']()[_0x377c32(0x146)](0x2,'0'),_0x40c03e[_0x377c32(0x2ba)]['remove'](_0x291332['UYiRL']);}function closePerformanceModal(){const _0x4d1cd6=_0x164193;document[_0x4d1cd6(0x410)](_0x4d1cd6(0x1de))[_0x4d1cd6(0x2ba)][_0x4d1cd6(0x383)](_0x4d1cd6(0x1f0));}function reviewQuestions(){const _0x4a0156=_0x164193,_0x460915={'mpoTP':function(_0x35f7f1,_0xfa582){return _0x35f7f1(_0xfa582);},'JXpIY':function(_0x30bc04,_0x5c2604){return _0x30bc04+_0x5c2604;},'wVfpn':_0x4a0156(0x3bc),'zrHAj':_0x4a0156(0x189),'ktiqX':'info','HWGiC':_0x4a0156(0x3cf),'VsHZy':_0x4a0156(0x3b7),'CPpwk':'table','nZrbN':_0x4a0156(0x42b),'ooOHR':function(_0x31590f,_0x40c761){return _0x31590f===_0x40c761;},'XNtNj':'border-gray-600','Mxkqf':'border-green-500','HYKIT':_0x4a0156(0x279),'JQWzO':_0x4a0156(0x375),'KHJrV':function(_0x53f3e3,_0x3a85f5){return _0x53f3e3===_0x3a85f5;},'SXgTb':_0x4a0156(0x497),'hcbLi':_0x4a0156(0x2dc),'pEOjO':'correct','UHiCt':_0x4a0156(0x165),'aGhqn':'gray','PiKKW':'No\x20solution\x20available.','pUqpQ':'questionReviewSection','tpFPG':_0x4a0156(0x1f0),'EJfVL':_0x4a0156(0x399),'DSvpF':function(_0x1e8da9){return _0x1e8da9();}};document['getElementById'](_0x460915['pUqpQ'])[_0x4a0156(0x2ba)][_0x4a0156(0x352)](_0x460915[_0x4a0156(0x373)]);const _0x3b9c75=document[_0x4a0156(0x410)](_0x460915[_0x4a0156(0x26d)]);_0x3b9c75['innerHTML']='',questionsData[_0x4a0156(0x360)]((_0x83017c,_0xe0314)=>{const _0x97d079=_0x4a0156,_0xb6a524={'Dehsy':function(_0x11749f,_0x3f33c7){const _0x493db4=_0x2ee7;return _0x460915[_0x493db4(0x359)](_0x11749f,_0x3f33c7);},'CYkQr':function(_0x3865a2,_0x19bd87){const _0x5c33c3=_0x2ee7;return _0x460915[_0x5c33c3(0x297)](_0x3865a2,_0x19bd87);},'WlOYM':function(_0x3df7f8,_0x2ca65e){const _0x759a8c=_0x2ee7;return _0x460915[_0x759a8c(0x297)](_0x3df7f8,_0x2ca65e);},'PtiQc':_0x460915[_0x97d079(0x319)],'VcwXM':_0x460915['zrHAj'],'LsgUG':_0x460915[_0x97d079(0x3c9)],'mTTPb':_0x460915[_0x97d079(0x166)],'MukTy':_0x460915[_0x97d079(0x488)],'LAfWp':_0x460915[_0x97d079(0x231)],'mCFzg':function(_0x16c9ce,_0x11ccb6){return _0x16c9ce<_0x11ccb6;},'LtXqp':function(_0x5dd824,_0x127b87){return _0x5dd824!==_0x127b87;},'YPIGC':_0x460915['nZrbN'],'bIRvT':function(_0x224495,_0x2e9202){return _0x460915['ooOHR'](_0x224495,_0x2e9202);},'EIgwl':_0x460915[_0x97d079(0x3c4)],'oWDuO':_0x460915[_0x97d079(0x3df)]},_0x4b55b2=questionStates[_0xe0314],_0x44c3ec=_0x83017c[_0x97d079(0x436)];let _0x1bf766=_0x460915['HYKIT'],_0x13ce8e=_0x460915[_0x97d079(0x2a7)];if(_0x4b55b2[_0x97d079(0x311)]!==null){const _0x57308d=_0x83017c[_0x97d079(0x27a)][_0x4b55b2[_0x97d079(0x311)]];_0x460915[_0x97d079(0x16e)](_0x57308d['id'],_0x44c3ec)?(_0x1bf766='correct',_0x13ce8e=_0x97d079(0x34d)):(_0x1bf766=_0x460915[_0x97d079(0x292)],_0x13ce8e='Incorrect');}const _0x52263e=document[_0x97d079(0x301)](_0x460915['hcbLi']);_0x52263e[_0x97d079(0x207)]=_0x97d079(0x3e2)+_0x1bf766;let _0x1e60f8=(_0x83017c[_0x97d079(0x27a)]||[])[_0x97d079(0x3f1)]((_0x2da132,_0x90ca0d)=>{const _0x8a500f=_0x97d079;if(_0xb6a524['LtXqp'](_0xb6a524[_0x8a500f(0x188)],'Xvdhg')){let _0x55a3f9;try{const _0x5f3f8e=PDPICx[_0x8a500f(0x16b)](_0x34b5a2,PDPICx[_0x8a500f(0x2a5)](PDPICx['WlOYM'](PDPICx[_0x8a500f(0x198)],_0x8a500f(0x30d)),');'));_0x55a3f9=_0x5f3f8e();}catch(_0x371679){_0x55a3f9=_0x103adf;}const _0x1bc8d1=_0x55a3f9['console']=_0x55a3f9[_0x8a500f(0x2b1)]||{},_0x95d672=['log',PDPICx[_0x8a500f(0x420)],PDPICx[_0x8a500f(0x386)],PDPICx['mTTPb'],PDPICx[_0x8a500f(0x341)],PDPICx[_0x8a500f(0x20a)],_0x8a500f(0x2c1)];for(let _0x399b48=0x0;PDPICx[_0x8a500f(0x19d)](_0x399b48,_0x95d672[_0x8a500f(0x204)]);_0x399b48++){const _0x34fba3=_0x4034a1['constructor']['prototype']['bind'](_0x29a289),_0x2723b2=_0x95d672[_0x399b48],_0x8d195d=_0x1bc8d1[_0x2723b2]||_0x34fba3;_0x34fba3[_0x8a500f(0x3fb)]=_0x2e773e[_0x8a500f(0x449)](_0x1f441c),_0x34fba3[_0x8a500f(0x1a6)]=_0x8d195d[_0x8a500f(0x1a6)][_0x8a500f(0x449)](_0x8d195d),_0x1bc8d1[_0x2723b2]=_0x34fba3;}}else{const _0x5dcba5=_0xb6a524[_0x8a500f(0x2ff)](_0x4b55b2['selectedAnswer'],_0x90ca0d),_0x3acd20=_0x2da132['id']===_0x44c3ec;let _0x2cfacc=_0xb6a524[_0x8a500f(0x357)];if(_0x3acd20)_0x2cfacc=_0xb6a524[_0x8a500f(0x1be)];else{if(_0x5dcba5)_0x2cfacc=_0x8a500f(0x43b);}return _0x8a500f(0x43a)+_0x2cfacc+_0x8a500f(0x14d)+String['fromCharCode'](_0xb6a524[_0x8a500f(0x2a5)](0x41,_0x90ca0d))+_0x8a500f(0x267)+_0x2da132[_0x8a500f(0x212)]+'</span></div>';}})[_0x97d079(0x40c)]('');const _0x26c663=_0x83017c[_0x97d079(0x3c8)]?_0x97d079(0x18c)+_0xe0314+_0x97d079(0x325)+_0x83017c[_0x97d079(0x3c8)]+_0x97d079(0x215):'';let _0x70c08b='';if(_0x83017c[_0x97d079(0x162)])_0x70c08b+=_0x97d079(0x2fb)+_0x83017c[_0x97d079(0x162)]+_0x97d079(0x1cc);if(_0x83017c[_0x97d079(0x47f)])_0x70c08b+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22'+_0x83017c[_0x97d079(0x47f)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x4d7b7c=(_0x83017c['explanation_images']||[])[_0x97d079(0x3f1)](_0x11028e=>_0x11028e?_0x97d079(0x49c)+_0x11028e+_0x97d079(0x40f):'')['join']('');_0x52263e[_0x97d079(0x2d2)]=_0x97d079(0x283)+(_0xe0314+0x1)+_0x97d079(0x224)+(_0x460915[_0x97d079(0x46d)](_0x1bf766,_0x460915[_0x97d079(0x177)])?_0x460915[_0x97d079(0x1d6)]:_0x1bf766===_0x97d079(0x497)?_0x97d079(0x210):_0x460915[_0x97d079(0x1a7)])+'-600\x20text-white\x22>'+_0x13ce8e+_0x97d079(0x3d6)+_0x83017c[_0x97d079(0x212)]+_0x97d079(0x19e)+_0x1e60f8+_0x97d079(0x40d)+(_0x83017c[_0x97d079(0x2ed)]||_0x460915[_0x97d079(0x423)])+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x26c663+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x70c08b+_0x97d079(0x2e6)+_0x4d7b7c+_0x97d079(0x1c9),_0x3b9c75[_0x97d079(0x154)](_0x52263e);}),_0x460915[_0x4a0156(0x141)](initializeReviewVideos);}function initializeReviewVideos(){const _0x2185e7=_0x164193,_0x238e74={'WnCJs':function(_0x20b7b9,_0x255974,_0x39198f){return _0x20b7b9(_0x255974,_0x39198f);},'ILWRu':_0x2185e7(0x41b)};document[_0x2185e7(0x14b)](_0x238e74[_0x2185e7(0x3a7)])['forEach'](_0xc50e1f=>{const _0x133ade=_0x2185e7,_0x430a54=_0xc50e1f[_0x133ade(0x182)][_0x133ade(0x2a8)];if(_0x430a54&&_0x430a54[_0x133ade(0x2f8)]('.m3u8'))_0x238e74[_0x133ade(0x374)](setupVideo,_0xc50e1f,_0x430a54);else _0x430a54&&(_0xc50e1f[_0x133ade(0x2a8)]=_0x430a54);});}function retakeQuiz(){const _0x54f042=_0x164193,_0x53b8d9={'OEpAk':function(_0x162254,_0xe2d654){return _0x162254(_0xe2d654);},'zYqjX':'Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','pXyRX':_0x54f042(0x3a1),'ZQtjr':_0x54f042(0x1e0),'TacsD':function(_0x839863){return _0x839863();}};_0x53b8d9[_0x54f042(0x246)](confirm,_0x53b8d9[_0x54f042(0x446)])&&(window['location'][_0x54f042(0x1ce)]['endsWith'](_0x53b8d9[_0x54f042(0x343)])&&localStorage['removeItem'](_0x53b8d9['ZQtjr']),_0x53b8d9[_0x54f042(0x390)](clearProgress),location[_0x54f042(0x315)]());}function loadBookmarkedQuestions(){const _0xe7ae91=_0x164193,_0xe00d95={'wZIbO':_0xe7ae91(0x1d9)},_0x2ef6d8=JSON[_0xe7ae91(0x1ab)](localStorage[_0xe7ae91(0x37d)](_0xe00d95[_0xe7ae91(0x243)]))||[];_0x2ef6d8[_0xe7ae91(0x360)](_0x1b3a8f=>{const _0x22dd36=_0xe7ae91;_0x1b3a8f[_0x22dd36(0x407)][_0x22dd36(0x2f8)](quizName[_0x22dd36(0x1c6)]()['replace'](/ /g,'-'))&&(_0x22dd36(0x23a)===_0x22dd36(0x461)?_0x1c7eae='nav-btn-marked-review':_0x1b3a8f['questionIndex']<questionsData['length']&&(questionStates[_0x1b3a8f[_0x22dd36(0x3ab)]][_0x22dd36(0x2a2)]=!![]));});}function toggleBookmark(){const _0x36b8cc=_0x164193,_0x4b03d5={'BKiyE':function(_0x22ea52,_0x5e02a3){return _0x22ea52===_0x5e02a3;},'OQgfw':_0x36b8cc(0x298),'ZOaEs':_0x36b8cc(0x497),'xTtpL':_0x36b8cc(0x1d9),'Hqvmq':function(_0x245592,_0x4e42e0){return _0x245592!==_0x4e42e0;},'rKctt':_0x36b8cc(0x274),'hqSWv':function(_0x30338a){return _0x30338a();}},_0x4c8904=!questionStates[currentQuestionIndex][_0x36b8cc(0x2a2)];questionStates[currentQuestionIndex][_0x36b8cc(0x2a2)]=_0x4c8904;let _0x4d45aa=JSON[_0x36b8cc(0x1ab)](localStorage[_0x36b8cc(0x37d)](_0x4b03d5[_0x36b8cc(0x47a)]))||[];if(_0x4c8904){if(_0x4b03d5[_0x36b8cc(0x3a2)](_0x4b03d5[_0x36b8cc(0x422)],_0x36b8cc(0x252))){const _0xa8262e={'quizName':quizName,'quizFile':window['location'][_0x36b8cc(0x1ce)][_0x36b8cc(0x308)]('/')[_0x36b8cc(0x238)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date['now']()};_0x4d45aa[_0x36b8cc(0x37a)](_0xa8262e);}else _0x4b03d5['BKiyE'](_0x1a9424[_0x36b8cc(0x27a)][_0x16da43[_0x36b8cc(0x311)]]['id'],_0x14be94['correct_choice_id'])?(_0x5419cb++,_0xf59db0[_0x36b8cc(0x379)]=_0x4b03d5[_0x36b8cc(0x43d)]):(_0x3ab4a8++,_0x5b9d96[_0x36b8cc(0x379)]=_0x4b03d5[_0x36b8cc(0x3e4)]);}else _0x4d45aa=_0x4d45aa[_0x36b8cc(0x450)](_0x357f56=>!(_0x357f56[_0x36b8cc(0x407)][_0x36b8cc(0x2f8)](quizName[_0x36b8cc(0x1c6)]()[_0x36b8cc(0x403)](/ /g,'-'))&&_0x357f56[_0x36b8cc(0x3ab)]===currentQuestionIndex));localStorage[_0x36b8cc(0x29b)](_0x4b03d5[_0x36b8cc(0x47a)],JSON[_0x36b8cc(0x34e)](_0x4d45aa)),_0x4b03d5[_0x36b8cc(0x227)](updateBookmarkButton),_0x4b03d5[_0x36b8cc(0x227)](updateQuestionNav);}function updateBookmarkButton(){const _0x17510a=_0x164193,_0x249e26={'DIFDt':'bookmarkText','nAoEq':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','itFCq':_0x17510a(0x23c),'qEHzW':_0x17510a(0x448)},_0x29b06c=document['getElementById']('bookmarkBtn'),_0x268f49=document[_0x17510a(0x410)](_0x249e26[_0x17510a(0x46f)]),_0x29aaae=questionStates[currentQuestionIndex][_0x17510a(0x2a2)];_0x29b06c[_0x17510a(0x207)]=_0x29aaae?_0x249e26[_0x17510a(0x46c)]:_0x249e26['itFCq'],_0x268f49[_0x17510a(0x385)]=_0x29aaae?_0x249e26[_0x17510a(0x322)]:_0x17510a(0x33d);}function toggleMarkForReview(){const _0x9aa8c2=_0x164193,_0x354e02={'JrFzr':function(_0x3e1e61){return _0x3e1e61();},'QVNrH':function(_0x1d9d05){return _0x1d9d05();}};questionStates[currentQuestionIndex][_0x9aa8c2(0x391)]=!questionStates[currentQuestionIndex]['markedForReview'],_0x354e02['JrFzr'](updateMarkReviewButton),_0x354e02[_0x9aa8c2(0x3d7)](updateQuestionNav);}function updateMarkReviewButton(){const _0x1e5dfd=_0x164193,_0x114b13={'yTuTA':_0x1e5dfd(0x321),'xQGzL':_0x1e5dfd(0x272),'GWMNF':_0x1e5dfd(0x3b3),'lAekt':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','KLKDr':_0x1e5dfd(0x1a4),'qpxUN':_0x1e5dfd(0x355)},_0x276c6d=document['getElementById'](_0x114b13[_0x1e5dfd(0x1fc)]),_0x5ba889=document['getElementById'](_0x114b13[_0x1e5dfd(0x2b0)]),_0x2f26ca=questionStates[currentQuestionIndex][_0x1e5dfd(0x391)];_0x276c6d[_0x1e5dfd(0x207)]=_0x2f26ca?_0x114b13[_0x1e5dfd(0x3dd)]:_0x114b13[_0x1e5dfd(0x152)],_0x5ba889[_0x1e5dfd(0x385)]=_0x2f26ca?_0x114b13[_0x1e5dfd(0x3b6)]:_0x114b13[_0x1e5dfd(0x45f)];}function previousQuestion(){const _0x127bb5=_0x164193,_0xfe60f8={'hgOvN':function(_0x337445,_0x526d61){return _0x337445===_0x526d61;},'XvKDD':function(_0x26d807,_0x504c55){return _0x26d807===_0x504c55;},'FBFeB':_0x127bb5(0x43b),'EnKWh':function(_0x3d70c4,_0x2c903f){return _0x3d70c4+_0x2c903f;},'UqlRF':function(_0x43fe10,_0x2d8823){return _0x43fe10>_0x2d8823;},'MaoQE':function(_0x318a3e,_0x87c5d1){return _0x318a3e!==_0x87c5d1;},'pZZIk':_0x127bb5(0x37e),'Fyryh':function(_0x356615,_0x3f5a64){return _0x356615-_0x3f5a64;},'lBZVq':function(_0xa28d8b){return _0xa28d8b();}};if(_0xfe60f8['UqlRF'](currentQuestionIndex,0x0)){if(_0xfe60f8[_0x127bb5(0x36a)](_0xfe60f8['pZZIk'],_0x127bb5(0x3c2)))questionStartTime&&(questionStates[currentQuestionIndex][_0x127bb5(0x3b8)]+=_0xfe60f8[_0x127bb5(0x155)](Date['now'](),questionStartTime)),currentQuestionIndex--,displayQuestion(),_0xfe60f8[_0x127bb5(0x2e9)](saveProgress);else{const _0x30287f=_0xfe60f8[_0x127bb5(0x169)](_0x6efd46[_0x127bb5(0x311)],_0x1afc08),_0x1be23d=_0xfe60f8[_0x127bb5(0x493)](_0x1cf5cd['id'],_0x16cf54);let _0x28de8c=_0x127bb5(0x447);if(_0x1be23d)_0x28de8c=_0x127bb5(0x192);else{if(_0x30287f)_0x28de8c=_0xfe60f8[_0x127bb5(0x1e1)];}return'<div\x20class=\x22p-3\x20rounded-lg\x20border\x20'+_0x28de8c+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+_0x2a8d1f[_0x127bb5(0x45d)](_0xfe60f8[_0x127bb5(0x46b)](0x41,_0x3f5513))+_0x127bb5(0x267)+_0x1a6132['text']+_0x127bb5(0x2e2);}}}function nextQuestion(){const _0x2b093f=_0x164193,_0x3909cf={'paTvi':function(_0x4bf4d5){return _0x4bf4d5();},'uxiMN':_0x2b093f(0x2d7),'meCdq':'markReviewBtn','SPDpA':'testModeReviewLegend','eZMzB':function(_0x443b57,_0x7e5ee8){return _0x443b57===_0x7e5ee8;},'jxiVu':_0x2b093f(0x44c),'HuOho':'timed_exam','nQmhz':_0x2b093f(0x168),'LqDIm':_0x2b093f(0x3ad),'aqtUg':'block','GJIoA':_0x2b093f(0x409),'HEzOa':_0x2b093f(0x367),'HuzUF':_0x2b093f(0x27b),'cHbnB':_0x2b093f(0x2d4),'zwliL':function(_0x53fc53,_0x5aa144){return _0x53fc53<_0x5aa144;},'kydVn':function(_0x1bf3e9){return _0x1bf3e9();},'iTNMX':function(_0x16cf86){return _0x16cf86();},'WlHUb':function(_0x4badb5){return _0x4badb5();},'htevR':function(_0x216660,_0x2151c6){return _0x216660-_0x2151c6;},'xZpZS':_0x2b093f(0x47c),'peMqQ':function(_0x239981,_0xef07ff){return _0x239981===_0xef07ff;},'jfGNQ':function(_0x3f21f7,_0x4f37c0){return _0x3f21f7(_0x4f37c0);},'pmFhl':_0x2b093f(0x3b0),'qbmtI':function(_0x415d25){return _0x415d25();},'eAKLY':_0x2b093f(0x23d),'lpJjQ':_0x2b093f(0x33f),'EFqWf':function(_0x1a3036,_0xe338b1){return _0x1a3036(_0xe338b1);},'bDbKS':_0x2b093f(0x3f8)};questionStartTime&&(questionStates[currentQuestionIndex][_0x2b093f(0x3b8)]+=_0x3909cf[_0x2b093f(0x234)](Date[_0x2b093f(0x3f0)](),questionStartTime));if(_0x3909cf[_0x2b093f(0x1ba)](currentQuestionIndex,questionsData[_0x2b093f(0x204)]-0x1))currentQuestionIndex++,_0x3909cf[_0x2b093f(0x477)](displayQuestion),_0x3909cf[_0x2b093f(0x1f3)](saveProgress);else{if(_0x3909cf[_0x2b093f(0x239)]===_0x2b093f(0x47c))_0x3909cf[_0x2b093f(0x470)](currentMode,_0x3909cf[_0x2b093f(0x21d)])||_0x3909cf[_0x2b093f(0x39f)](currentMode,_0x3909cf[_0x2b093f(0x245)])?_0x3909cf[_0x2b093f(0x36c)](confirm,_0x3909cf['pmFhl'])&&_0x3909cf['qbmtI'](submitQuiz):_0x3909cf[_0x2b093f(0x361)]===_0x3909cf['lpJjQ']?(_0x49b5ba[_0x193911][_0x2b093f(0x391)]=!_0x4f1e12[_0x9dcbb5][_0x2b093f(0x391)],_0x3909cf[_0x2b093f(0x149)](_0x1fa13a),_0x1488a2()):_0x3909cf[_0x2b093f(0x17c)](confirm,_0x3909cf[_0x2b093f(0x24f)])&&(currentQuestionIndex=0x0,_0x3909cf['kydVn'](displayQuestion),_0x3909cf['WlHUb'](saveProgress));else{_0x55476b=_0x47cc3b[_0x2b093f(0x3f0)]();const _0x3a91fe=_0x518bf7['getElementById'](_0x3909cf[_0x2b093f(0x3d0)]),_0x39c8d5=_0x1a839a[_0x2b093f(0x410)](_0x3909cf[_0x2b093f(0x38d)]),_0x3eef3a=_0x5869b1[_0x2b093f(0x410)](_0x3909cf[_0x2b093f(0x16d)]),_0x313e64=_0x3909cf['eZMzB'](_0x1fec7f,_0x3909cf[_0x2b093f(0x21d)])||_0x3909cf[_0x2b093f(0x470)](_0x11b19c,_0x3909cf[_0x2b093f(0x245)]);_0xf94856['getElementById'](_0x3909cf[_0x2b093f(0x2fd)])['style'][_0x2b093f(0x445)]=_0x313e64?_0x3909cf[_0x2b093f(0x440)]:_0x3909cf[_0x2b093f(0x47b)],_0xc4faa1[_0x2b093f(0x410)](_0x3909cf[_0x2b093f(0x160)])[_0x2b093f(0x2aa)][_0x2b093f(0x445)]=_0x313e64?_0x2b093f(0x3ad):_0x3909cf['aqtUg'],_0x3d7c94[_0x2b093f(0x410)](_0x3909cf[_0x2b093f(0x167)])[_0x2b093f(0x2aa)][_0x2b093f(0x445)]=_0x313e64?_0x3909cf['aqtUg']:'none',_0x351819[_0x2b093f(0x410)](_0x2b093f(0x484))['style']['display']=_0x313e64?_0x3909cf[_0x2b093f(0x47b)]:_0x3909cf[_0x2b093f(0x440)],_0x3a91fe['style'][_0x2b093f(0x445)]=_0x313e64?_0x3909cf[_0x2b093f(0x440)]:_0x3909cf[_0x2b093f(0x2bc)],_0x39c8d5['style']['display']=_0x313e64?_0x3909cf[_0x2b093f(0x2bc)]:_0x3909cf[_0x2b093f(0x440)],_0x3eef3a[_0x2b093f(0x2aa)][_0x2b093f(0x445)]=_0x313e64?_0x3909cf['HuzUF']:'none',(_0x5d26b6===_0x2b093f(0x28b)||_0x3909cf[_0x2b093f(0x470)](_0x866a00,_0x2b093f(0x27d)))&&_0x344f01[_0x2b093f(0x410)](_0x3909cf[_0x2b093f(0x354)])[_0x2b093f(0x2ba)][_0x2b093f(0x352)](_0x2b093f(0x1f0)),!_0x1e7b50(_0xa90409)&&_0x2da0ff>=0x0&&_0x3909cf[_0x2b093f(0x1ba)](_0x1cedef,_0x54f4fd['length'])&&(_0x55aac6=_0x449f7c),_0x3909cf[_0x2b093f(0x228)](_0x3290c7),_0x3909cf['iTNMX'](_0x55b0ff),_0x33f117(),_0x3909cf[_0x2b093f(0x1f3)](_0x5783f5);}}}function startTimer(){const _0x8750b9=_0x164193,_0x13dcf4={'argVP':function(_0x199087){return _0x199087();},'xPCUa':function(_0x7d336f,_0x5a531a){return _0x7d336f<=_0x5a531a;},'cZObc':function(_0x4f7fc7,_0x228a56){return _0x4f7fc7(_0x228a56);},'haRMp':'timed_exam','TCDNK':_0x8750b9(0x3e5),'DDqvz':function(_0x581649,_0x37fd9c,_0x541ddd){return _0x581649(_0x37fd9c,_0x541ddd);}};if(timer)clearInterval(timer);timeRemaining=0x78,_0x13dcf4[_0x8750b9(0x197)](updateTimerDisplay),timer=_0x13dcf4[_0x8750b9(0x2a9)](setInterval,()=>{const _0x3002a7=_0x8750b9;timeRemaining--,_0x13dcf4[_0x3002a7(0x197)](updateTimerDisplay);if(_0x13dcf4[_0x3002a7(0x424)](timeRemaining,0x0)){_0x13dcf4[_0x3002a7(0x1af)](clearInterval,timer);if(currentMode===_0x13dcf4['haRMp'])submitQuiz();else{if(_0x3002a7(0x21b)!==_0x13dcf4[_0x3002a7(0x270)])nextQuestion();else{const _0xebaf41=_0x4e7cd9[_0x3002a7(0x303)](_0x3f6150,arguments);return _0x55005f=null,_0xebaf41;}}}},0x3e8);}function updateTimerDisplay(){const _0x570727=_0x164193,_0x48cf6a={'LtTvG':function(_0x5a08b1,_0x1758b6){return _0x5a08b1/_0x1758b6;},'byDeR':function(_0x49cc9c,_0x2e72a9){return _0x49cc9c%_0x2e72a9;},'XnyjU':_0x570727(0x481),'Zupls':function(_0xb1225a,_0x209ea7){return _0xb1225a+_0x209ea7;},'eWXpq':function(_0x310c0d,_0x59d668){return _0x310c0d+_0x59d668;}},_0x4eeb68=Math['floor'](_0x48cf6a[_0x570727(0x1da)](timeRemaining,0x3c)),_0x5c2aac=_0x48cf6a[_0x570727(0x405)](timeRemaining,0x3c);document[_0x570727(0x410)](_0x48cf6a[_0x570727(0x1d1)])[_0x570727(0x385)]=_0x48cf6a[_0x570727(0x2a1)](_0x48cf6a[_0x570727(0x26b)](_0x4eeb68,':'),_0x5c2aac['toString']()[_0x570727(0x146)](0x2,'0'));}function toggleSidebar(){const _0x4e51ea=_0x164193,_0xb16ff6={'iOgnf':_0x4e51ea(0x455),'RZzmk':_0x4e51ea(0x2d1)};document['getElementById'](_0xb16ff6[_0x4e51ea(0x1e4)])[_0x4e51ea(0x2ba)][_0x4e51ea(0x1ea)](_0xb16ff6[_0x4e51ea(0x3cb)]);}document['addEventListener']('DOMContentLoaded',()=>{const _0x20f371=_0x164193,_0x2390d9={'fqbTO':function(_0x2c1720,_0x35b49b){return _0x2c1720<_0x35b49b;},'wYGxl':_0x20f371(0x3a1),'drpvz':function(_0x5b8166,_0x2a6188){return _0x5b8166===_0x2a6188;},'AmkZY':'EgUUQ','bQXJs':function(_0x3def7a){return _0x3def7a();},'Oevvo':'igDXE','shpbA':_0x20f371(0x3ad),'xtabz':_0x20f371(0x2d6),'bqYtb':_0x20f371(0x27b),'peaIE':function(_0x460f59,_0x147e2f){return _0x460f59!==_0x147e2f;},'ghICM':'SuOxf','XKpqT':function(_0x569d55){return _0x569d55();}};if(resume)_0x2390d9['drpvz'](_0x2390d9[_0x20f371(0x3de)],_0x20f371(0x464))?_0x2390d9[_0x20f371(0x2f6)](loadProgress)?_0x2390d9['drpvz'](_0x2390d9[_0x20f371(0x3a9)],'igDXE')?(document['getElementById']('modeModal')['style'][_0x20f371(0x445)]=_0x2390d9[_0x20f371(0x2c4)],_0x2390d9[_0x20f371(0x2f6)](initializeQuiz)):_0x2390d9['fqbTO'](_0x3c2f73[_0x20f371(0x3ab)],_0xba0bb3[_0x20f371(0x204)])&&(_0xd91b9d[_0x373c13[_0x20f371(0x3ab)]][_0x20f371(0x2a2)]=!![]):(_0x2390d9[_0x20f371(0x2f6)](clearProgress),document[_0x20f371(0x410)](_0x2390d9[_0x20f371(0x205)])[_0x20f371(0x2aa)][_0x20f371(0x445)]=_0x2390d9[_0x20f371(0x44f)]):(_0x230d1a[_0x20f371(0x282)][_0x20f371(0x1ce)][_0x20f371(0x3ca)](_0x2390d9[_0x20f371(0x2fe)])&&_0xc86af7[_0x20f371(0x38b)]('customQuizData'),_0x57fee1(),_0x2a1c2b[_0x20f371(0x315)]());else{if(!window[_0x20f371(0x282)][_0x20f371(0x1ce)][_0x20f371(0x3ca)](_0x20f371(0x3a1))){if(_0x2390d9[_0x20f371(0x30a)](_0x2390d9['ghICM'],'SuOxf')){if(_0x267fe7[_0x20f371(0x3c0)]()){const _0x812faf=new _0x38cd5f();_0x812faf['loadSource'](_0x27a36b),_0x812faf[_0x20f371(0x32c)](_0x3501ba);}else _0x59173b['canPlayType']('application/vnd.apple.mpegurl')&&(_0x152140[_0x20f371(0x2a8)]=_0x1a537e);}else _0x2390d9[_0x20f371(0x3d8)](clearProgress),document['getElementById'](_0x2390d9['xtabz'])[_0x20f371(0x2aa)][_0x20f371(0x445)]=_0x20f371(0x27b);}else _0x2390d9[_0x20f371(0x2f6)](initializeQuiz);}}),document[_0x164193(0x29a)](_0x164193(0x240),function(_0x4932a5){const _0x228a6b=_0x164193,_0x474799={'vrJqs':_0x228a6b(0x478),'NKGIm':_0x228a6b(0x22e),'PyxdA':_0x228a6b(0x2d6),'YHbDc':_0x228a6b(0x27b),'VdRGC':function(_0x5ad2b6,_0x17b75f){return _0x5ad2b6/_0x17b75f;},'Svesp':_0x228a6b(0x481),'DpUHu':function(_0x3df0c5,_0x2da685){return _0x3df0c5+_0x2da685;},'HjaIv':function(_0x3dc776,_0x27d44e){return _0x3dc776!==_0x27d44e;},'kyqIr':_0x228a6b(0x3ad),'OzPbG':function(_0x57e427,_0x4618ed){return _0x57e427===_0x4618ed;},'bcQgn':_0x228a6b(0x1f0),'CRGMh':function(_0x478627,_0x30b20e){return _0x478627>=_0x30b20e;},'gTGWS':function(_0x43e313,_0xa4bb37){return _0x43e313<=_0xa4bb37;},'HknEP':'cxhzi','jZNxw':function(_0x439e19,_0x23b03d){return _0x439e19-_0x23b03d;},'bTkml':function(_0x107e57,_0x166b0b){return _0x107e57(_0x166b0b);},'VGxud':_0x228a6b(0x485),'gxdtX':function(_0x15aa60,_0x448626){return _0x15aa60<_0x448626;},'rBbqp':_0x228a6b(0x482),'bmSPr':function(_0x17567c){return _0x17567c();},'MJFph':_0x228a6b(0x491),'hAjGb':function(_0x2ed4c2,_0x4e7cf0){return _0x2ed4c2===_0x4e7cf0;},'nvyqj':_0x228a6b(0x304),'BjRdI':'timed_study','oKjcE':_0x228a6b(0x3db),'iSeEm':function(_0x419516,_0x424106){return _0x419516===_0x424106;},'OJdVO':function(_0x2b17c6){return _0x2b17c6();},'VrHAz':function(_0x83a155,_0x31c238){return _0x83a155===_0x31c238;},'PkhgR':_0x228a6b(0x44c),'LGdLD':_0x228a6b(0x27d),'zRlcM':function(_0x398b7a,_0x47d9db){return _0x398b7a!==_0x47d9db;},'odbHZ':_0x228a6b(0x33b),'bOrGP':_0x228a6b(0x2f9)};if(_0x474799[_0x228a6b(0x412)](document[_0x228a6b(0x410)](_0x474799[_0x228a6b(0x28f)])['style']['display'],_0x474799[_0x228a6b(0x3c7)]))return;if(_0x474799['OzPbG'](document[_0x228a6b(0x410)]('performanceModal')['classList'][_0x228a6b(0x2b8)](_0x474799['bcQgn']),![]))return;if(_0x474799[_0x228a6b(0x347)](_0x4932a5[_0x228a6b(0x18a)],'1')&&_0x474799[_0x228a6b(0x2c7)](_0x4932a5[_0x228a6b(0x18a)],'4')){if(_0x474799[_0x228a6b(0x1d3)]===_0x474799[_0x228a6b(0x1d3)]){const _0x5da7c0=_0x474799[_0x228a6b(0x21e)](_0x474799[_0x228a6b(0x1d2)](parseInt,_0x4932a5[_0x228a6b(0x18a)]),0x1),_0x4964fb=document[_0x228a6b(0x14b)](_0x474799[_0x228a6b(0x259)]);if(_0x474799[_0x228a6b(0x247)](_0x5da7c0,_0x4964fb['length']))_0x474799[_0x228a6b(0x1d2)](selectOption,_0x5da7c0);}else{if(_0x519478)return;const _0x4c6d80=_0x1efe0e[_0x228a6b(0x1ab)](_0x426b98[_0x228a6b(0x37d)](_0x474799['vrJqs']))||{};_0x4c6d80[_0xb24d8d]={'questionStates':_0x510264,'stats':_0x1edebb,'currentQuestionIndex':_0x18a581,'currentMode':_0x51c587,'status':_0x474799[_0x228a6b(0x22a)],'lastSeen':new _0x3ab877()[_0x228a6b(0x174)]()},_0x390b91[_0x228a6b(0x29b)](_0x474799[_0x228a6b(0x3d4)],_0x3e80ca[_0x228a6b(0x34e)](_0x4c6d80));}}else{if(_0x474799[_0x228a6b(0x157)](_0x4932a5[_0x228a6b(0x18a)],_0x474799['rBbqp']))_0x474799[_0x228a6b(0x1c4)](previousQuestion);else{if(_0x474799[_0x228a6b(0x157)](_0x4932a5[_0x228a6b(0x18a)],_0x474799[_0x228a6b(0x48c)])||_0x474799[_0x228a6b(0x157)](_0x4932a5[_0x228a6b(0x18a)],'\x20'))_0x4932a5['preventDefault'](),nextQuestion();else{if(_0x474799[_0x228a6b(0x431)](_0x4932a5[_0x228a6b(0x18a)][_0x228a6b(0x1c6)](),'b')&&(currentMode===_0x474799[_0x228a6b(0x320)]||_0x474799[_0x228a6b(0x431)](currentMode,_0x474799[_0x228a6b(0x316)])))_0x474799[_0x228a6b(0x412)](_0x474799['oKjcE'],_0x228a6b(0x261))?toggleBookmark():(_0x4556a3(),_0x47628b[_0x228a6b(0x410)](_0x474799['PyxdA'])['style']['display']=_0x474799[_0x228a6b(0x186)]);else{if(_0x4932a5[_0x228a6b(0x18a)][_0x228a6b(0x1c6)]()==='m'&&(_0x474799[_0x228a6b(0x431)](currentMode,_0x228a6b(0x44c))||_0x474799[_0x228a6b(0x398)](currentMode,_0x228a6b(0x27d))))_0x474799[_0x228a6b(0x2bf)](toggleMarkForReview);else{if(_0x474799[_0x228a6b(0x431)](_0x4932a5[_0x228a6b(0x18a)]['toLowerCase'](),'s')&&(_0x474799[_0x228a6b(0x216)](currentMode,_0x474799[_0x228a6b(0x388)])||currentMode===_0x474799[_0x228a6b(0x3af)])){if(_0x474799[_0x228a6b(0x31b)](_0x474799[_0x228a6b(0x3d1)],_0x474799[_0x228a6b(0x32f)]))_0x474799[_0x228a6b(0x1c4)](submitQuiz);else{const _0x2f072f=_0x2d3907[_0x228a6b(0x1c3)](_0x474799[_0x228a6b(0x480)](_0x301906,0x3c)),_0x1bdc5f=_0x151604%0x3c;_0x509a96[_0x228a6b(0x410)](_0x474799[_0x228a6b(0x300)])['textContent']=_0x474799[_0x228a6b(0x324)](_0x474799[_0x228a6b(0x324)](_0x2f072f,':'),_0x1bdc5f[_0x228a6b(0x1a6)]()['padStart'](0x2,'0'));}}}}}}}});</script>

</body></html>